0001104659-11-034030.txt : 20110609 0001104659-11-034030.hdr.sgml : 20110609 20110609162916 ACCESSION NUMBER: 0001104659-11-034030 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20110331 FILED AS OF DATE: 20110609 DATE AS OF CHANGE: 20110609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN SCIENCE & ENGINEERING, INC. CENTRAL INDEX KEY: 0000005768 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] IRS NUMBER: 042240991 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06549 FILM NUMBER: 11903451 BUSINESS ADDRESS: STREET 1: C/O AS&E STREET 2: 829 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 9782628700 MAIL ADDRESS: STREET 1: C/O AS&E STREET 2: 829 MIDDLESEX TURNPIKE CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN SCIENCE & ENGINEERING INC DATE OF NAME CHANGE: 19920703 10-K 1 a11-14447_110k.htm 10-K

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-K

 

x       ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended March 31, 2011

 

o          TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 1-6549

 


 

AMERICAN SCIENCE AND ENGINEERING, INC.

(Exact name of registrant as specified in its charter)

 

Massachusetts

 

04-2240991

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer Identification No.)

 

829 Middlesex Turnpike,

Billerica, Massachusetts

 

01821

(Address of principal executive offices)

 

(Zip Code)

 

(978) 262-8700

(Registrant’s telephone number, including area code)

 


 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Name of each exchange on which registered

Common Stock ($.66 2/3 par value)

 

NASDAQ Stock Market

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by checkmark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act:  Yes o No x

 

Indicate by checkmark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act:  Yes o No x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes o No o

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See the definitions of “large accelerated filer, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filero

 

Accelerated filer x

 

 

 

Non-accelerated filero

 

Smaller reporting company o

(do not check if smaller reporting company)

 

 

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes o No x

 

The aggregate market value of voting stock held by non-affiliates of the registrant, computed using the closing sale price of common stock of $73.65 on September 30, 2010 was $644,895,000.

 

9,198,852 shares of registrant’s common stock were outstanding on June 1, 2011.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

The registrant intends to file a definitive Proxy Statement pursuant to Regulation 14A not later than 120 days after the registrant’s fiscal year end of March 31, 2011. Portions of such Proxy Statement are incorporated by reference in Part III.

 

 

 



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC.

FORM 10-K

FOR THE PERIOD ENDED MARCH 31, 2011

TABLE OF CONTENTS

 

 

 

Page
Number

PART I

 

 

ITEM 1.

Business

3

ITEM 1A.

Risk Factors

9

ITEM 1B.

Unresolved Staff Comments

15

ITEM 2.

Properties

15

ITEM 3.

Legal Proceedings

15

ITEM 4.

[Removed and Reserved]

15

 

 

 

PART II

 

 

ITEM 5.

Market for the Company’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

16

ITEM 6.

Selected Financial Data

18

ITEM 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

18

ITEM 7A.

Quantitative and Qualitative Disclosures about Market Risk

23

ITEM 8.

Financial Statements and Supplementary Data

24

ITEM 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

24

ITEM 9A.

Controls and Procedures

24

ITEM 9B.

Other Information

24

 

 

 

PART III

 

 

ITEM 10.

Directors, Executive Officers and Corporate Governance

25

ITEM 11.

Executive Compensation

25

ITEM 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

25

ITEM 13.

Certain Relationships and Related Transactions, and Director Independence

25

ITEM 14.

Principal Accounting Fees and Services

25

 

 

 

PART IV

 

 

ITEM 15.

Exhibits and Financial Statement Schedules

25

SIGNATURES

 

48

EXHIBIT INDEX

 

49

 

Z Backscatter, ZBV, MobileSearch, Shaped Energy®, AS&E®, Gemini, Omniview, Sentry, SmartCheck®,  Z Portal®  and all AS&E product names and AS&E logos are either registered trademarks or trademarks of American Science and Engineering, Inc. in the United States and/or other countries. Other product and company names mentioned herein may be the trademarks of their respective owners.

 

2



Table of Contents

 

CAUTIONARY STATEMENT

 

This Annual Report and the documents incorporated by reference contain forward-looking statements.  For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements.  Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “intends”, “should” and similar expressions are intended to identify forward-looking statements.  The factors discussed under “Item 1A. Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time.  We expressly disclaim any obligation to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

All references in this Annual Report to “AS&E”, the “Company”, “we”, “our” and “us” means American Science and Engineering, Inc. and its subsidiaries.

 

PART I

 

ITEM 1.  BUSINESS

 

American Science and Engineering, Inc., a Massachusetts corporation formed in 1958, develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security and other targeted markets.  AS&E provides maintenance, warranty, engineering, and training services related to these products.

 

The Company manufactures sophisticated X-ray inspection products that can be used to inspect parcels, baggage, vehicles, pallets, cargo containers, and people.  The Company sells its products throughout the world to a variety of customers, including:

 

·                  authorities responsible for port and border security;

 

·                  customs agencies;

 

·                  military organizations;

 

·                  high threat commercial and government facilities;

 

·                  aviation security agencies; and

 

·                  law enforcement agencies.

 

AS&E’s products are used by these customers to help combat terrorism, trade fraud, drug trafficking, weapons smuggling, and illegal immigration.  Our products are also used for military force protection and general facility security.

 

Beginning with the terrorist attacks on September 11, 2001 and continuing with the proliferation of global terrorism, homeland security and force protection concerns have become of paramount importance around the world. The Company believes that homeland defense, force protection and military security initiatives will continue to provide new opportunities, with additional growth in the seaports and borders, federal and military facilities, critical infrastructure and corporate security markets.

 

The Company’s objective is to distinguish itself from its competitors by offering innovative products which provide customers with superior threat detection and/or improved operating efficiencies. To achieve this objective, AS&E incorporates a variety of X-ray imaging and image processing technologies into its products.  A number of the Company’s products use our patented Z Backscatter technology applications.  Z Backscatter is a unique X-ray imaging technique that has distinct advantages for the detection of organic or low atomic number (Z) or “low Z” materials, such as plastic explosives, composite weapons and illegal drugs, even when concealed by complex backgrounds.

 

Technology

 

The Company’s X-ray imaging products utilize several technologies including traditional transmission X-ray technology, our proprietary Z Backscatter technology, high-energy transmission technology and Radioactive Threat Detection (RTD).

 

X-ray imaging devices contain these basic subsystems: X-ray sources, detectors and image formation/ processing software.  The source generates an X-ray beam that is directed at the object to be scanned (baggage, container, or similar object).  When the source X-rays encounter the object, they are either absorbed by the object, pass directly through the object, or scatter from the object.  Dense materials, typically composed of atoms having a high atomic number (Z), tend to absorb X-rays.  Materials that are less dense and that are typically composed of low Z atoms tend to scatter X-rays.  The detectors record the intensity of the transmitted or scattered X-rays.  Software is then used to interpret the signals from the detectors and to construct and display X-ray images.

 

3



Table of Contents

 

Transmission X-ray Technology:  Transmission images are created from X-rays that pass through the object that is being examined.  Medical X-ray images are a type of transmission X-ray.  In transmission imaging, the detector measures the relative intensity of the X-rays that pass directly through the object.  The degree to which X-rays are transmitted through an object is dependent upon the energy of the X-ray source and the composition and quantity of the material in the path of the X-ray beam.  Transmission X-ray images are useful for seeing “through” the object of interest.  A transmission image, however, is a shadow-gram that superimposes the X-ray transmission characteristics of all objects in the path on the beam and can therefore be difficult to interpret.

 

Z Backscatter Technology:   Many of the Company’s X-ray systems utilize Z Backscatter technology applications covered under AS&E’s patents.  The term “Backscatter” refers to those X-rays that scatter back from molecules in the object under examination back toward the X-ray source.  Z Backscatter detectors capture these scattered X-rays which are then used to create easily readable, photo-like images.

 

Many threat items are organic in nature and have correspondingly low atomic numbers.  Such items include drugs, explosives, composite weapons, and stowaways.  These items tend to scatter X-rays much more so than inorganic materials like steel and other metals.  As a result, these organic threat items tend to stand out as bright, visible objects when scanned by a Z Backscatter imaging system.

 

Z Backscatter images complement transmission images and several of the Company’s products employ both technologies.  The combination of backscatter and transmission images gives the operator more information about the contents of the baggage or container by differentiating higher Z materials, such as metals, from low-Z materials such as explosives.  In addition, the two images enable an inspector to perform a quicker and more thorough examination of the object in question.

 

Other Technologies:   Two other technologies employed by AS&E are Shaped Energy and Radioactive Threat Detection (RTD).  Shaped Energy technology is a specialized form of high energy transmission X-ray which is used in AS&E’s OmniView and MobileSearch HE (High-Energy) products.  Radioactive Threat Detection (RTD) is a technology which is used to detect radioactive materials in vehicles, simultaneously with the creation of a Z Backscatter image, and is an option on selected AS&E detection systems.

 

Products and Systems

 

The Company’s products and services can be grouped into five different areas: Cargo Inspection Systems, Z Backscatter Systems, Parcel and Personnel Screening Inspection Systems, Contract Research and Development, and Service and Support.

 

Cargo Inspection Systems: The Cargo Inspection family of systems includes non-intrusive inspection products which are primarily used for the screening of trucks, cars, cargo containers, pallets, and air cargo at locations including border crossings, seaports, military bases, airports, and cargo and transportation hubs. The Cargo Inspection systems are designed to combat trade fraud, drug trafficking, weapons smuggling, and terrorism. The Cargo Inspection systems include:

 

OmniView Gantry System:  a multi-view, relocatable high-energy cargo and vehicle inspection system.  This system combines 6 MeV high-energy transmission imaging and three Z Backscatter X-ray views for left, right and top-side imaging of cargo.  The OmniView Gantry System utilizes AS&E’s patented Shaped Energy technology to penetrate densely loaded cargo containers. Shaped Energy “shapes” the high energy spectrum to filter out non-essential radiation, making the system safe for operators and staff and reducing the need for extensive exclusion zones.  High energy 6 MeV transmission X-rays can penetrate almost 16 inches (400 mm) of steel, a capability that enables inspection of the overwhelming majority of cargo containers.   The Z Backscatter images, on the other hand, are ideal for the detection of organic or “low Z” materials including explosives, drugs, alcohol, and tobacco that transmission X-rays alone can miss. The System’s multiple Z Backscatter views of the cargo improve detection while facilitating interpretation of the X-ray image.  The OmniView Gantry System’s scanning platform operates by moving on rails over vehicles and cargo.  The system is bi-directional allowing for a throughput of approximately 25 trucks per hour.  OmniView Gantry is ideal for ports, borders, and high-threat facilities.

 

Z  Portal Systema multi-view, high throughput, drive-through inspection system capable of scanning cargo and vehicles for threats and contraband.  The Z Portal System is available in two basic configurations: a large tunnel version for screening trucks, buses, and cargo containers; and a small tunnel version for scanning passenger vehicles. The relocatable Z Portal System can be installed with one, two or three Z Backscatter X-ray modules, allowing for left, right and/or top-side imaging of the vehicle under examination.  The images produced by the Z Portal System are ideal for the detection of organic materials including explosives, drugs, alcohol, tobacco, and stowaways.  The Z Portal System is well-suited for scanning vehicles at border crossings, high threat facilities, and other vehicle entry checkpoints.

 

Z Gantry System: a multi-view Z Backscatter inspection system capable of scanning cars, vans, trucks, and their cargo for concealed threats and contraband in a gantry configuration. The relocatable Z Gantry System is configured with three Z

 

4



Table of Contents

 

Backscatter imaging modules, allowing a left, right, and top view of the vehicle under examination.  The rail-mounted Z Gantry System moves over vehicles and cargo while scanning for threats and contraband such as stowaways, explosives, drugs, and alcohol.

 

Sentry Portal System: a high-throughput drive through transmission X-ray inspection system designed to screen cargo for security threats and contraband. The Sentry Portal System enables high volume scanning while producing a transmission image able to penetrate 12 inches (300 mm) of steel, sufficient for the inspection of even densely loaded cargo containers. The system employs an advanced cargo sensing subsystem that begins scanning only after the cab has passed to maintain a safe environment for vehicle drivers.

 

MobileSearch HE (High-Energy): a mobile inspection system for scanning trucks, cargo containers, and vehicles which utilizes both high energy transmission imaging and Z Backscatter imaging for superior contraband and threat detection, along with flexible scan modules for added versatility. MobileSearch HE’s transmission imaging offers penetration of up to 12 inches (300 mm) of steel while the complementary backscatter imaging highlights organic materials for improved detection of explosives, drugs and other contraband. Together, transmission and backscatter imaging provide the most information about the contents of the cargo. The system can be used as a conventional mobile cargo scanner that drives past vehicles or containers to be scanned or in backscatter-only mode, which allows MobileSearch HE to scan oversized or oddly-shaped cargo and to scan vehicles as they are driven past the system.

 

Z Backscatter Systems:  Z Backscatter Systems include single-sided imaging systems that use Z Backscatter imaging only.

 

Z Backscatter Van (ZBV): a mobile X-ray screening system built into a commercially available chassis.  ZBV utilizes Z Backscatter X-ray technology to produce photo-like images of the contents of a vehicle or cargo container, highlighting organic materials such as plastic explosives or other anomalies. With one-sided, backscatter-only imaging, security officials can use ZBV for screening vehicles, sea containers, and other cargo for terrorist threats, trade fraud, and contraband, simply by driving past the objects.   The ZBV can be equipped with Radioactive Threat Detection (RTD) capability.  With RTD, the ZBV can produce Z Backscatter images for general screening while simultaneously scanning the object for the presence of radioactive material.  The ZBV is available on a variety of chassis in several versions.

 

ZBV Military Trailer: a rugged X-ray screening system built onto a standard 5-ton military trailer. With Z Backscatter X-ray imaging, security officials can use ZBV Military Trailer for screening vehicles, containers, and other cargo for terrorist threats and contraband — simply by towing the trailer past the subjects, or by remaining stationary while vehicles drive past the trailer.

 

Parcel and Personnel Screening Inspection Systems: Parcel Inspection systems are designed for the non-intrusive X-ray scanning of parcels, baggage, and mail. These systems are primarily located in government facilities, airports, commercial office buildings, high-security federal facilities and convention centers.

 

Personnel screening is a crucial part of any threat detection effort.  Today, threats can take the smallest of forms and are often easily hidden on a person.  With the advent of suicide bombers, personnel screening has taken on an even more important role.  Personnel screening is also important in the effort to intercept prohibited substances, such as drugs and alcohol.

 

Gemini System:  a parcel and baggage inspection system which combines AS&E’s Z Backscatter technology with dual-energy transmission X-ray to provide enhanced detection for a wide range of threats.  Dual-energy transmission is best suited for the detection of threats such as guns and knives, and for identifying wires and other components of improvised explosive devices (IEDs). Z Backscatter imaging provides enhanced detection of organic materials such as explosives and narcotics, which may be missed by transmission-only systems in cluttered baggage.  In addition, the complementary photo-like Z Backscatter image makes it easier for security officers to interpret images, thus reducing analysis time and minimizing operator fatigue. The Gemini system is offered in a range of tunnel sizes to suit a range of customer applications.

 

SmartCheck System:  a personnel screening system for the effective screening for contraband and threats hidden under a person’s clothing.  The SmartCheck system simultaneously detects both metallic and non-metallic objects, such as guns and knives, plastic explosives, liquid explosives, composite weapons, drugs and other hidden threats and contraband.  Smartcheck’s Z Backscatter image gives the operator an easy-to-read display of where the threat or contraband is hidden, thus eliminating the need for intrusive and time-consuming pat-downs and strip searches.  The SmartCheck system employs proprietary advanced image processing algorithms to enhance privacy, while maintaining a high level of threat detection.  The SmartCheck system is also available in a ruggedized container configuration called the SmartCheck Imaging Module (SIM) for deployment in harsh environments.

 

5



Table of Contents

 

Contract Research & Development:  AS&E engages in a variety of contract research and development (CRAD) programs, primarily for agencies of the U.S. government.  AS&E pursues CRAD opportunities which it believes provide avenues for advancing our core technologies or developing product offerings for strategic customers or markets.

 

Service and Support:   AS&E’s highly skilled Field Service Engineers (“FSE”) provide support services worldwide. Each FSE has a technical degree in Electrical and/or Mechanical Engineering (or equivalent experience), and is trained in the operation and repair of electronics, hydraulics, pneumatics, mechanics, electrical systems, and/or computers. FSEs are available 7 days a week, 24 hours a day, and are located at AS&E sites in Asia, Europe, the Middle East, Africa and North and South America.  In addition, Technical Support is provided at the Company’s headquarters in Billerica, Massachusetts. AS&E provides comprehensive, cost-effective spare parts customized for each system.  The Company maintains an inventory of field-replaceable components in various depots around the world in order to meet customer needs for spare parts.

 

AS&E provides comprehensive technical training on all X-ray inspection systems. Our instructors specialize in current threat detection techniques and employ both classroom theory and hands-on training to help clients become expert users of AS&E equipment. Our technical training informs customers about detection technologies and best practices through demonstrations and field activities that simulate real-life threat and contraband encounters.  Technical training is included with each system sale and additional training for service and maintenance training, and other customized training courses are provided aftermarket to interested customers.

 

Component Availability

 

Critical material and subsystems are procured from both domestic and global supply partners.  These supply sources may be single sources for certain components and the material provided can have extended lead times.  In response to expanding customer demand in the global security screening market, the Company has taken steps to mitigate sourcing risks by working closely with its suppliers to ensure future material and subsystem availability to support its production plans. In some cases, the Company has chosen to stock reserve material to ensure future availability. Efforts have also included identifying and qualifying second source suppliers for critical material and a number of key subsystems in support of its product lines. The Company currently does not expect to experience sustained difficulties in securing required material and subsystems to support its future business operations.

 

Intellectual Property

 

The Company relies on a combination of patent, copyright, trademark, and trade secret laws, and contractual provisions to protect its intellectual property.  In general, the Company pursues a policy of obtaining patent protection both in the United States and in selected foreign countries for subject matter we consider patentable and important to our business strategy.  As of March 31, 2011, the Company has in excess of 45 active patents issued by the United States Patent and Trademark Office and multiple pending applications directed to a variety of technologies.  The Company also has been granted patents or has pending applications in over 30 countries outside of the United States. A significant number of our patents have been issued in the last five years.

 

Generally, if pending on June 8, 1995, a patent issued in the United States is effective for the longer of 17 years from the date of issue or 20 years from the United States filing date of the earliest non-provisional application upon which the patent is based.  If filed after June 8, 1995, a patent is generally effective for a term of 20 years from the United States filing date of the earliest non-provisional application upon which the patent is based.  The duration of foreign patents varies in accordance with applicable local law. While the duration of our patents varies, we believe that the duration of our patents is adequate relative to the expected lives of our products.

 

The Company also has various trademarks registered and pending registration with the United States Patent and Trademark Office, as well as marks registered and pending registration in various jurisdictions around the world.  Company patents and trademarks are reviewed regularly, and those with no foreseeable commercial value are abandoned to eliminate costly maintenance fees.  The Company has ongoing research and development efforts and expects to seek additional intellectual property protection in the future.

 

Although the Company believes the ownership of such patents and trademarks, and its copyrights, is an important factor in its business and that its success depends in part on the ownership thereof, the Company also relies on the innovative skills, technical competence, and marketing abilities of its personnel for its business success.

 

In addition to patents and pending patent applications, the Company uses trade secrets and proprietary know-how in our products. Any of our know-how or trade secrets not protected by a patent could be disclosed to, or independently developed by, a competitor.

 

6



Table of Contents

 

The Company believes that its patents, proprietary technology, trade secrets, know-how, and trademarks provide substantial protection for the Company’s competitive position and the Company intends to aggressively protect its intellectual property assets, by litigation or other means, as appropriate.  We monitor the activities of other parties with respect to their use of intellectual property. In addition, we require our employees, consultants, outside collaborators, and certain distributors and suppliers to execute confidentiality and, where appropriate, non-compete agreements upon commencing employment or other relationships with us.  Nevertheless, there can be no assurances that the steps taken by the Company in this regard will be adequate to prevent misappropriation or infringement of its technology or that the Company’s competitors will not independently develop technologies that are substantially equivalent or superior to the Company’s technology.  Effective protection of intellectual property rights may be limited or unavailable in certain foreign countries.

 

Customers

 

The Company has a customer base consisting of government and commercial clients from both the United States and abroad. Domestically, the Company’s primary client base is comprised of agencies of the U.S. government. Approximately 65%, 63%, and 56%, of the Company’s total sales in the fiscal year ended March 31, 2011 (“fiscal 2011”), the fiscal year ended March 31, 2010 (“fiscal 2010”), and the fiscal year ended March 31, 2009 (“fiscal 2009”), respectively, were derived from either (i) contracting directly with the U.S. government, or (ii) contracting with contractors working directly with the U.S. government. A significant number of the Company’s contracts with the U.S. government provide the U.S. government with the standard unilateral right to terminate these contracts for convenience. In fiscal 2011 one of the Company’s contracts, in 2010 one of the Company’s contracts and in fiscal 2009 two of the Company’s contracts with the U.S. government were terminated in whole or in part for convenience by the U.S. Government.  These terminations did not result in any material losses to the Company.   The Company is heavily dependent upon sales to agencies of the U.S. government and systemic reductions or delays in procurement of the Company’s systems and services by these agencies may have a material adverse effect on the Company.

 

International sales, primarily to foreign governments, accounted for approximately 32%, 32%, and 37% of the Company’s total sales in fiscal 2011, 2010, and 2009 respectively, and continue to be a high priority for the Company as part of its long-term growth strategy. International sales often entail longer sales cycles and project financing requirements; however the Company continues to focus on these sales as a means of broadening its customer base. The Company manages its overseas risk in a number of ways, including actively pursuing multiple opportunities at a time and obtaining downpayments and letters of credit to secure its international receivables. The majority of international contracts are bid in U.S. dollars. For those contracts that are bid in other currencies, the Company considers the need to engage in hedging contracts to control foreign exchange risk, balanced against the cost of such contracts. In fiscal 2010, the Company entered into one foreign currency option contract to hedge currency risk in one region.   This hedge contract was closed in fiscal 2011 and the Company entered into no further hedges in fiscal 2011. There were no hedging activities in fiscal 2009.

 

In fiscal 2011, the Company had sales to three major customers, two of which are agencies of the U.S. government and one international customer.  These customers accounted for 30%, 12% and 11% of total sales, respectively.  In fiscal 2010, the Company had sales to two major customers, both agencies of the U.S. government, which accounted for 24% and 12% of total sales, respectively.  In fiscal 2009, the Company had sales to two major customers, one agency of the U.S. government and one international government, which accounted for 18% and 16% of total sales, respectively.  The loss of these significant customers could substantially reduce our revenues and our business and prospects could be harmed.

 

Sales Backlog

 

The Company’s sales backlog was $215,228,000, $195,729,000, and $155,349,000 at March 31, 2011, March 31, 2010, and March 31, 2009, respectively.  We define sales backlog as the value of orders for which funding is authorized, appropriated and contractually obligated by the customers, less the cumulative amount of sales recognized on such orders. We do not include negotiated contracts for which funding has not been appropriated or otherwise authorized, unexercised options or potential indefinite-delivery/ indefinite-quantity (IDIQ) orders in our backlog.

 

A significant number of the Company’s contracts with the U.S. government contain clauses permitting the government to terminate the contract for convenience or make changes to the contract, upon certain terms and conditions, including payment to the Company for work performed.    This right was exercised in fiscal 2011 by one U.S. government agency, in fiscal 2010 by one U.S. government agency and in fiscal 2009 by two U.S. government agencies.

 

Total contracts with U.S Government agencies and subcontractors in the backlog were $151,507,000, $89,610,000, and $71,545,000 at March 31, 2011, 2010 and 2009, respectively. It is estimated that approximately 74% of the 2011 backlog will be converted to revenue within the fiscal year ending March 31, 2012.

 

7



Table of Contents

 

Sales and Marketing

 

The Company’s products are marketed to corporate and governmental organizations through a sales force that contacts potential customers and responds to public tenders and other expressions of interest. This sales force includes Company personnel based in the United States and abroad, as well as independent representatives under contracts to sell in foreign countries.

 

Competition

 

The Company has many competitors in the homeland security X-ray detection market, including several large and well-established manufacturers of security equipment with financial and other resources greater than those of the Company. AS&E competes with at least five other companies, who compete using a variety of methods including price, warranty coverage, and product performance.  Certain X-ray security system customers select such systems based largely on price. Other customers, including some agencies of the U.S. government and certain users in countries with high levels of concern over security, tend to select systems based largely on detection capability.  Many of the Company’s systems offer premium performance and have in some cases been priced higher than competing systems. The Company believes that its patented and proprietary technology gives it a strong competitive position in the sale of security systems to customers concerned with performance and detection. The Company also believes that its strategy of concentrating on products with unique features, such as Z Backscatter and Radiation Threat Detection, and/or competitive pricing place it in a strong position with regard to its sales of X-ray inspection systems. However, a number of companies have developed products that compete with the Company’s X-ray inspection products. (See “Item 1A.  Risk Factors” below).

 

Research and Development

 

The Company spent approximately $22,619,000 of its own funds for research and development during fiscal 2011, compared to $19,764,000 and $18,070,000 in fiscal 2010 and 2009, respectively. The fiscal 2011 research and development efforts were focused on new product development, researching new technologies, the development of new applications, and design modifications and enhancements to existing products.

 

In addition, the Company conducted government-sponsored research primarily focused on advances in X-ray systems, image analysis and integrated system development for security inspection problems. The Company recognized revenues of $4,821,000, $2,306,000, and $12,524,000 in fiscal 2011, 2010, and 2009, respectively, for these efforts.  Many of the Company’s government sponsored research and development contracts provide for a fixed fee or a reimbursement of allowable costs plus a fixed fee. The Company’s contracts in these areas are obtained by submitting research and development proposals to various organizations, sometimes in response to requests for such proposals.  .

 

ISO 9001 Certification

 

In August 2009, the Company’s Quality Management System was recertified and upgraded to the ISO 9001:2008 Standard of the International Organization for Standardization.  American Science and Engineering has been an ISO 9001 registered company since 2000.   ISO 9001 is an internationally recognized quality management and assurance standard.  In qualifying, the Company met or exceeded the standards for establishing a quality management system for preventing non-conformity at every level of the product life cycle, from customer order, through development and production, to installation and support.  The Company believes that demonstrating continuous quality improvement is vital for building customer satisfaction and making business processes more efficient in order to enhance its competitive edge.

 

Personnel

 

As of March 31, 2011 the Company had 420 employees as compared to 395 employees at March 31, 2010.   It is the Company’s policy to have employees sign a non-compete and non-disclosure agreement as a condition of employment. None of the Company’s employees are represented by labor unions.

 

Financial Information about Foreign and Domestic Operations and Export Sales

 

Most export sales are transacted in U.S. dollars, and most are either secured by irrevocable letters of credit or paid in advance. The following table shows the breakdown of net sales and contract revenues to international and domestic customers based upon the customer’s country of domicile and the major regions of international activity. All assets are maintained within the United States with the exception of inventory depots, inventory in transit or awaiting installation and cash accounts maintained at foreign locations (approximately 1.6% of the Company’s assets at March 31, 2011).

 

8



Table of Contents

 

Net Sales and Contract Revenues

 

 

 

Fiscal Year

 

(Dollars in thousands)

 

2011

 

2010

 

2009

 

Domestic

 

$

190,769

 

68

%

$

163,873

 

68

%

$

138,240

 

63

%

International

 

87,807

 

32

%

78,220

 

32

%

80,127

 

37

%

Net Sales and Contract Revenues

 

$

278,576

 

100

%

$

242,093

 

100

%

$

218,367

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Percent of International Revenue by Major Region:

 

 

 

 

 

 

 

 

 

 

 

 

 

Middle East & Africa

 

 

 

84

%

 

 

81

%

 

 

85

%

Pacific Rim

 

 

 

7

%

 

 

8

%

 

 

7

%

Europe

 

 

 

7

%

 

 

9

%

 

 

8

%

All Other

 

 

 

2

%

 

 

2

%

 

 

%

 

Our foreign operations involve certain risks, as discussed under “Item 1A.  Risk Factors” under the risk factor entitled “We conduct our business worldwide, which exposes us to a number of difficulties in coordinating our international activities and dealing with multiple regulatory environments, as well as risks associated with geopolitical and economic instability.”

 

Available Information

 

The Company’s principal executive offices are located at 829 Middlesex Turnpike, Billerica, MA 01821; telephone number 978-262-8700; corporate website www.as-e.com. We are subject to the informational requirements of the Securities Exchange Act of 1934 (the “Exchange Act”), and, accordingly, we file reports, proxy statements, and other information with the Securities and Exchange Commission (the “SEC”).  We make available, free of charge through our website, our annual Form 10-K, current reports on Form 10-Q and Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) of the Exchange Act as soon as practicable. In addition, our reports, proxy and information statements and other information filed with the SEC are available at the SEC’s Public Reference Room at 100 F Street, NE, Room 1580, Washington, DC 20549, and are also available from the SEC’s website at www.sec.gov.  Information regarding the operation of the Public Reference Room may be obtained by calling the SEC at 1-800-SEC-0330.

 

ITEM 1A.  RISK FACTORS

 

You should carefully consider the following risk factors, in addition to other information included in this Annual Report on Form 10-K and other reports we file with the Securities and Exchange Commission.  If any of the following risks occur, our business, financial condition and operating results could be materially adversely affected.

 

Our reliance on a small number of customers for a large portion of our revenues could harm our business and prospects.  A number of contracts held by those customers may be terminated, or the scope and funding reduced, at the customer’s discretion.

 

Our business is dependent on sales to a small number of customers, which include agencies of the U.S. government.  During fiscal 2011, three customers accounted for 53% of our total revenues.  During fiscal 2010, two customers accounted for 36% of our total revenues.  We can provide no assurance that our existing customers will increase or maintain their level of demand for our products.

 

A significant number of our government contracts may be terminated at the government’s discretion. During fiscal 2011, one of our contracts with the U.S. government was terminated for convenience by the U.S. government.   During fiscal 2010, one of our contracts with the U.S. government was terminated for convenience by the U.S. government.  During fiscal 2009, two of our contracts with the U.S. government were partially terminated for convenience by the U.S. government.  Although these terminations did not result in material losses to us, future contract terminations could negatively impact our results of operations.  The termination of our relationship with one or more of our significant customers or the reduction or delay of orders of our systems by these customers would substantially reduce our revenues, and our business and prospects may be harmed.

 

Our results of operations are affected by the overall economy and governmental spending.

 

Our results of operations may be materially adversely affected by the conditions in the global economy, global political climate and the impact of those conditions on U.S. and foreign government spending. The global economic recession has caused extreme volatility and disruptions in the capital and credit markets, including a significant reduction in the availability of capital resources to many business enterprises. U.S. and foreign economies have experienced significant declines in employment, spending, household wealth and lending.  Businesses have faced, and may continue to face, weakened demand for their products and services, difficulty obtaining access to financing, increased funding costs, and barriers to expanding operations. U.S. and foreign government spending for programs involving products such as ours may be reduced or delayed, now or in the future, due to reduced tax revenues and other spending imperatives, including financial institution support and economic stimulus programs.  Economic and market conditions may continue to worsen and could negatively impact our results of operations.

 

9



Table of Contents

 

Our business is dependent upon governmental policies and appropriations.

 

Our largest customers are government agencies, in the U.S. and abroad, and demand for our products is dependent upon national priorities and governmental initiatives. These priorities and initiatives are subject to change from time to time in response to the economic and political environment.   In addition, political uprisings have created uncertainty in the continuity of certain regimes who are potential purchasers of our products and services.  We are also exposed to budget approval and appropriation decisions and processes which are driven by numerous factors, including geo-political events and macroeconomic conditions which are beyond our control. While the overall level of U.S. defense spending has increased in recent years for numerous reasons, we can give no assurance that such spending will continue to grow, or not be reduced. Significant changes in defense spending could have long-term consequences for our size and structure. In addition, changes in government priorities and requirements could impact the funding, or the timing of funding, of our programs which could negatively impact our results of operations and financial condition.  In addition, changes to political leadership in other countries can delay or curtail our results of operation.

 

Our lengthy sales cycle requires us to incur significant expenses with no assurance that we will generate revenue or recover such expenses.

 

A substantial portion of our sales depends upon the decision of governmental agencies to upgrade or expand security at border crossing inspection sites, existing airports, seaports and other facilities. Accordingly, a portion of our product sales is subject to delays associated with the lengthy approval processes that often accompany such capital expenditures. During these approval periods, we expend significant financial and managerial resources in anticipation of future orders that may not occur. If we fail to receive an order after expending these resources, we may be unable to generate sufficient revenue to recover the costs incurred and our business and prospects may be harmed.

 

We use estimates in recognizing revenues and if we make changes to estimates used in recognizing revenues, our profitability may be adversely affected.

 

Revenues for certain of our contracts are recognized using the percentage-of-completion method based on progress towards completion, which requires estimates of total costs at completion. Estimating costs at completion on our long-term contracts, particularly due to the technical nature of the services being performed, is complex and involves significant judgment. Adjustments to original estimates are often required as work progresses and additional information becomes known, even though the scope of the work required under the contract may not change. Any adjustment as a result of a change in estimate is recognized as events become known. Changes in the underlying assumptions, circumstances or estimates could result in adjustments that may adversely affect future financial results.

 

We conduct our business worldwide, which exposes us to a number of difficulties in coordinating our international activities and dealing with multiple regulatory environments, as well as risks associated with geopolitical and economic instability.

 

The continued threat of terrorist activity and other acts of war or hostility have created uncertainty in the foreign markets and have significantly increased the political, economic and social instability of some of the geographic areas in which we operate.  Acts of terrorism could create further uncertainties and instability.  To the extent this results in disruption or delays in the sale or shipments of our products, our business, operating results and financial condition could be adversely affected.  Our revenues from international customers accounted for approximately 32%, 32% and 37% of our net revenues for the fiscal years ended March 31, 2011, March 31, 2010 and March 31, 2009, respectively, and a significant number of domestic customer orders require shipments to, and services provided in, overseas locations. In addition, we transact business internationally with a number of our key suppliers. As a result of our worldwide business operations, we are subject to various risks, including:

 

· international regulatory requirements and policy changes;

 

· lengthy sales cycles;

 

· longer payment cycles by foreign customers;

 

· difficulties in inventory management, accounts receivable collection and the management of distributors or representatives;

 

· difficulties in staffing and managing foreign operations;

 

· geopolitical instability;

 

· political and economic changes and disruptions;

 

10



Table of Contents

 

· preference towards local suppliers;

 

· governmental currency controls;

 

· interruption of transportation flow for delivery of parts to us and finished goods to our customers;

 

· currency exchange rate fluctuations; and

 

· tariff regulations.

 

Although our international sales have been denominated primarily in U.S. dollars, changes in currency exchange rates that increase the relative value of the U.S. dollar may make it more difficult for us to compete with foreign manufacturers on price or otherwise have a material adverse effect on our sales and operating results.

 

Changes in governmental regulations may reduce demand for our products or increase our expenses.

 

We compete in markets in which we or our customers must comply with federal, state, local and foreign regulations, such as health and safety regulations. We develop, configure and market our products to meet our customers’ needs created by these regulations. Any significant change in these regulations could reduce demand for our products or increase our costs to comply with new regulations, both of which may adversely affect our operating results.

 

We could be prohibited from shipping our products to certain countries if we are unable to obtain U.S. government authorization regarding the export of our products, or if current or future export laws limit or otherwise restrict our business.

 

We must comply with U.S. laws regulating the export of our products. In some cases, explicit authorization from the U.S. government is needed to export our products. The export regulations and the governing policies applicable to our business are subject to change. We cannot provide assurance that such export authorizations will be available for our products in the future. If we cannot obtain required government approvals under applicable regulations, we may not be able to sell our products in certain international jurisdictions.

 

Our reliance on a limited number of suppliers for some key components and subsystems for our products could harm our business and prospects.

 

We rely on a number of suppliers to provide materials and subsystems for our products. We are reliant on a limited number of key international supply partners for core technology products, including subsystems with complex sub-tier supply chains.  In addition, certain material or subsystems used in our products may be available from a sole source or limited number of suppliers, increasing the risk of supply disruption. Although our products may be able to be redesigned to avoid using any sole source supplier, it would be expensive and time consuming to make such a change. If we change any of our suppliers, a qualification process would need to be completed and the affected product may require redesign, creating potential delays in product shipments.

 

Increases in the cost for certain commodity materials or commodity components may increase our costs of manufacturing and transporting products and may result in lower operating margins if we are unable to find ways to mitigate these increased costs.

 

Some of our suppliers may allocate material due to market demand for the products they produce or market constraints such as the global availability of raw materials. We have no guaranteed supply arrangements with our suppliers and there can be no assurance that our suppliers will continue to meet our requirements. Many of our competitors are much larger and may be able to obtain priority allocations from these shared suppliers, thereby limiting or making our sources of supply unreliable for these critical materials. There is also the possibility that a key single source supplier may be acquired by or form a strategic alignment with a competitor, which could impact our ability to secure required materials.  If our supply of materials is disrupted, we cannot ensure that we would be able to find another supplier on a timely basis.

 

We depend on our subcontractors and suppliers to deliver material that is in full compliance with critical quality and specification requirements. Quality issues may affect the reliability and performance of our products, customer confidence, and adversely impact financial performance. Any difficulty in obtaining sufficient and timely delivery of conforming material could result in delays or reductions in product shipments that could materially and adversely affect our business, financial condition and consolidated results of operations. This in turn could also damage our reputation in the market and cause us to lose market share. We do not expect to experience sustained difficulties in securing required material and subsystems to support forward business operations.

 

11



Table of Contents

 

Fluctuations in our operating results and unanticipated contract terminations may cause our stock price to fluctuate.

 

Given the nature of the markets in which we participate, and given the right of key customers to terminate contracts at their discretion or otherwise reduce the scope of contracts, we cannot reliably predict future revenue and profitability. A high proportion of our costs are fixed, due in part to our significant sales, research and development, and manufacturing costs. As a result of our fixed costs, declines in revenue could disproportionately affect our operating results and stock price at any time. Factors that may affect our quarterly operating results and the market price of our common stock include:

 

· demand for and market acceptance of our X-ray inspection systems;

 

· lengthy sales cycles and the effect of large orders;

 

· termination of contracts and contractual awards at the customer’s convenience;

 

· changes in political agendas or national priorities;

 

· adverse changes in the level of economic activity in regions in which we do business;

 

· political unrest in the regions where we transact business;

 

· adverse changes in industries on which we are particularly dependent;

 

· competitive pressures resulting in lower selling prices for our products;

 

· delays or problems in the introduction of new products;

 

· our competitors’ announcement or introduction of new products, services or technological innovations;

 

· variations in our product mix;

 

· the timing and amount of our expenditures in anticipation of future sales;

 

· increased costs of raw materials or supplies; and

 

· changes in the volume or timing of product orders.

 

We could incur substantial costs as a result of liability claims and adverse publicity if our X-ray inspection systems fail to detect bombs, explosives, weapons, contraband or other threats to personal safety.

 

If our X-ray inspection systems fail to detect the presence of bombs, explosives, weapons, contraband or other threats to personal safety, we could be subject to product and other liability claims and negative publicity, which could result in increased costs, reduced sales, and a decline in the market price of our common stock. There are many factors beyond our control that could result in the failure of our products to detect the presence of bombs, explosives, weapons, contraband or other threats to personal safety. Examples of these factors include operator error or misuse of or malfunction of our equipment. The failure of our systems to detect the presence of these dangerous materials may lead to personal injury, loss of life, and extensive property damage and may result in potential claims against us.

 

Our insurance may be insufficient to protect us from product liability claims.

 

Our product liability and umbrella liability insurance may be insufficient to protect us in the event of product liability claims. Moreover, there is a risk that product liability insurance will not continue to be available to us at a reasonable cost, if at all. If liability claims exceed our current or available insurance coverage, our business and prospects may be harmed. Regardless of the adequacy of our product liability insurance protection, any significant claim may have an adverse affect on our industry and market reputation, leading to a substantial decrease in demand for our products and reduced revenues.

 

We may not be able to fund our research and development activities.

 

We generate funds for our research and development activities from operations, private sources and the government. We may be unable to generate the funds necessary to support our research and development activities if we do not generate sufficient funds from operations, other potential private sources, or the government. We may not successfully compete with other companies and research institutions for government funding and funding from other private sources. Additionally, government-funding priorities are subject to frequent changes. For example, in fiscal 2011, 2010, and 2009, we recorded $4,821,000,

 

12



Table of Contents

 

$2,306,000, and $12,524,000, respectively, for government-sponsored research and development. There is no guarantee that we will receive funds for government-sponsored research in the future. If we are unable to fund our research and development activities through our operations or from outside sources, we may be unable to continue to innovate or bring our innovations to market on a timely or cost effective basis, or our innovations may be surpassed by other competitors or new technologies.

 

Our success depends on new product development.

 

Our continuing research and development program is designed to develop new products and to enhance and improve our current products. We plan to expend significant resources on the development of our new products. The successful development of our products and product enhancements is subject to numerous risks, both known and unknown, including:

 

· unanticipated delays;

 

· access to capital;

 

· budget overruns;

 

· technical problems; and

 

· other difficulties that could result in the abandonment or substantial change in the design, development and commercialization of new products and product enhancements, including for example, changes requested or required by governmental and regulatory agencies.

 

Given the uncertainties inherent with product development and introduction of X-ray inspection systems, we cannot assure that our product development efforts will be successful on a timely basis or within budget, if at all. Our failure to develop new products and product enhancements on a timely basis or within budget would harm our business and prospects.

 

Our success depends upon our ability to adapt to rapid changes in technology and customer requirements.

 

The market for our products has been characterized by rapid technological changes, frequent product introductions and evolving industry standards and customer requirements. We believe that these trends are expected to continue into the foreseeable future. Our success will depend, in part, upon our ability to enhance our existing products, successfully develop new products that meet changing customer and regulatory requirements and gain market acceptance. If we fail to do so, our products may be rendered obsolete or noncompetitive by new industry standards or changing technology, in which case our revenue and operating results would suffer. In developing any new product, we may be required to make a substantial investment before we can determine the commercial viability of the new product. If we fail to accurately foresee our customers’ needs and future activities, we may invest heavily in research and development of products that do not lead to significant revenue.

 

We may not be able to compete successfully.

 

A number of companies have developed products that compete with our X-ray inspection products. Many of our competitors are larger and have greater financial resources. Some of our competitors have more extensive research, marketing and manufacturing capabilities and greater technical and personnel resources, and may be better positioned to continue to improve their technology in order to compete in an evolving industry. Our failure to compete successfully could decrease demand for our products or make our products obsolete.

 

In the inspection systems market, competition is based primarily on the following factors:

 

· product performance, functionality and quality;

 

· price;

 

· the overall cost of ownership of the system;

 

· prior customer relationships;

 

· technological capabilities of the product;

 

· certification by government authorities;

 

· local market presence; and

 

· breadth of the sales and service organization.

 

13



Table of Contents

 

To remain competitive, we must develop new products and periodically enhance our existing products in a timely manner. We recognize that we may have to adjust the prices of some of our products to stay competitive. In addition, new competitors may emerge, and entire product lines may be threatened by new technologies or market trends that reduce the value of these product lines.

 

Our business could be harmed if we are unable to protect our intellectual property.

 

We rely on a combination of trade secrets, patents, trademarks, copyrights and confidentiality procedures to protect our technology. Despite our efforts, the steps we have taken to protect our technology may be inadequate. Existing trade secret, patent, trademark and copyright laws offer only limited protection. Our patents could be invalidated or circumvented.  In addition, others may develop substantially equivalent or superseding proprietary technology, or competitors may offer equivalent products in competition with our products, thereby substantially reducing the value of our proprietary rights. The laws of some foreign countries in which our products are or may be manufactured or sold may not protect our products or intellectual property rights to the same extent as do the laws of the United States. We cannot assure that the steps we have taken to protect our intellectual property will be adequate to prevent misappropriation of our technology. Our inability to protect our intellectual property could have a negative impact on our operations and financial results.

 

Our business may be materially and adversely affected by infringement claims initiated by us or our competitors.

 

Initiating or defending against the enforcement of our intellectual property rights may result in significant, protracted, and costly litigation. We have previously been involved in various litigations involving our intellectual property and have been successful in protecting such interests to date. We expect intellectual property disputes to be an ordinary part of our business for the foreseeable future. We may initiate claims or litigation against third parties for infringement of our intellectual property rights, or to establish the validity of our property rights. There can be no assurance that we will prevail in any such action. Litigation by or against us could result in significant expense and divert the efforts of technical and management personnel, whether or not such litigation results in a favorable outcome for us. In the event of an adverse result in any such litigation, we could be required to pay substantial damages, cease the manufacture, use and sale of infringing products, expend significant resources to develop non-infringing technology, discontinue the use of certain processes, or obtain licenses for the infringing technology. If a license were required, we cannot assure that we would be able to obtain one on commercially reasonable terms, if at all. We cannot assure that we will be successful in developing non-infringing technology or that the cost or time required to develop such technology will be reasonable.

 

We rely significantly on information technology and any failure, inadequacy, interruption or security lapse of that technology could harm our ability to effectively operate our business.

 

Our ability to effectively manage and maintain our inventory and internal reports, and to ship products to customers and invoice them on a timely basis depends significantly on our enterprise resource planning, production management, and other information systems. The failure of these systems to operate effectively or to integrate with other systems, or a breach in security of these systems could cause delays in product fulfillment and reduced efficiency of our operations, and it could require significant capital investments to remediate any such failure, problem or breach.

 

Our success depends on our ability to attract and retain qualified management professionals.

 

Our future success depends in large measure upon the continued contributions of our senior management team and other key personnel.  We cannot guarantee that we will be able to attract and retain key personnel or executive management in sufficient numbers, with the requisite skills or on acceptable terms necessary or advisable to support our continued growth.  If we lose professionals or are unable to attract new talent, we will not be able to maintain our position in the market or grow our business.

 

Existing external financing may not be available in the future.

 

We may require additional capital to finance continuing operations. We cannot assure that operations will continue to be profitable, that we will generate levels of revenues and cash flows sufficient to fund operations, or, if necessary, that we will be able to obtain additional financing on satisfactory terms, if at all. Any existing financing arrangements may not be available or sufficient to meet our cash needs or may not be available in the future, or, if available, at a cost that we believe is reasonable.

 

Future sales of our common stock by existing stockholders could depress the market price of our common stock.

 

Substantially all of our outstanding shares of common stock are freely tradable without restriction or further registration. Affiliates must sell all shares they own in compliance with the volume and other requirements of Rule 144. Nevertheless, sales of

 

14



Table of Contents

 

substantial amounts of common stock by our stockholders, or even the potential for such sales, may cause the market price of our common stock to decline and could impair our ability to raise capital through the sale of our equity securities.

 

The volatility of our stock price could adversely affect an investment in our common stock.

 

The market price of our common stock has been, and may continue to be, highly volatile. We believe that a variety of factors could cause the price of our common stock to fluctuate, perhaps substantially, including:

 

· announcements of developments related to our business;

 

· quarterly fluctuations in our actual or anticipated operating results and order levels;

 

· general conditions in the worldwide economy;

 

· announcements of technological innovations;

 

· new products or product enhancements by us or our competitors;

 

· developments in patents or other intellectual property rights and litigation; and

 

· developments in our relationships with our customers and suppliers.

 

In recent years the stock market in general, and the markets for shares of small capitalization and “high-tech” companies, have experienced extreme price fluctuations which have often been unrelated to the operating performance of affected companies. Any such fluctuations in the future could adversely affect the market price of our common stock.

 

Provisions in our articles of organization and our shareholder rights plan may have the effect of discouraging advantageous offers for our business or common stock, and limit the price that investors might be willing to pay in the future for shares of our common stock.

 

Provisions in our articles of organization and our shareholder rights plan may have the effect of discouraging or preventing a change in control. These provisions could limit the price that acquirers might be willing to pay in the future for shares of our common stock. Specifically, our articles of organization authorize our Board of Directors to issue up to 100,000 shares of preferred stock in one or more series, to fix certain rights, preferences, privileges and restrictions granted to or imposed upon any wholly unissued shares of preferred stock, to fix the number of shares constituting any such series, and to fix the designation of any such series, without further vote or action by our shareholders. The terms of any series of preferred stock, which may include priority claims to assets and dividends and special voting rights, could adversely affect the rights of the holders of common stock and thereby reduce the value of our common stock. We have no present plans to issue shares of preferred stock. We have in place a shareholder rights plan, which was renewed in April of 2008, under which our stockholders are entitled to purchase shares of our preferred stock under certain circumstances. These circumstances include the purchase of 15% or more of the outstanding shares of common stock by a person or group, or the announcement of a tender or exchange offer to acquire 15% or more of the outstanding common stock.

 

ITEM 1B.  UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 2. PROPERTIES

 

The Company leases an 186,000 square foot facility located in Billerica, Massachusetts which is owned by an unaffiliated real estate limited partnership and serves as the Company’s executive offices, research, manufacturing and warehouse facilities.  The lease expires on February 29, 2016. The Company believes that its facilities are adequate and provide sufficient production capacity for its present intended purposes. The Company’s facilities are currently utilized primarily on a one-shift basis. The Company is able to add additional capacity by adding second and third shifts if necessary.

 

ITEM 3.  LEGAL PROCEEDINGS

 

None.

 

ITEM 4. [REMOVED AND RESERVED]

 

15



Table of Contents

 

PART II

 

ITEM 5. MARKET FOR THE COMPANY’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

Our common stock is traded on the NASDAQ Global Select Market under the symbol ASEI. The market price range for the common stock for the last two fiscal years as reported on the NASDAQ Global Market is as follows:

 

Fiscal Year

 

Quarter Ended

 

High

 

Low

 

2011

 

March 31, 2011

 

$

94.90

 

$

83.29

 

 

 

December 31, 2010

 

$

87.42

 

$

72.43

 

 

 

September 30, 2010

 

$

80.95

 

$

69.73

 

 

 

June 30, 2010

 

$

81.00

 

$

66.29

 

2010

 

March 31, 2010

 

$

84.49

 

$

72.81

 

 

 

December 31, 2009

 

$

81.59

 

$

63.01

 

 

 

September 30, 2009

 

$

71.29

 

$

60.00

 

 

 

June 30, 2009

 

$

69.99

 

$

53.66

 

 

Holders

 

As of June 1, 2011, there were approximately 564 holders of record of the Company’s common stock.

 

Common Stock Dividends

 

In May of 2007, the Company began declaring quarterly cash dividends for its common stock shareholders.   Common stock cash dividends declared during the fiscal years ended March 31, 2011 and March 31, 2010 were as follows:

 

Date Declared

 

Dividend per common
share

 

May 11, 2010

 

$

0.30

 

August 9, 2010

 

0.30

 

November 9, 2010

 

0.30

 

February 8, 2011

 

0.30

 

Fiscal year ended March 31, 2011

 

$

1.20

 

 

 

 

 

May 13, 2009

 

$

0.20

 

August 6, 2009

 

0.20

 

November 5, 2009

 

0.20

 

February 9, 2010

 

0.30

 

Fiscal year ended March 31, 2010

 

$

0.90

 

 

On May 9, 2011, the Company declared another quarterly dividend of $0.30 for holders of record on May 23, 2011 to be paid June 2, 2011.  Future dividend payments will depend on our earnings, capital requirements, financial condition and capital needs and other factors considered relevant by our Board of Directors.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

The following table provides information about the Company’s equity compensation plans and the common stock that may be issued upon the exercise of options and rights under all existing equity compensation plans as of March 31, 2011.

 

16



Table of Contents

 

Plan Category

 

Number of securities to
be issued upon exercise
of outstanding options
and rights as of
March 31, 2011
(a)

 

Weighted average
exercise price of
outstanding options
and rights
(b)

 

Number of securities
remaining available for
future issuance under
equity compensation
plans as of March 31,
2011 (excluding securities
reflected in column (a))
(c)

 

1995 Combination Plan

 

500

 

$

13.08

 

 

1999 Combination Plan

 

12,417

 

14.76

 

 

2000 Combination Plan

 

12,000

 

37.91

 

 

2002 Combination Plan

 

52,021

 

29.80

 

1,300

(1)

2003 Stock Plan for Non-Employee Directors

 

45,000

 

66.45

 

 

2005 Equity and Incentive Plan

 

329,669

 

61.55

 

300,432

(2)

Equity compensation plans not approved by security holders:

 

 

 

 

 

 

 

1997 Non-Qualified Option Plan

 

3,000

 

39.06

 

 

1998 Non-Qualified Option Plan

 

17,839

 

42.39

 

 

Total

 

472,446

 

$

55.77

 

301,732

 

 


(1)

Shares under the 2002 Combination Plan may be issued in the form of incentive stock options or non-qualified stock options.

(2)

Shares under the 2005 Equity and Incentive Plan may be issued in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock and restricted stock units.

 

Purchases of Equity Securities

 

On May 13, 2008, the Board of Directors approved a Stock Repurchase Program which authorized the Company to repurchase up to $35 million in shares of its common stock from time to time on the open market. As of March 31, 2011, the remaining balance available under the program to purchase shares was $20,068,000.  The Company made no repurchases of equity securities in the quarter ended March 31, 2011.

 

Stock Performance Graph

 

The following chart graphs the performance of the cumulative total return to shareholders (stock price appreciation plus dividends, if applicable) during the previous five years in comparison to the returns of the Standard & Poor’s 500 Composite Stock Price Index (“S&P500”) and the S&P SmallCap 600 Index.  The S&P SmallCap 600 Index is a published index which measures the performance of small-cap companies which meet certain financial metrics.  The Company was added to the S&P SmallCap 600 Index in January of 2009.

 

 

Note:

Assumes $100 invested at the close of trading on the last trading day preceding the first day of the fifth preceding fiscal year (and reinvestment of dividends) in the Company’s common stock, Standard & Poor’s 500 Composite Stock Price Index, and the S&P SmallCap 600 Index.

 

The information included under the heading “Stock Performance Graph” in Item 5 of this Annual Report on Form 10-K is “furnished” and not “filed” and shall not be deemed to be “soliciting material” or subject to Regulation 14A, shall not be deemed

 

17



Table of Contents

 

“filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

ITEM 6. SELECTED FINANCIAL DATA

 

The following selected financial data is qualified by reference to, and should be read in conjunction with, the consolidated financial statements, including the notes thereto, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this Annual Report.  The results below are not necessarily indicative of the results to be expected for any future periods.

 

(Dollars in thousands,

 

Fiscal Year

 

except per share amounts)

 

2011

 

2010

 

2009

 

2008

 

2007

 

Net sales and contract revenues

 

$

278,576

 

$

242,093

 

$

218,367

 

$

166,733

 

$

153,186

 

Net income

 

$

42,817

 

$

36,176

 

$

28,353

 

$

17,478

 

$

24,610

 

Income per share—diluted

 

$

4.63

 

$

3.97

 

$

3.18

 

$

1.87

 

$

2.38

 

Total assets

 

$

336,574

 

$

299,853

 

$

268,287

 

$

235,534

 

$

221,725

 

Long-term obligations

 

$

9,069

 

$

14,380

 

$

13,125

 

$

13,298

 

$

14,610

 

Stockholders’ equity

 

$

266,080

 

$

221,768

 

$

182,066

 

$

166,072

 

$

167,698

 

Dividends per common share

 

$

1.20

 

$

0.90

 

$

0.80

 

$

0.60

 

$

 

 

ITEM 7.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our consolidated financial statements and notes thereto which appear elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements and should also be read in conjunction with the “Cautionary Statement” included at the beginning of this Annual Report on Form 10-K.

 

Overview     American Science and Engineering, Inc. develops and manufactures state-of-the-art X-ray inspection systems for homeland security, force protection, and other critical defense applications.   We provide maintenance, warranty, engineering, and training services related to these products.

 

Our primary technologies are Z Backscatter technology which is used to detect explosives, illegal drugs, and other contraband even when artfully concealed in complex backgrounds; and other technologies that expand the detection capability of our products beyond the material discrimination features of the Z Backscatter technology to include the penetration capability of high-energy transmission X-rays for dense cargos and/or other detection techniques, such as radioactive threat detection.

 

Net sales and contract revenues for fiscal 2011 increased by 15% to $278,576,000 compared to fiscal 2010 revenues of $242,093,000. We reported income before taxes of $64,875,000 in fiscal 2011 compared to an income before taxes of $54,846,000 in the previous fiscal year. Net income for fiscal 2011 was $42,817,000 ($4.63 per share, on a diluted basis) as compared to a net income of $36,176,000 ($3.97 per share, on a diluted basis) in fiscal 2010. Backlog at March 31, 2011 was $215,228,000, a 10% increase from the year-end backlog of $195,729,000 reported at March 31, 2010.

 

2011 Compared to 2010

 

Results of Operations    Total net sales and contract revenues of $278,576,000 in fiscal 2011 increased by $36,483,000 or 15% from the previous year. Revenues related to product sales and contracts increased by $27,108,000 or 16% due to the following factors.  Z Backscatter system revenues increased by $18,744,000, attributable to sales of both our ZBV Militarized Trailer system, which was introduced in fiscal 2009, and our Z Backscatter Van, which had an increase in number of units sold during the year to U.S. government and international customers.  Parcel Inspection system sales increased by $7,520,000 from the prior year due to an increase in the number of units delivered in the current year.  Cargo Inspection system revenues increased by $3,095,000 over the previous year as the volume of systems under construction and/or delivered increased over the previous year.  Contract research and development (CRAD) revenues increased by $2,515,000, which was attributable primarily to two contracts worked during the year.  These revenue increases were offset by a decrease in aftermarket sales of $4,764,000 due to a large spare parts order fulfilled in fiscal 2010 which was not repeated in fiscal 2011.  Service revenues increased in fiscal 2011 by $9,375,000 or 12% to $85,758,000, due primarily to new service contracts entered into in the current year on the increased installed base.

 

In both fiscal 2011 and fiscal 2010, 68% of our revenues were from domestic (based upon the customer’s country of domicile) customers. In fiscal 2011, we had sales to three customers which accounted for 53% of total sales.  In fiscal 2010, we had sales to two customers which accounted for 36% of total sales.

 

18



Table of Contents

 

Cost of sales and contracts of $149,374,000 in fiscal 2011 increased by $18,351,000 or 14% from the previous year. Cost of product sales and contracts of $104,062,000 in fiscal 2011 increased by $12,508,000 or 14% as compared to the prior year. Cost of product sales and contracts totaled 54% of revenues in fiscal 2011, as compared to 55% of revenues in fiscal 2010. This decrease in costs as a percentage of revenue is due primarily to an increase in shipments of higher margin Z Backscatter systems over the prior year and improved margins on both Cargo and Parcel Inspection systems as a result of increased volume.   The cost of service revenues increased $5,843,000 or 15% from the prior year. Cost of service revenues totaled 53% of revenues in fiscal 2011 as compared to 52% of revenues in fiscal 2010.  This increase in costs as a percentage of revenue is due primarily to increased material and travel-related costs being incurred to service equipment under fixed price service contracts as compared to the prior year.

 

Selling, general and administrative expenses in fiscal 2011 increased by $5,157,000 to $42,139,000 as compared to fiscal 2010 and represented 15% of revenues in both fiscal 2011 and fiscal 2010. The increase in selling, general and administrative expenses over the prior period was primarily the result of:  1) an increase in payroll and payroll related costs of $2,430,000 attributable to increased headcount;  2) an increase in legal fees of $876,000  attributable primarily to due diligence activities on a potential acquisition that was abandoned earlier in the year and other routine business activities;  3) an increase in incentive compensation costs of $761,000 as we achieved certain incentive compensation goals in the current year;  4) an increase in travel expenses of $644,000 related to sales and marketing related efforts; and 5) an increase in marketing costs of $456,000 related primarily to trade show and demonstration related costs.

 

Company-funded research and development spending increased by $2,855,000 to $22,619,000 in fiscal 2011 which is a 14% increase as compared to the $19,764,000 spent in fiscal 2010.  Research and development spending represented 8% of revenues in both fiscal 2011 and fiscal 2010. The fiscal 2011 research and development efforts were focused on new product development, new technologies,  the development of new applications, and design modifications and enhancements to existing products.

 

Other income was $431,000 in income in fiscal 2011 as compared to $522,000 in income in fiscal 2010.

 

We reported pre-tax income of $64,875,000 in fiscal 2011 as compared to a pre-tax income of $54,846,000 in the previous fiscal year primarily due to the items noted above. We recorded income tax expense of $22,058,000 in fiscal 2011 as compared to $18,670,000 in the prior fiscal year.  Our effective tax rate was 34.0% in both fiscal 2011 and in fiscal 2010, as decreases in fiscal 2011 state income tax credits were offset by increased usage of manufacturing and research and development credits.

 

We reported net income of $42,817,000 in fiscal 2011 as compared to net income of $36,176,000 in fiscal 2010.

 

2010 Compared to 2009

 

Results of Operations    Total net sales and contract revenues of $242,093,000 in fiscal 2010 increased by $23,726,000 or 11% from the previous year. Revenues related to product sales and contracts increased by $22,779,000 or 16% due to the following factors.  Cargo Inspection system revenues increased by $17,279,000 over the previous year as the volume of system installation and acceptances increased over the previous year.  The number of customers receiving Cargo Inspection systems in fiscal 2010 also increased as the client base for these products expanded on increased orders.  Z Backscatter system revenues increased by $15,679,000, attributable to sales of our ZBV Militarized Trailer system introduced in fiscal 2009 and an increase in number of units sold to both international customers and to the U.S. government and the Department of Defense.  These revenue increases were offset by a decrease in contract research and development (CRAD) revenues of $9,925,000 as one large CRAD contract terminated in the fourth quarter of the fiscal 2009.  Parcel Inspection system sales decreased $936,000 from fiscal 2009 due to a decrease in the number of units delivered in fiscal 2010.  Service revenues increased in fiscal 2010 by $947,000 or 1% to $76,383,000 due primarily to new service contracts entered into in fiscal 2010 on the increased installed base.

 

In fiscal 2010, 68% of our revenues were from domestic (based upon the customer’s country of domicile) customers as compared to 63% in fiscal 2009. In fiscal 2010, we had sales to two customers which accounted for 36% of total sales.  In fiscal 2009, we had sales to two customers which accounted for 34% of total sales.

 

Cost of sales and contracts of $131,023,000 in fiscal 2010 increased by $5,621,000 or 4% from the previous year. Cost of product sales and contracts of $91,554,000 increased by $8,480,000 or 10% as compared to the prior year. Cost of product sales and contracts totaled 55% of revenues in fiscal 2010 as compared to 58% of revenues in fiscal 2009. This decrease in costs as a percentage of revenue is due primarily to an increase in shipments of higher margin Z Backscatter systems over the prior year and improved margins on Cargo Inspection system projects with higher per unit revenues and decreased per unit costs as we overcame the learning curve and streamlined the production of the new products introduced in the past two years.   The cost of service revenues decreased $2,859,000 or 7% from the prior year. Cost of service revenues totaled 52% of revenues in fiscal 2010 as compared to 56% of revenues in fiscal 2009.  This decrease in costs as a percentage of revenue is due primarily to improved performance of units under contract resulting in reduced replacement material costs from the prior year.

 

19



Table of Contents

 

Selling, general and administrative expenses in fiscal 2010 increased by $4,111,000 to $36,982,000 as compared to fiscal 2009 and represented 15% of revenues in both fiscal 2010 and fiscal 2009. This increase in spending can be attributed to increased incentive compensation costs ($2,100,000) as we achieved certain incentive compensation goals in fiscal 2010, increased payroll and payroll related costs ($867,000) due to increased headcount, increased marketing and bid and proposal related costs ($985,000) and increased consulting costs ($433,000) as we utilized additional marketing consultants in fiscal 2010.  These expenses were offset in part by a decrease in legal fees ($509,000) due to the settlement in fiscal 2010 of some patent litigation, and a decrease in accounting fees ($181,000) as we reduced certain outsourced accounting and compliance activities.

 

Company-funded research and development spending increased by $1,694,000 to $19,764,000 in fiscal 2010 which is a 9% increase as compared to the $18,070,000 spent in fiscal 2009.  Research and development spending represented 8% of revenues in both fiscal 2010 and fiscal 2009. The fiscal 2010 research and development efforts were focused on new product development, new technologies,  the development of new applications, and design modifications and enhancements to existing products.

 

Other income (expense) was $522,000 in income in fiscal 2010 as compared to $1,676,000 in income in fiscal 2009. Interest and investment income decreased by $1,687,000 due to reduced yields on all investments and a need to move to more conservative, shorter term, lower yield investments as a result of the economic recession.

 

We reported pre-tax income of $54,846,000 in fiscal 2010 as compared to a pre-tax income of $43,700,000 in fiscal 2009 primarily due to the items noted above. We recorded income tax expense of $18,670,000 in fiscal 2010 as compared to $15,347,000 in fiscal 2009.  Our effective tax rate was 34.0% in fiscal 2010 as compared to 35.1% in fiscal 2009.  This decrease in rate can be attributed to a decrease in state taxes attributable to changes in state apportionment and other state tax planning activities offset by an increase in non-deductible stock compensation expense and an establishment of a valuation reserve on certain state tax credits.

 

We reported net income of $36,176,000 in fiscal 2010 as compared to net income of $28,353,000 in fiscal 2009.

 

Liquidity and Capital Resources

 

Cash and cash equivalents at year-end increased by $25,232,000 to $60,144,000 at March 31, 2011 as compared to $34,912,000 at March 31, 2010.   In addition, we had $110,141,000 and $144,166,000 of short-term investments at March 31, 2011 and March 31, 2010, respectively.

 

Cash flow provided by operations of $33,204,000 resulted from the following:

 

· Reported net income of $42,817,000 adjusted for the following non-cash items:

 

· Depreciation and amortization of $4,961,000;

· Stock compensation expense of $5,216,000;

· Increases in deferred income taxes of $2,716,000;

· The amortization of bond premiums of $2,057,000; and

· The provision for contracts, inventory and accounts receivable reserves of $1,608,000.

 

· An increase in accrued expenses and other liabilities of $4,344,000 from the prior year attributable primarily to increased accruals for incentive compensation and sales commissions.

 

· A decrease in prepaid expenses and other assets of $3,048,000 from the prior year due to the utilization in fiscal 2011 of vendor prepayments and prepaid agent commissions outstanding at March 31, 2010.

 

These cash contributors were offset by:

 

· An increase in unbilled costs and fees of $15,004,000 and a decrease in customer deposits of $4,521,000 due to the timing of billing milestones and revenue recognition on projects in process at year end.

 

· An increase in inventories of $3,139,000 due primarily to raw material component purchases for systems introduced in fiscal 2011.

 

· A decrease in accrued income taxes of $2,267,000 due to the timing of the payment of estimated taxes in fiscal 2011.

 

· A decrease in deferred revenue of $2,034,000 as certain service contracts, which were billed in fiscal 2010 at the outset of the contract period, were earned during fiscal 2011.

 

· A decrease in accounts payable of $1,592,000 due to the timing of check runs at the respective fiscal year ends.

 

20



Table of Contents

 

Net cash of $26,683,000 was provided by investing activities in fiscal 2011. We purchased $160,422,000 in short-term investments during the year, and had maturities of $192,406,000 on short-term investments.   Fiscal 2011 capital expenditures totaled $5,304,000 versus $3,266,000 for fiscal 2010. Investments in fixed assets were comprised primarily of information technology expenditures, leasehold improvements, and equipment used in production.

 

At March 31, 2011, short-term investments and cash equivalents were invested primarily in commercial paper, corporate debentures/bonds, treasury bills, government agency bonds, money market funds and certificates of deposit.  We do not invest in auction rate securities.  Although management believes our investment policy is conservative in nature, certain short-term investments in commercial paper can be exposed to the credit risk of the underlying companies to which they relate and interest earned on these investments is subject to interest rate fluctuations. The maturities within our investment portfolio generally range from 30 to 365 days.

 

Net cash used for financing activities was $34,655,000 in fiscal 2011. We used $29,425,000 to collateralize outstanding standby letters of credit upon the expiration of our Loan and Security Agreement (see below).  In addition we made quarterly dividend payments totaling $10,866,000 during the year and used $3,736,000 to repurchase 51,269 shares as part of our Stock Repurchase Program.  Cash provided by financing activities consisted primarily of the receipt of $6,943,000 in proceeds from the exercise of employee stock options.

 

We had in place a Loan and Security Agreement with Silicon Valley Bank which provided a $30.0 million facility to support routine letters of credit and working capital needs.  The Loan and Security Agreement expired on November 12, 2010 and we decided not to renew this facility given the cash flows provided from operations and our available cash and investments balance.  At the time of such decision, we had not drawn on this facility since June of 2002 and had used this credit facility exclusively to issue standby letters of credit.

 

Under the terms of this Loan and Security Agreement, we were required to pay certain one-time facility fees which were being amortized over the life of the facility and other unused credit fees.  Total expenses incurred related to these fees were $94,000, $227,000 and $214,000 in fiscal 2011, 2010, and 2009, respectively.

 

In the normal course of business, we may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, we would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which is remote in management’s opinion.  At March 31, 2011, we had outstanding $28,041,000 in standby letters of credit. Upon expiration of our Loan and Security Agreement as noted above, these outstanding standby letters of credit became cash-secured at amounts ranging from 105% to 110% of the value of outstanding letters of credit.  This resulted in a restricted cash balance of $29,460,000 at March 31, 2011 of which $9,062,000 was considered long-term restricted cash due to the expiration date of the underlying letters of credit.

 

In recent years, we have funded our operations and capital expenditures with cash generated by operations, including deposits from customers on long-term projects and from proceeds received from option exercises. We currently have no line of credit facility and believe that our cash flows from operations, and cash and investments on hand are sufficient to meet the current and foreseeable operating requirements of our business.

 

Contractual Obligations:  We lease certain facilities under non-cancelable leases. In addition, in the normal course of business, we enter into purchase orders with our vendors for the purchase of materials or services to meet our production needs. The following table summarizes our contractual obligations as of March 31, 2011.

 

 

 

Payment due by period

 

(In thousands)

 

Total

 

Less than 1
year

 

1-3 years

 

3-5 years

 

After 5
years

 

Recorded Contractual Obligations:

 

 

 

 

 

 

 

 

 

 

 

Lease financing liability

 

$

7,076

 

$

1,321

 

$

2,841

 

$

2,914

 

$

 

Other long-term obligations

 

34

 

8

 

17

 

9

 

 

Unrecorded Contractual Obligations:

 

 

 

 

 

 

 

 

 

 

 

Operating leases

 

1,626

 

651

 

505

 

470

 

 

Purchase commitments

 

16,589

 

15,170

 

1,419

 

 

 

Total contractual obligations

 

$

25,325

 

$

17,150

 

$

4,782

 

$

3,393

 

$

 

 

Inflation:  We do not believe that inflation has had a material effect on our results of operations in each of fiscal 2011, 2010 and 2009. There can be no assurance, however, that our business will not be affected by inflation in the future.

 

21



Table of Contents

 

Off-Balance Sheet Arrangements:  During the fiscal year ended March 31, 2011 we did not have any material off-balance sheet arrangements.

 

Critical Accounting Policies

 

We consider certain accounting policies related to revenue recognition, inventories and related allowances for obsolete and excess inventory, and income taxes to be critical policies due to the estimation processes involved in each.

 

Revenue Recognition:  We recognize certain Cargo Inspection, Z Backscatter, Parcel and Personnel Screening System and after-market part sales, in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 605-10, Revenue Recognition, which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured.

 

Infrequently, the Company receives requests from customers to hold product being purchased from us for a valid business purpose. We recognize revenue for such bill and hold arrangements provided the transaction meets, at a minimum, the following criteria: a valid business purpose for the arrangement exists; risk of ownership of the purchased product has been transferred to the buyer; there is a fixed delivery date that is reasonable and consistent with the buyer’s business purpose; the product is ready for shipment; the Company has no continuing performance obligation in regards to the product and the products have been segregated from our inventories and cannot be used to fill other orders received.   There were no products being held under these arrangements at March 31, 2011, March 31, 2010 or March 31, 2009.

 

Certain of our contracts are multiple-element arrangements, which include standard products, custom-built systems or contract engineering projects, services (such as training), and service and maintenance contracts. In accordance with FASB ASC 605-25, Revenue Recognition — Multiple Element Arrangements as amended by Accounting Standards Update No. 2009-13 adopted retroactively to April 1, 2009, revenue arrangements that include multiple elements are analyzed to determine whether the deliverables can be divided into separate units of accounting or treated as a single unit of accounting. The consideration we receive is allocated among the separate units of accounting based on their relative selling prices determined based on prices of these elements as sold on a stand-alone basis, and the applicable revenue recognition criteria are applied to each of the separate units. Generally, there is no customer right of return provision in the Company’s sales agreements.  Revenues are allocated to a delivered product or service when all of the following criteria are met: (1) the delivered item has value to the customer on a standalone basis; and (2) if the arrangement includes a general right of return relative to the delivered item, delivery or performance of the undelivered item is considered probable and substantially in our control.

 

Revenues for certain long-term, custom-built systems or contract engineering projects are recognized on a percentage of completion basis. The lengths of these contracts typically range from one to three years from order to delivery and acceptance. Percentages-of-completion are determined by relating the actual costs of work performed to date for each contract to our estimated final costs. Revisions in costs and profit estimates are reflected in the period in which the facts causing the revision become known.

 

We recognize sales for our systems that are produced in a standard manufacturing operation, have minimal customer site installation requirements and have shorter order to delivery cycles, when title passes and when other revenue recognition criteria are met. Management believes the customer’s post-delivery acceptance provisions and installation requirements on certain of these systems are perfunctory and inconsequential and the costs of installation at the customer’s site are accrued at the time of revenue recognition.  We have demonstrated a history of customer acceptance subsequent to shipment and installation of these systems.  For systems which entail more significant installation efforts and site work and/or have non-standard customer acceptance provisions, revenue recognition is deferred until installation is complete and customer acceptance has occurred.

 

Service revenues are recognized on time and materials engagements as the services are provided. Service contract revenues are recognized as service is performed over the length of the contract which reasonably approximates the period service revenues are earned.

 

Training and service contracts deliverables are accounted for separately from the delivered product elements as our undelivered products have value to our customers on a stand-alone basis. Accordingly, service revenue is deferred and recognized as such services are performed.

 

For all fixed price and long-term contracts, if a loss is anticipated on the contract, a provision is made in the period in which such losses are determined.

 

We record billed shipping and handling fees and billed out-of-pocket expenses as revenue and the associated costs as cost of goods sold in the accompanying consolidated statements of operations.

 

22



Table of Contents

 

Certain contracts require payments from the customer upon execution of the agreement that are included in customer deposits. Individual customer deposits are reduced by the amount of revenue recognized on the contract until a zero balance is reached. Revenue recognized in excess of billings under the contracts is included in unbilled costs and fees in the accompanying balance sheet. Of the amounts in unbilled costs and fees at March 31, 2011, $17,016,000 (99%) is expected to be billed and collected during fiscal 2012.

 

Under the terms of certain of our cost reimbursement contracts, we are not permitted to bill customers a specified portion of the contract value until completion. Such retainages (approximately $76,000 and $58,000 at March 31, 2011 and March 31, 2010, respectively) result from both commercial contract retentions and government contract withholdings generally for up to 15% of fees, as well as the difference between the actual and provisional indirect cost billing rates. Retainages are included in the accompanying consolidated balance sheets as components of unbilled costs and fees. The accuracy and appropriateness of our direct and indirect costs and expenses under these cost reimbursement contracts and our accounts receivable recorded pursuant to such contracts, are subject to regulation and audit, including by the U.S.  Defense Contract Audit Agency (“DCAA”) or by other appropriate agencies of the U.S. government.  Such agencies have the right to challenge the Company’s cost estimates or allocations with respect to any government contract.  Additionally, a portion of the payments to the Company under government contracts are provisional payments that are subject to potential adjustment upon audit by such agencies.  Historically, such audits have not resulted in any significant disallowed costs.  Although we can give no assurances, in the opinion of management,  any adjustments likely to result from inquiries or audits of our contracts will not have a material adverse impact on our financial condition or results of operations.

 

Inventories and Related Allowance for Obsolete and Excess Inventory:   Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost or net realizable value. Excessive manufacturing overhead costs such as idle facility expense, freight, handling costs and wasted material (spoilage) attributable to abnormally low volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred. We regularly review inventory quantities on hand and record a provision for excess and obsolete inventory based primarily on the estimated forecast of product demand over the next twelve to eighteen months. Demand for products can fluctuate significantly. A significant increase in the demand for our products could result in a short-term increase in inventory balances, while a significant decrease in demand could result in an increase in the amount of excess inventory quantities on hand. Additionally, inventory reserves require estimates of future product demand, which may materially impact the provision required for excess and obsolete inventory. In the future, if inventory were determined to be overvalued, we would be required to recognize such costs in our cost of goods sold at the time of such determination. Likewise, if inventory is determined to be undervalued, we may have over-reported costs of goods sold in previous periods and would be required to recognize such additional operating income at the time of sale. Therefore, although we make every effort to ensure the accuracy of forecasts of future product demand, any significant unanticipated changes in demand or technological developments could have a significant impact on the value of our inventory and reported operating results.

 

Income Taxes:  We account for income taxes in accordance with FASB ASC 740, Income Taxes. Accordingly, we recognize deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. We evaluate the need for a valuation allowance against our net deferred tax assets at year end based upon our three year cumulative income and our projections of future income, and record a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.

 

New Accounting Pronouncements

 

In October 2009, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2009-14, Revenue Recognition (Topic 605)—Applicability of AICPA Statement of Position 97-2 to Certain Arrangements That Include Software Elements (ASU 2009-14). ASU 2009-14 excludes tangible products containing software components and non-software components that function together to deliver the product’s essential functionality from the scope of FASB Accounting Standards Codification (“ASC”) 605-985, Software-Revenue Recognition. ASU 2009-14 shall be applied on a prospective basis to revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption was permitted. Upon adoption, the Company must apply ASU 2009-14 retrospectively to the beginning of the fiscal year of adoption or to all periods presented. The adoption of ASU 2009-14 is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

 

ITEM 7A. QUANTITIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The cash accounts for our operations in Hong Kong, England, the Netherlands, and Abu Dhabi are maintained in Hong Kong dollars, pounds sterling, Euros and dirham, respectively. The gains and losses from foreign currency transactions are included in the condensed consolidated statements of operations for the period and were immaterial. In the fourth quarter of fiscal 2010, we purchased a foreign currency put option which provided us with the option to exchange Euros for U.S. dollars at a fixed exchange rate such that, if the Euro were to depreciate against the U.S. dollar to predetermined levels as set by the contract, we could

 

23



Table of Contents

 

exercise our option and mitigate our foreign currency exchange losses. This put option was sold during the quarter ended September 30, 2010 at a price near cost resulting in no material gain or loss.  A hypothetical 10 percent change in foreign currency rates would not have a material impact on our results of operations or financial condition.

 

As of March 31, 2011, we held short-term investments and cash equivalents consisting of commercial paper, corporate debentures/bonds, treasury bills, government agency bonds, money market funds and certificates of deposit. Our primary objective with our investment portfolio is to invest available cash while preserving principal and meeting liquidity needs. These investments have an average interest rate of approximately 0.3% and are subject to interest rate risk. As a result of the average maturity and conservative nature of the investment portfolio, a sudden change in interest rates would not have a material adverse effect on the value of these investments.  To minimize this risk, we maintain a significant portion of our cash balances in money market funds.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The financial statements and supplementary financial information listed in the Index to Consolidated Financial Statements on page 26 are filed as part of this Annual Report on Form 10-K and are incorporated into this item by reference.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, the Company reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures pursuant to Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2011 to ensure that information required to be disclosed by the Company in the reports filed and submitted by it under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and to provide reasonable assurance that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.  Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

 

Management’s Annual Report on Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act.  Our management conducted an evaluation of the effectiveness of our internal control over financial reporting using the framework in “Internal Control-Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission.  Based on this evaluation under the criteria established in “Internal Control — Integrated Framework”, our management concluded that the Company’s internal control over financial reporting was effective as of March 31, 2011.  McGladrey & Pullen, LLP, our independent registered public accounting firm, has audited the effectiveness of our internal control over financial reporting as of March 31, 2011, and has issued their report thereon which is included in this Annual Report on Form 10-K and incorporated herein by reference.

 

Changes in Internal Controls over Financial Reporting

 

There have been no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act, during the quarter ended March 31, 2011 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

24



Table of Contents

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Code of Conduct

 

The Company has adopted a Code of Business Conduct and Ethics that applies to our Board of Directors, Chief Executive Officer, Chief Financial Officer, and all employees of the Company. The Company’s Code of Business Conduct and Ethics is posted on our website at www.as-e.com and may be accessed in the Corporate Governance section of the Investor Information page. The Company intends to satisfy the disclosure requirement under Item 5.05 of Form 8-K, regarding an amendment to, or waiver from, our Code of Conduct, by posting such information on our website at the location specified above.

 

The other information called for by this item is hereby incorporated by reference from our Definitive Proxy Statement relating to the 2011 Annual Meeting of Stockholders, which we expect to file with the Securities and Exchange Commission on or about July 29, 2011.

 

ITEM 11. EXECUTIVE COMPENSATION

 

The information called for by this item is hereby incorporated by reference from our Definitive Proxy Statement relating to the 2011 Annual Meeting of Stockholders, which we expect to file with the Securities and Exchange Commission on or about July 29, 2011.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

 

The information called for by this item is hereby incorporated by reference from our Definitive Proxy Statement relating to the 2011 Annual Meeting of Stockholders, which we expect to file with the Securities and Exchange Commission on or about July 29, 2011.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

The information called for by this item is hereby incorporated by reference from our Definitive Proxy Statement relating to the 2011 Annual Meeting of Stockholders, which we expect to file with the Securities and Exchange Commission on or about July 29, 2011.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

The information called for by this item is hereby incorporated by reference from our Definitive Proxy Statement relating to the 2011 Annual Meeting of Stockholders, which we expect to file with the Securities and Exchange Commission on or about July 29, 2011.

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

The financial statements listed in the Index to Consolidated Financial Statements on page 26 are filed as part of this report, and such Index is incorporated in this item by reference.

 

The exhibits listed in the Exhibit Index on page 49 are filed as part of this report, and such Index is incorporated in this item by reference.

 

25



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

(Submitted in answer to Item 8, Item 9A and Item 15 of Form 10-K, Securities and Exchange Commission)

 

 

PAGE

CONSOLIDATED FINANCIAL STATEMENTS

 

Report of Independent Registered Public Accounting Firm

27

Consolidated Balance Sheets—March 31, 2011 and 2010

29

Consolidated Statements of Operations for the Years Ended March 31, 2011, 2010 and 2009

30

Consolidated Statements of Stockholders’ Equity and Comprehensive Income for the Years Ended March 31, 2011, 2010 and 2009

31

Consolidated Statements of Cash Flows for the Years Ended March 31, 2011, 2010 and 2009

32

Notes to Consolidated Financial Statements

33

 

 

CONSOLIDATED SUPPLEMENTARY FINANCIAL INFORMATION

 

Unaudited Quarterly Consolidated Financial Data for the Years Ended March 31, 2011 and 2010

47

 

Financial statement schedules have been omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or notes thereto.

 

26



Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders

of American Science and Engineering, Inc.

 

We have audited the accompanying consolidated balance sheet of American Science and Engineering, Inc. and subsidiaries (“the Company”) as of March 31, 2011, and the related consolidated statements of operations, stockholders’ equity and comprehensive income, and cash flows for the year ended March 31, 2011.  We also have audited American Science and Engineering, Inc. and subsidiaries’ internal control over financial reporting as of March 31, 2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.  The Company’s management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting.  Our responsibility is to express an opinion on these financial statements and an opinion on the Company’s internal control over financial reporting based on our audits.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States).  Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects.  Our audit of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audit also included performing such other procedures as we considered necessary in the circumstances.  We believe that our audit provides a reasonable basis for our opinion.

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company’s internal control over financial reporting includes those policies and procedures that (a) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (b) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (c) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of American Science and Engineering, Inc. and subsidiaries as of March 31, 2011, and the consolidated results of its operations and its cash flows for the year ended March 31, 2011, in conformity with accounting principles generally accepted in the United States of America.  Also in our opinion, American Science and Engineering, Inc. maintained, in all material respects, effective internal control over financial reporting as of March 31, 2011, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.

 

 

/s/ McGladrey & Pullen, LLP

 

Boston, Massachusetts

June 9, 2011

 

27



Table of Contents

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of
American Science and Engineering, Inc.

 

We have audited the accompanying consolidated balance sheet of American Science and Engineering, Inc. and subsidiary (“the Company”) as of March 31, 2010 and the related consolidated statements of operations, stockholders’ equity and comprehensive income and cash flows for each of the years ended March 31, 2010 and 2009. Management is responsible for these financial statements. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement and whether effective internal control over financial reporting was maintained in all material respects. Our audits of the financial statements included examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of American Science and Engineering, Inc. and subsidiary as of March 31, 2010, and the consolidated results of their operations, stockholders’ equity and their cash flows for each of the two years in the period ended March 31, 2010 in conformity with accounting principles generally accepted in the United States of America.

 

/s/ CATURANO AND COMPANY, P.C.

 

Boston, Massachusetts
June 7, 2010

 

28



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

MARCH 31, 2011 AND 2010

(Amounts in thousands, except share and per share amounts)

 

 

 

2011

 

2010

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

60,144

 

$

34,912

 

Restricted cash and investments

 

20,398

 

35

 

Short-term investments, at fair value

 

110,141

 

144,166

 

Accounts receivable, net of allowances of $334 at March 31, 2011 and $330 at March 31, 2010

 

37,180

 

37,735

 

Unbilled costs and fees

 

17,082

 

2,078

 

Inventories

 

46,922

 

45,387

 

Prepaid expenses and other current assets

 

6,698

 

8,998

 

Deferred income taxes

 

3,469

 

2,389

 

Total current assets

 

302,034

 

275,700

 

Building, equipment and leasehold improvements, net

 

18,559

 

18,216

 

Restricted cash

 

9,062

 

 

Deferred income taxes

 

6,779

 

5,171

 

Other assets, net

 

140

 

766

 

Total assets

 

$

336,574

 

$

299,853

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

9,378

 

$

10,970

 

Accrued salaries and benefits

 

15,988

 

13,663

 

Accrued warranty costs

 

1,225

 

965

 

Accrued income taxes

 

1,936

 

4,203

 

Deferred revenue

 

16,924

 

14,975

 

Customer deposits

 

9,193

 

13,714

 

Current portion of lease financing liability

 

1,321

 

1,302

 

Other current liabilities

 

5,460

 

3,913

 

Total current liabilities

 

61,425

 

63,705

 

Lease financing liability, net of current portion

 

5,755

 

7,075

 

Deferred revenue

 

3,288

 

7,271

 

Other long term liabilities

 

26

 

34

 

Total liabilities

 

70,494

 

78,085

 

 

 

 

 

 

 

Commitments and contingencies (Notes 2 and 10)

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, no par value Authorized—100,000 shares Issued—None

 

 

 

Common stock, $0.662/3 par value Authorized—20,000,000 shares Issued and outstanding— 9,169,965 shares at March 31, 2011 and 9,013,508 shares at March 31, 2010

 

6,113

 

6,008

 

Capital in excess of par value

 

110,087

 

97,819

 

Accumulated other comprehensive income (loss), net

 

21

 

33

 

Retained earnings

 

149,859

 

117,908

 

Total stockholders’ equity

 

266,080

 

221,768

 

Total liabilities and stockholders’ equity

 

$

336,574

 

$

299,853

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

29



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE YEARS ENDED MARCH 31, 2011, 2010, AND 2009

(Amounts in thousands except per share amounts)

 

 

 

2011

 

2010

 

2009

 

Net sales and contract revenues:

 

 

 

 

 

 

 

Net product sales and contract revenues

 

$

192,818

 

$

165,710

 

$

142,931

 

Net service revenues

 

85,758

 

76,383

 

75,436

 

Total net sales and contract revenues

 

278,576

 

242,093

 

218,367

 

 

 

 

 

 

 

 

 

Cost of sales and contracts:

 

 

 

 

 

 

 

Cost of product sales and contracts

 

104,062

 

91,554

 

83,074

 

Cost of service revenues

 

45,312

 

39,469

 

42,328

 

Total cost of sales and contracts

 

149,374

 

131,023

 

125,402

 

Gross profit

 

129,202

 

111,070

 

92,965

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

42,139

 

36,982

 

32,871

 

Research and development expenses

 

22,619

 

19,764

 

18,070

 

Total operating expenses

 

64,758

 

56,746

 

50,941

 

Operating income

 

64,444

 

54,324

 

42,024

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

Interest and investment income, net

 

678

 

701

 

2,388

 

Interest expense

 

(110

)

(136

)

(144

)

Other, net

 

(137

)

(43

)

(568

)

Total other income

 

431

 

522

 

1,676

 

 

 

 

 

 

 

 

 

Income before provision for income taxes

 

64,875

 

54,846

 

43,700

 

Provision for income taxes

 

22,058

 

18,670

 

15,347

 

 

 

 

 

 

 

 

 

Net income

 

$

42,817

 

$

36,176

 

$

28,353

 

Income per share

— Basic

 

$

4.73

 

$

4.06

 

$

3.26

 

 

— Diluted

 

$

4.63

 

$

3.97

 

$

3.18

 

Weighted average shares

— Basic

 

9,045

 

8,900

 

8,692

 

 

— Diluted

 

9,247

 

9,107

 

8,928

 

Dividends declared per share

 

$

1.20

 

$

0.90

 

$

0.80

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

30



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY AND COMPREHENSIVE INCOME

FOR THE YEARS ENDED MARCH 31, 2011, 2010, AND 2009

(Amounts in thousands, except share amounts)

 

 

 

Common
Stock
Shares

 

Common
Stock
Par Value

 

Capital in
Excess of
Par Value

 

Retained
Earnings

 

Accumulated
Other Comp.
Income (Loss)

 

Total

 

Comprehensive
Income

 

Balance, March 31, 2008

 

8,945,663

 

$

5,963

 

$

91,544

 

$

68,451

 

$

114

 

$

166,072

 

 

 

Net income

 

 

 

 

28,353

 

 

28,353

 

$

28,353

 

Repurchase of common stock

 

(349,327

)

(233

)

(17,827

)

 

 

(18,060

)

 

Exercise of stock options

 

161,753

 

108

 

5,795

 

 

 

5,903

 

 

Issuance of stock under employee compensation plans

 

13,117

 

8

 

768

 

 

 

776

 

 

Issuances of restricted stock, net of forfeitures

 

39,554

 

27

 

(27

)

 

 

 

 

Tax benefit accrued on stock option exercises

 

 

 

1,284

 

 

 

1,284

 

 

Compensation expense on stock options

 

 

 

1,458

 

 

 

1,458

 

 

Compensation expense on restricted stock and restricted stock units

 

 

 

3,482

 

 

 

3,482

 

 

Dividends declared

 

 

 

 

(7,041

)

 

(7,041

)

 

Other

 

 

 

 

 

(161

)

(161

)

(161

)

Balance, March 31, 2009

 

8,810,760

 

5,873

 

86,477

 

89,763

 

(47

)

182,066

 

$

28,192

 

Net income

 

 

 

 

36,176

 

 

36,176

 

$

36,176

 

Repurchase of common stock

 

(51,299

)

(34

)

(2,888

)

 

 

(2,922

)

 

Exercise of stock options

 

158,863

 

106

 

6,302

 

 

 

6,408

 

 

Issuance of stock under employee compensation plans

 

14,192

 

9

 

941

 

 

 

950

 

 

Issuances of restricted stock, net of forfeitures

 

80,992

 

54

 

(54

)

 

 

 

 

Tax benefit accrued on stock option exercises

 

 

 

1,087

 

 

 

1,087

 

 

Compensation expense on stock options

 

 

 

1,264

 

 

 

1,264

 

 

Compensation expense on restricted stock and restricted stock units

 

 

 

4,690

 

 

 

4,690

 

 

Dividends declared

 

 

 

 

(8,031

)

 

(8,031

)

 

Other

 

 

 

 

 

80

 

80

 

80

 

Balance, March 31, 2010

 

9,013,508

 

$

6,008

 

$

97,819

 

$

117,908

 

$

33

 

$

221,768

 

$

36,256

 

Net income

 

 

 

 

42,817

 

 

42,817

 

42,817

 

Repurchase of common stock

 

(51,269

)

(34

)

(3,702

)

 

 

(3,736

)

 

Exercise of stock options

 

197,669

 

132

 

6,811

 

 

 

6,943

 

 

Issuance of stock under employee compensation plans

 

2,939

 

2

 

218

 

 

 

220

 

 

Issuances of restricted stock, net of forfeitures

 

7,118

 

5

 

(5

)

 

 

 

 

Tax benefit accrued on stock option exercises

 

 

 

3,730

 

 

 

3,730

 

 

Compensation expense on stock options

 

 

 

1,703

 

 

 

1,703

 

 

Compensation expense on restricted stock and restricted stock units

 

 

 

3,513

 

 

 

3,513

 

 

Dividends declared

 

 

 

 

(10,866

)

 

(10,866

)

 

Net change in unrealized gains (losses) on investment securities, available-for-sale, net of tax

 

 

 

 

 

(12

)

(12

)

(12

)

Balance, March 31, 2011

 

9,169,965

 

$

6,113

 

$

110,087

 

$

149,859

 

$

21

 

$

266,080

 

$

42,805

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

31



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE YEARS ENDED MARCH 31, 2011, 2010, AND 2009

(Amounts in thousands)

 

 

 

2011

 

2010

 

2009

 

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income

 

$

42,817

 

$

36,176

 

$

28,353

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

4,961

 

4,538

 

4,294

 

Provisions for contracts, inventory, and accounts receivable reserves

 

1,608

 

1,170

 

2,790

 

Gain on sale of fixed assets

 

(3

)

 

 

Amortization of bond premium (discount)

 

2,057

 

1,119

 

(384

)

Stock compensation expense

 

5,216

 

5,954

 

4,940

 

Other

 

(122

)

122

 

 

Deferred income taxes

 

(2,716

)

(463

)

(289

)

Change in assets and liabilities:

 

 

 

 

 

 

 

Accounts receivable

 

551

 

(835

)

(9,622

)

Unbilled costs and fees

 

(15,004

)

4,238

 

(202

)

Inventories

 

(3,139

)

1,474

 

(10,409

)

Prepaid expenses and other assets

 

3,048

 

(1,269

)

(2,964

)

Accrued income taxes

 

(2,267

)

4,140

 

63

 

Accounts payable

 

(1,592

)

331

 

(2,021

)

Deferred revenue

 

(2,034

)

(10,453

)

5,873

 

Customer deposits

 

(4,521

)

(1,104

)

8,271

 

Accrued expenses and other current liabilities

 

4,344

 

1,138

 

6,483

 

Sale of leased equipment

 

 

 

116

 

Total adjustments

 

(9,613

)

10,100

 

6,939

 

Net cash provided by operating activities

 

33,204

 

46,276

 

35,292

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Proceeds from sales and maturities of short-term investments

 

192,406

 

104,261

 

101,966

 

Purchases of short-term instruments

 

(160,422

)

(213,157

)

(65,347

)

Proceeds from sale of fixed assets

 

3

 

 

 

Purchases of property and equipment

 

(5,304

)

(3,266

)

(2,350

)

 

 

 

 

 

 

 

 

Net cash provided by (used for) investing activities

 

26,683

 

(112,162

)

34,269

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Decrease in restricted cash and investments

 

(29,425

)

 

2,488

 

Repurchase of shares of common stock

 

(3,736

)

(2,922

)

(18,060

)

Payment of common stock dividend

 

(10,866

)

(8,031

)

(7,041

)

Repayment of leasehold financing

 

(1,301

)

(1,163

)

(1,134

)

Proceeds from exercise of stock options

 

6,943

 

6,408

 

5,903

 

Reduction of income taxes paid due to the tax benefit from employee stock option expense

 

3,730

 

1,087

 

1,284

 

 

 

 

 

 

 

 

 

Net cash used for financing activities

 

(34,655

)

(4,621

)

(16,560

)

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

25,232

 

(70,507

)

53,001

 

Cash and cash equivalents at beginning of year

 

34,912

 

105,419

 

52,418

 

Cash and cash equivalents at end of year

 

$

60,144

 

$

34,912

 

$

105,419

 

 

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information:

 

 

 

 

 

 

 

Interest paid

 

$

110

 

$

185

 

$

144

 

Income taxes paid

 

$

24,079

 

$

15,661

 

$

13,625

 

 

 

 

 

 

 

 

 

Non-cash transactions:

 

 

 

 

 

 

 

Issuance of stock for 401K match

 

$

220

 

$

950

 

$

776

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

32



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Nature of Operations and Basis of Presentation

 

American Science and Engineering, Inc. (the “Company”) is engaged in the development and manufacture of sophisticated X-ray inspection systems for critical detection and security screening products for sale primarily to U.S. and foreign government agencies.

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all investments with original maturities of 90 days or less to be cash equivalents.  The Company maintains cash and cash equivalent balances with financial institutions that exceed federally insured limits.  The Company has not experienced any losses related to these balances, and management believes its risk of loss to be minimal.

 

Restricted Cash and Investments

 

The Company’s  former loan and security agreement with its bank required certain cash and investment balances to be restricted as collateral against outstanding standby letters of credit if the Company exceeded its credit availability under this credit facility.   Upon expiration of that loan and security agreement in November of 2010, all outstanding standby letters of credit became restricted cash-secured at amounts ranging from 105% to 110% of the outstanding letters of credit.

 

Short-term Investments and Cash Equivalents

 

Short-term investments and cash equivalents consist of investments in commercial paper, corporate debentures/bonds, treasury bills, government agency bonds, money market funds and certificates of deposit. These investments are classified as available-for-sale and are recorded at their fair values using the specific identification method. The unrealized holding gains or losses on these securities are included as a component of comprehensive income in the Consolidated Statements of Stockholders’ Equity and Comprehensive Income.

 

Accounts Receivable and Unbilled Costs and Fees

 

Accounts receivable are recorded at the invoiced amount. Amounts collected on trade accounts receivable are included in net cash provided by operating activities in the consolidated statements of cash flows. The Company maintains an allowance for doubtful accounts for estimated losses inherent in its accounts receivable portfolio. The allowance for doubtful accounts reflects our best estimate of probable losses inherent in the accounts receivable balance. We determine the allowance based on known troubled accounts, historical experience, and other currently available evidence.  It is the Company’s policy to write off uncollectible receivables when management determines the receivable has become uncollectible. Activity in the allowance for doubtful accounts is as follows:

 

(In thousands)

 

Balance at
Beginning
of Year

 

Charged to
Costs and
Expenses

 

Deductions
or Write-
offs
Charged to
Reserves

 

Balance at
End of
Year

 

2011

 

$

330

 

$

4

 

$

 

$

334

 

2010

 

$

286

 

$

56

 

$

12

 

$

330

 

2009

 

$

230

 

$

249

 

$

193

 

$

286

 

 

33



Table of Contents

 

Included in accounts receivable and unbilled costs and fees at March 31, 2011 and 2010 are $30,417,000 and $23,952,000, respectively, attributable to both prime and subcontracts with federal and state governments. The Company establishes a reserve against unbilled costs and fees based on known troubled accounts or contracts, historical experience, and other currently available evidence. There was no activity in the reserve for unbilled costs and fees during fiscal 2011, 2010 and 2009.

 

Inventories

 

Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excessive manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred.

 

The components of inventories at March 31, 2011 and 2010, net of inventory reserves, were as follows:

 

(In thousands)

 

2011

 

2010

 

Raw materials, completed subassemblies and spares parts

 

$

27,436

 

$

19,821

 

Work-in-process

 

16,828

 

15,813

 

Finished goods

 

2,658

 

9,753

 

Total

 

$

46,922

 

$

45,387

 

 

The Company periodically reviews quantities of inventory on hand and compares these amounts to expected usage of each particular product or product line. The Company records, as a charge to cost of sales, any amounts required to reduce the carrying value to net realizable value.

 

Activity in the reserve for excess or obsolete inventory is as follows:

 

(In thousands)

 

Balance at
Beginning
of Year

 

Charged to
Costs and
Expenses

 

Deductions
/ Write-
offs
Charged to
Reserves

 

Balance at
End of
Year

 

2011

 

$

3,982

 

$

1,604

 

$

704

 

$

4,882

 

2010

 

$

4,165

 

$

1,114

 

$

1,297

 

$

3,982

 

2009

 

$

2,187

 

$

2,542

 

$

564

 

$

4,165

 

 

Building, Equipment and Leasehold Improvements

 

The Company provides for depreciation and amortization of its fixed assets on a straight-line basis over estimated useful lives of 1-25 years or remaining lease terms. Expenditures for normal maintenance and repairs are charged to expense as incurred. Significant additions, renewals or betterments that extend the useful lives of the assets are capitalized at cost. The cost and accumulated depreciation applicable to equipment and leasehold improvements sold, or otherwise disposed of, are removed from the accounts, and any resulting gain or loss is included in the consolidated statements of operations.

 

Building, equipment and leasehold improvements consisted of the following at March 31, 2011 and 2010.

 

(In thousands)

 

Estimated Useful Lives

 

2011

 

2010

 

Building and leasehold improvements

 

Lesser of 25 years or remaining lease term

 

$

20,047

 

$

19,581

 

Equipment and tooling

 

5-10 years

 

4,522

 

3,240

 

Computer equipment and software

 

5 years

 

19,539

 

17,977

 

Furniture and fixtures

 

5-7 years

 

2,420

 

1,703

 

Demo and test equipment

 

2-5 years

 

4,796

 

3,741

 

Leased equipment

 

1-2 years or life of lease

 

63

 

63

 

Motor vehicles

 

3 years

 

72

 

71

 

Total

 

 

 

51,459

 

46,376

 

Less accumulated depreciation and amortization

 

 

 

(32,900

)

(28,160

)

Building, equipment and leasehold improvements, net

 

 

 

$

18,559

 

$

18,216

 

 

34



Table of Contents

 

Revenue Recognition

 

The Company recognizes certain Cargo Inspection, Z Backscatter and Parcel and Personnel Screening system sales and after-market part sales, in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 605-10, Revenue Recognition, which requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectability is reasonably assured.

 

Infrequently, the Company receives requests from customers to hold product being purchased for a valid business purpose. The Company recognizes revenue for such bill and hold arrangements provided the transaction meets, at a minimum, the following criteria: a valid business purpose for the arrangement exists; risk of ownership of the purchased product has transferred to the buyer; there is a fixed delivery date that is reasonable and consistent with the buyer’s business purpose; the product is ready for shipment; the Company has no continuing performance obligation in regards to the product and the products have been segregated from its inventories and cannot be used to fill other orders received.   There was no product being held under these arrangements at March 31, 2011, March 31, 2010 or March 31, 2009.

 

Certain of the Company’s contracts are multiple-element arrangements, which include standard products, custom-built systems or contract engineering projects, services (such as training), and service and maintenance contracts. In the quarter ended December 31, 2009 the Company adopted FASB ASC 605-25, Revenue Recognition — Multiple Element Arrangements as amended by Accounting Standards Update No. 2009-13, retroactively to April 1, 2009.  This adoption did not have a material impact on the Company’s previously reported Consolidated Financial Statements.   In accordance with FASB ASC 605-25, revenue arrangements that include multiple elements are analyzed to determine whether the deliverables can be divided into separate units of accounting or treated as a single unit of accounting. The consideration received is allocated among the separate units of accounting based on their relative selling prices determined based on prices of these elements as sold on a stand-alone basis, and the applicable revenue recognition criteria are applied to each of the separate units. Generally, there is no customer right of return provision in the Company’s sales agreements.  Revenues are allocated to a delivered product or service when the following criteria are met: (1) the delivered item has value to the customer on a standalone basis; and (2) if the arrangement includes a general right of return relative to the delivered item, delivery or performance of the undelivered item is considered probable and substantially in our control.

 

Revenues for certain long-term, custom-built systems or contract engineering projects are recognized on a percentage of completion basis. The lengths of these contracts typically range from one to three years from order to delivery and acceptance. Percentages-of-completion are determined by relating the actual costs of work performed to date for each contract to its estimated final costs. Revisions in costs and profit estimates are reflected in the period in which the facts causing the revision become known.

 

For all fixed price and long-term contracts, if a loss is anticipated on the contract, a provision is made in the period in which such losses are determined.

 

The Company recognizes sales for its systems that are produced in a standard manufacturing operation, have minimal customer site installation requirements and have shorter order to delivery cycles, when title passes and when other revenue recognition criteria are met. Management believes the customer’s post-delivery acceptance provisions and installation requirements on certain of these systems are perfunctory and inconsequential and the costs of installation at the customer’s site are accrued at the time of revenue recognition.  The Company has demonstrated a history of customer acceptance subsequent to shipment and installation of these systems.  For systems which entail more significant installation efforts and site work and/or have non-standard customer acceptance provisions, revenue recognition is deferred until installation is complete and customer acceptance has occurred.

 

Service revenues are recognized on time and materials engagements as the services are provided. Service contract revenues are recognized as service is performed over the length of the contract which reasonably approximates the period service revenues are earned.

 

The Company records billed shipping and handling fees and billed out-of-pocket expenses as revenue and the associated costs as cost of goods sold in the accompanying consolidated statements of operations.

 

Training and service contracts deliverables are accounted for separately from the delivered product elements as the Company’s undelivered products have value to its customers on a stand-alone basis. Accordingly, this service revenue is deferred and recognized as such services are performed.

 

Certain contracts require payments from the customer upon execution of the agreement that are included in customer deposits. Individual customer deposits are reduced by the amount of revenue recognized on the contract until a zero balance is reached.

 

35



Table of Contents

 

Revenue recognized in excess of billings under the contracts is included in unbilled costs and fees in the accompanying consolidated balance sheets. Of the amounts in unbilled costs and fees at March 31, 2011, $17,016,000 (99%) is expected to be billed and collected during fiscal 2012.

 

Under the terms of certain of its cost reimbursement contracts, the Company is not permitted to bill customers a specified portion of the contract value until completion. Such retainages (approximately $76,000 and $58,000 at March 31, 2011 and March 31, 2010, respectively) result from both commercial contract retentions and government contract withholdings generally for up to 15% of fees, as well as the difference between the actual and provisional indirect cost billing rates. Retainages are included in the accompanying consolidated balance sheets as components of unbilled costs and fees. The accuracy and appropriateness of the Company’s direct and indirect costs and expenses under these cost reimbursement contracts and its accounts receivable recorded pursuant to such contracts, are subject to regulation and audit, including by the U.S. Defense Contract Audit Agency (“DCAA”) or by other appropriate agencies of the U.S. government.  Such agencies  have the right to  challenge  the  Company’s  cost  estimates  or allocations  with  respect  to any  government  contract.  Additionally, a portion of the payments to the Company under government contracts are provisional payments that are subject to potential adjustment upon audit by such agencies.  Historically, such audits have not resulted in any significant disallowed costs.  Although the Company can give no assurances, in the opinion of management, any adjustments likely to result from inquiries or audits of its contracts will not have a material adverse impact on the Company’s financial condition or results of operations.

 

Warranty Costs

 

The Company generally provides on certain of its products a one year parts and labor warranty with the purchase of domestic equipment, and a one year parts only or parts and labor warranty on international equipment. The anticipated cost for this one year warranty is accrued for at the time of the sale based upon historical experience and management’s estimates of future liabilities, and is recorded as accrued warranty costs (See Note 5).

 

Deferred Revenue

 

The Company offers to its customers extended warranty and service contracts. These contracts typically have a coverage period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as service is performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of goods sold as incurred.

 

Impairment of Long-Lived Assets

 

Long-lived assets are reviewed for possible impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable.

 

Impairment is assessed by comparing the estimated undiscounted cash flows over the asset’s remaining life to the carrying amount of the asset. If the estimated cash flows are insufficient to recover the asset, an impairment loss is recognized based on the difference between the carrying value of the asset and the fair value of the asset less any costs of disposal.  No impairment costs were recorded in the fiscal years ended March 31, 2011, 2010 and 2009.

 

Accrued Salaries and Benefits

 

Accrued salaries and benefits at March 31, 2011 and March 31, 2010 include the following:

 

(In thousands)

 

2011

 

2010

 

Accrued payroll and payroll related taxes

 

$

1,727

 

$

1,162

 

Accrued benefits

 

 

227

 

Accrued incentive compensation

 

12,227

 

10,485

 

Accrued vacation

 

2,034

 

1,789

 

Total accrued salaries and benefits

 

$

15,988

 

$

13,663

 

 

Customer Deposits

 

For most international orders, the Company generally includes, as part of its terms and conditions, an advance deposit with order acceptance. For long-term international contracts, the Company will generally include milestone payments tied to a specific event and/or passage of time. These deposit amounts are recorded as a liability under Customer Deposits until reduced by revenue recognized against the specific contract.

 

36



Table of Contents

 

Research and Development

 

Internally funded research and development costs including direct labor, material, subcontractor expenses and related overheads are expensed as incurred. Internally funded research and development costs were $22,619,000, $19,764,000 and $18,070,000, in fiscal 2011, 2010, and 2009, respectively.  In addition, the Company recognized revenues of $4,821,000, $2,306,000 and $12,524,000, in fiscal 2011, 2010, and 2009, respectively related to government-sponsored research and development earned primarily on a cost reimbursement and fee basis as discussed above.

 

Fair Value of Financial Instruments

 

The Company’s financial instruments consist primarily of cash and cash equivalents, restricted cash, short-term investments, accounts receivable, unbilled costs and fees, accounts payable and letters of credit. The recorded amounts of these instruments approximate their fair value (see Note 8).

 

Income per Common and Potential Common Shares

 

Basic earnings per common share is computed by dividing net income available to common stockholders by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per share include the dilutive impact of options, warrants, restricted stock and restricted stock units using the average share price of the Company’s common stock for the period. For the years ended March 31, 2011, 2010, and 2009, respectively, common stock equivalents of approximately 35,000, 132,000, and 215,000 are excluded from diluted earnings per share, as their effect is anti-dilutive.

 

(In thousands except per share amounts)

 

March 31,
2011

 

March 31,
2010

 

March 31,
2009

 

Earnings per Share Basic:

 

 

 

 

 

 

 

Net income

 

$

42,817

 

$

36,176

 

$

28,353

 

Weighted average number of common shares outstanding — basic

 

9,045

 

8,900

 

8,692

 

Income per share — basic

 

$

4.73

 

$

4.06

 

$

3.26

 

Earnings per Share — Diluted:

 

 

 

 

 

 

 

Net income

 

$

42,817

 

$

36,176

 

$

28,353

 

Weighted average number of common shares outstanding — basic

 

9,045

 

8,900

 

8,692

 

Assumed exercise of stock options, warrants, restricted stock and restricted stock units, using the treasury stock method

 

202

 

207

 

236

 

Weighted average number of common and potential common shares Outstanding — diluted

 

9,247

 

9,107

 

8,928

 

Income per share — diluted

 

$

4.63

 

$

3.97

 

$

3.18

 

 

Income Taxes

 

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Accordingly, the Company recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.  The Company recognizes interest and penalties related to income tax matters in other income and expenses.

 

Concentrations of Credit Risk

 

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  The Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in high quality money market funds, commercial paper, investment grade corporate bonds, treasury bills, government agency bonds, and certificates of deposit.

 

Three customers, one agency of the U.S. government, one U.S. government subcontractor and one international customer, accounted for 62% of the accounts receivable balance at March 31, 2011.  The Company generally requires letters of credit and/or deposits or prepayments from international customers.  The Company has not experienced any significant losses from uncollectible accounts.

 

37



Table of Contents

 

Common Stock Dividends

 

In May of 2007, the Company began declaring quarterly cash dividends for its common stock shareholders.   Common stock cash dividends declared during the fiscal year ended March 31, 2011 were as follows:

 

Date Declared

 

Dividend per
common share

 

May 11, 2010

 

$

0.30

 

August 9, 2010

 

0.30

 

November 9, 2010

 

0.30

 

February 8, 2011

 

0.30

 

Fiscal year ended March 31, 2011

 

$

1.20

 

 

On May 9, 2011, the Company declared a quarterly dividend of $0.30 for holders of record on May 23, 2011 to be paid June 2, 2011.

 

Stock-Based Compensation

 

Compensation expense for the fair value of stock based awards made to employees and the Board of Directors is recognized over the requisite service period for awards expected to vest. The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes option pricing model. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock award, (2) the expected future stock volatility over the expected term, (3) the expected dividend yield and (4) risk-free interest rate. The expected term represents the expected period of time the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock.  The expected dividend yield was based on the expectation we would continue paying dividends on our common stock at the same rate for the foreseeable future.  The risk free interest rate is based on the U.S. Zero-Bond rate.

 

The Company recognized $5,216,000, $5,954,000 and $4,940,000 of stock-based compensation costs in the consolidated statements of income for the year ended March 31, 2011, 2010 and 2009, respectively. The income tax benefit related to such compensation for the years ended March 31, 2011, 2010 and 2009 was approximately $1,770,000, $2,038,000 and $1,724,000, respectively.

 

The following table summarizes share-based compensation costs included in the Company’s consolidated statements of operations:

 

 

 

Fiscal Year Ended

 

(In thousands)

 

March 31,
2011

 

March 31,
2010

 

March 31,
2009

 

Cost of revenues

 

$

797

 

$

975

 

$

754

 

Selling, general and administrative

 

4,419

 

4,979

 

4,186

 

Total share-based compensation expense before tax

 

$

5,216

 

$

5,954

 

$

4,940

 

 

The fair value of options at date of grant was estimated with the following assumptions:

 

 

 

Fiscal Year Ended

 

 

 

March 31,
2011

 

March 31,
2010

 

March 31,
2009

 

Assumptions:

 

 

 

 

 

 

 

Expected life

 

5 years

 

5 years

 

5 years

 

Risk-free interest rate

 

1.60

%

2.37

%

2.99

%

Stock volatility

 

44

%

46

%

49

%

Dividend yield

 

1.6

%

1.2

%

1.3

%

 

New Accounting Pronouncements

 

Accounting Changes to be Implemented.

 

In October 2009, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2009-14, Revenue Recognition (Topic 605)—Applicability of AICPA Statement of Position 97-2 to Certain Arrangements That Include Software Elements (ASU 2009-14). ASU 2009-14 excludes tangible products containing software components and non-software

 

38



Table of Contents

 

components that function together to deliver the product’s essential functionality from the scope of FASB Accounting Standards Codification (“ASC”) 605-985, Software-Revenue Recognition. ASU 2009-14 shall be applied on a prospective basis to revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. Early adoption was permitted. Upon adoption, the Company must apply ASU 2009-14 retrospectively to the beginning of the fiscal year of adoption or to all periods presented. The adoption of ASU 2009-14 is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.

 

2. LEASE AGREEMENTS

 

The Company leases certain facilities under non-cancelable operating leases with various renewal options. For operating leases which contain fixed escalations in rental payments, the Company records the total rent payable on a straight-line basis over the original lease term. The Company incurred $670,000, $262,000 and $253,000 of operating rent expense in the fiscal years ended March 31, 2011, 2010, and 2009 respectively.   In conjunction with the Company’s lease for its headquarters, the Company has issued security in the form of a standby letter of credit in the amount of $300,000 with an original expiration date of March 1, 2006 which contains automatic extensions through May 15, 2016.

 

In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts.  As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space.  The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period. In January 2007, the Company amended this lease agreement to expand its lease to include the remaining available space in the building.  During the fiscal year ended March 31, 2007, the Company capitalized $2,029,000 to record the facility on its books with an offsetting amount to the Lease Financing Liability.  In addition, amounts paid for construction were recorded as construction in progress and the landlord construction allowances of $367,000 in 2008 were recorded as additional lease financing liability.

 

At the completion of the construction of the initial renovations in February 2006, the lease was reviewed for potential sale-leaseback treatment in accordance with ASC 840 Leases.  Based on this review, it was determined that the lease did not qualify for sale-leaseback treatment.  As a result, building and tenant improvements and associated lease financing liabilities remained on the Company’s financial statements.  The Lease Financing Liability is being amortized over the lease term based on the payments designated in the agreement and the building and tenant improvement assets are being depreciated on a straight line basis over their useful lives.

 

Future minimum rental payments under the Company’s non-cancelable leases, excluding real estate taxes, insurance and operating costs paid by the Company, required over the initial terms of the leases are as follows (in thousands):

 

Year Ending March 31,

 

Operating Leases

 

Capital Leases

 

2012

 

$

651

 

$

1,413

 

2013

 

260

 

1,424

 

2014

 

245

 

1,542

 

2015

 

245

 

1,542

 

2016

 

225

 

1,414

 

Thereafter

 

 

 

Total payments

 

$

1,626

 

7,335

 

Imputed interest

 

 

 

(259

)

Lease financing liability

 

 

 

7,076

 

Less: Current portion of lease financing liability

 

 

 

1,321

 

Lease financing liability, net of current portion

 

 

 

$

5,755

 

 

3. LINE OF CREDIT

 

The Company previously had in place a Loan and Security Agreement with Silicon Valley Bank which provided a $30.0 million facility to support routine letters of credit and working capital needs.  The Loan and Security Agreement expired on November 12, 2010 and the Company decided not to renew this facility given the cash flows provided from operations and the Company’s available cash and investments balance.   As of the date of such decision, the Company had not drawn on this facility since June of 2002 and had used this credit facility exclusively to issue standby letters of credit.

 

Under the terms of this Loan and Security Agreement, the Company was required to pay certain one-time facility fees which were being amortized over the life of the facility and other unused credit fees.  Total expenses incurred related to these fees were $94,000, $227,000 and $214,000 in fiscal 2011, 2010, and 2009, respectively.

 

39



Table of Contents

 

In the normal course of business, the Company may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which is remote in management’s opinion.  At March 31, 2011, the Company had outstanding $28,041,000 in standby letters of credit. Upon expiration of the Company’s Loan and Security Agreement as noted above, these outstanding standby letters of credit became restricted cash-secured at amounts ranging from 105% to 110% of the value of outstanding letters of credit.  This resulted in a restricted cash balance of $29,460,000 at March 31, 2011 of which $9,062,000 was considered long-term restricted cash due to the expiration date of the underlying letters of credit.

 

4. INCOME TAXES

 

The provision for income taxes for the years ended March 31, 2011, 2010, and 2009 consisted of the following:

 

(In thousands)

 

2011

 

2010

 

2009

 

Current:

 

 

 

 

 

 

 

Federal

 

$

24,080

 

$

20,420

 

$

14,470

 

State

 

636

 

(1,288

)

1,108

 

Foreign

 

22

 

35

 

40

 

 

 

24,738

 

19,167

 

15,618

 

Deferred:

 

 

 

 

 

 

 

Federal

 

(2,354

)

(399

)

(227

)

State

 

(640

)

(954

)

(44

)

Change in valuation allowance

 

314

 

856

 

 

 

 

(2,680

)

(497

)

(271

)

Provision for income taxes

 

$

22,058

 

$

18,670

 

$

15,347

 

 

The difference between the total expected provision for income taxes computed by applying the statutory federal income tax rate to income before provision for income taxes and the recorded provision for income taxes for the three years in the period ended March 31, 2011 is as follows:

 

(In thousands)

 

2011

 

2010

 

2009

 

Provision for income taxes at statutory rate

 

$

22,706

 

$

19,196

 

$

15,295

 

State tax provision (benefit) net of federal effect

 

(2

)

(1,458

)

692

 

Stock based compensation

 

616

 

736

 

286

 

Research tax credits

 

(432

)

(291

)

(395

)

Qualifying manufacturing credits

 

(1,346

)

(719

)

(539

)

Change in valuation allowance

 

314

 

856

 

 

Other

 

202

 

350

 

8

 

Provision for income taxes

 

$

22,058

 

$

18,670

 

$

15,347

 

 

The significant components of the net deferred tax assets at March 31, 2011 and 2010 are as follows:

 

 

 

March 31, 2011

 

March 31, 2010

 

(In thousands)

 

Current

 

Non-current

 

Current

 

Non-current

 

Deferred tax assets (liabilities):

 

 

 

 

 

 

 

 

 

Accounts receivable and unbilled costs and fees

 

$

 

$

119

 

$

 

$

118

 

Inventory

 

318

 

1,558

 

319

 

1,412

 

Deferred revenue

 

 

2,555

 

 

1,617

 

Accrued vacation

 

651

 

 

571

 

 

Accrued warranty costs

 

436

 

 

342

 

 

Depreciation

 

 

(17

)

 

(559

)

Unearned compensation

 

1,861

 

2,564

 

919

 

2,583

 

State credit carryforwards

 

 

1,170

 

 

813

 

Other

 

203

 

 

281

 

 

Deferred income tax assets

 

3,469

 

7,949

 

2,432

 

5,984

 

Valuation allowance

 

 

(1,170

)

(43

)

(813

)

Net deferred income taxes

 

$

3,469

 

$

6,779

 

$

2,389

 

$

5,171

 

 

40



Table of Contents

 

During fiscal year 2010, state tax benefits, net of federal effect, of approximately $825,000 were realized as a result of state tax planning initiatives adopted by the Company.  At March 31, 2011 and March 31, 2010, the Company has $1,800,000 and $1,250,000 of state credit carryforwards, respectively.   Of these amounts, approximately $432,000 and $400,000 at March 31, 2011 and March 31, 2010, respectively, have unlimited carryforward and the remaining balances expire in various years through March 31, 2026.

 

At March 31, 2011 and March 31, 2010, the Company had a deferred tax valuation allowance of $1,170,000 and $856,000, respectively, on state credit carryforwards and other deferred tax assets for which management believes it is more-likely-than-not that realization of these assets will not occur.

 

The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2008 through 2010 and for various state taxing authorities for the years ending March 31, 2006 through 2010.  During fiscal 2010, the Company completed an audit by the Internal Revenue Service for tax years ended March 31, 2006 and 2007, the results of which did not have a material impact on the Company’s financial position or results of operations.   The Company believes that there were no uncertain tax positions that required a reserve as of March 31, 2011 and March 31, 2010.

 

5. WARRANTY OBLIGATIONS

 

Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at time of shipment or delivery. Accrual rates are based upon historical experience over the preceding twelve months and management’s judgment of future exposure. Warranty experience for the years ended March 31, 2011 and 2010 is as follows:

 

(In thousands)

 

2011

 

2010

 

Warranty accrual at beginning of period

 

$

965

 

$

1,130

 

Accruals for warranties issued during the period

 

2,153

 

1,212

 

Adjustment of preexisting accrual estimates

 

(158

)

(815

)

Warranty costs incurred during period

 

(1,735

)

(562

)

Warranty accrual at end of period

 

$

1,225

 

$

965

 

 

6. STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

The Company’s articles of organization authorize its Board of Directors to issue up to 100,000 shares of preferred stock in one or more series, to determine and fix certain relative rights and preferences of the shares of any series, to fix the number of shares constituting any such series, and to fix the designation of any such series, without further vote or action by its shareholders. The Company has no present plans to issue shares of preferred stock. In 1998, the Company designated a series of Preferred Stock (the “Series A Preferred Stock”) to be issued upon the exercise of Rights issued under the Company’s Shareholder Rights Plan. Under the Shareholder Rights Plan, adopted in 1998 and reissued upon its expiration in April 2008, its stockholders are entitled to purchase shares of its Series A Preferred Stock under certain circumstances. These circumstances include the purchase of 15% or more of the outstanding shares of common stock by a person or group, or the announcement of a tender or exchange offer to acquire 15% or more of the outstanding common stock.

 

Stock Repurchase Program

 

On May 17, 2007, the Board of Directors approved a Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market.  This Stock Repurchase Program was completed in the first quarter of fiscal 2009.  On May 8, 2008 the Board of Directors approved an additional Stock Repurchase Program which authorizes the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market.  During the fiscal year ended March 31, 2011, the Company repurchased 51,269 shares of common stock under this Program at an average price of $72.87.  As of March 31, 2011, the remaining balance available under the program to purchase shares was $20,068,000.

 

Stock Option and Other Compensation Plans

 

The Company has various stock option and other compensation plans for directors, officers, and employees. The Company had the following stock option plans outstanding as of March 31, 2011: the 1995 Combination Plan, the 1997 Non-Qualified Option Plan, the 1998 Non-Qualified Option Plan, the 1999 Combination Plan, the 2000 Combination Plan, the 2002 Combination Plan, the 2003 Stock Plan for Non-Employee Directors and the 2005 Equity and Incentive Plan. There are 3,980,000

 

41



Table of Contents

 

shares authorized under these plans. Vesting periods are at the discretion of the Board of Directors and typically range from one to three years. Certain of the options granted vest upon the achievement of certain performance based goals as well as service time incurred.  Options under these plans are granted at fair market value and have a term of ten years from the date of grant.

 

Stock Options:    A summary of the Company’s stock option activity is as follows:

 

 

 

2011

 

2010

 

2009

 

 

 

Number
of Shares

 

Weighted
Average
Exercise
Price

 

Number
of Shares

 

Weighted
Average
Exercise
Price

 

Number
of Shares

 

Weighted
Average
Exercise
Price

 

Options outstanding, beginning of year

 

613,934

 

$

47.37

 

709,254

 

$

44.47

 

828,063

 

$

41.70

 

Options granted

 

56,181

 

74.87

 

63,993

 

62.17

 

64,191

 

64.13

 

Options exercised

 

(197,669

)

35.12

 

(158,863

)

40.34

 

(161,753

)

36.49

 

Options canceled or expired

 

 

 

(450

)

53.55

 

(21,247

)

56.58

 

Options outstanding, end of year

 

472,446

 

$

55.77

 

613,934

 

$

47.37

 

709,254

 

$

44.47

 

Options exercisable, end of year

 

397,592

 

$

53.06

 

544,080

 

$

45.54

 

625,646

 

$

41.90

 

Options available for grant

 

301,732

 

 

 

365,572

 

 

 

294,629

 

 

 

Weighted average fair value per share of options granted during the year

 

 

 

$

26.21

 

 

 

$

23.52

 

 

 

$

26.54

 

 

The following summarizes certain data for options outstanding and exercisable at March 31, 2011:

 

 

 

Number of
Shares

 

Range of Exercise
Prices

 

Weighted
Average
Exercise Price

 

Weighted
Average
Remaining
Contractual Life

 

Options outstanding:

 

27,327

 

$6.50-$20.00

 

$

12.84

 

2.40

 

 

 

21,100

 

$20.01-$30.00

 

28.50

 

3.37

 

 

 

20,500

 

$30.01-$40.00

 

39.06

 

3.68

 

 

 

53,600

 

$40.01-$50.00

 

45.47

 

4.26

 

 

 

86,562

 

$50.01-$60.00

 

53.24

 

4.26

 

 

 

207,176

 

$60.01-$70.00

 

64.41

 

5.30

 

 

 

56,181

 

$70.01-$75.82

 

74.87

 

9.42

 

 

 

472,446

 

$6.50-$75.82

 

$

55.77

 

5.16

 

 

 

 

 

 

 

 

 

 

 

Options exercisable:

 

27,327

 

$6.50-$20.00

 

$

12.84

 

 

 

 

 

21,100

 

$20.01-$30.00

 

28.50

 

 

 

 

 

20,500

 

$30.01-$40.00

 

39.06

 

 

 

 

 

53,600

 

$40.01-$50.00

 

45.47

 

 

 

 

 

82,701

 

$50.01-$60.00

 

53.32

 

 

 

 

 

188,183

 

$60.01-$70.00

 

64.71

 

 

 

 

 

4,181

 

$70.01-$75.82

 

75.82

 

 

 

 

 

397,592

 

$6.50-$75.82

 

$

53.06

 

 

 

 

The total intrinsic value, representing the difference between market value on the date of exercise and the option price, of stock options exercised during fiscal 2011, 2010 and 2009 was $10,121,000, $4,796,000 and $5,265,000, respectively.   Nonvested stock option awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of March 31, 2011, there was $630,000 of total unrecognized compensation cost related to nonvested stock option awards granted under the Company’s stock plans. This cost is expected to be recognized over a weighted average of 0.5 years.

 

The Company realizes a tax deduction upon the exercise of non-qualified stock options and disqualifying dispositions of incentive stock options due to the recognition of compensation expense in the calculation of its taxable income. The amount of the compensation recognized for tax purposes is based on the difference between the market value of the common stock and the option price at the date the options are exercised and/or sold. The Company receives an additional tax deduction when restricted stock vests at a higher value than the value used to recognize compensation expense at the date of grant.  These tax benefits are credited to additional paid-in capital if it is considered more likely than not that they will be realized. During fiscal 2011, 2010 and 2009, a tax benefit of $3,730,000, $1,087,000 and $1,284,000, respectively, was recorded to additional paid-in capital for exercises and/or sales of stock options or stock.

 

42



Table of Contents

 

Restricted Stock and Restricted Stock Units:  The Company has instituted long term incentive plans for certain key employees. These plans call for the issuance of restricted stock, stock options, and/or cash awards which vest upon the achievement of certain performance based goals as well as service time incurred. In fiscal 2011, the Company opted to issue this long term incentive plan with only a cash award which resulted in fewer restricted stock awards and stock options being granted.

 

Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years.  In addition, annually on January 10th the Board of Directors is granted restricted stock. These restricted stock shares vest on a pro-rata basis on service time performed over a one year period.  The fair values of these restricted stock awards are equal to the market price per share of the Company’s common stock on the date of grant.

 

Nonvested restricted stock and stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of March 31, 2011 there was $852,000 of total unrecognized compensation cost related to nonvested restricted stock and stock unit awards granted under the Company’s stock plans. This cost is expected to be recognized over a weighted average of 1.1 years.

 

A summary of the Company’s restricted stock and stock unit activity is as follows:

 

 

 

2011

 

2010

 

2009

 

 

 

Number
of Shares

 

Weighted
Average
Exercise
Price

 

Number
of Shares

 

Weighted
Average
Exercise
Price

 

Number
of Shares

 

Weighted
Average
Exercise
Price

 

Unvested restricted stock and units outstanding, beginning of year

 

97,240

 

$

60.78

 

137,687

 

$

56.74

 

110,301

 

$

58.34

 

Granted

 

5,106

 

83.79

 

80,149

 

62.53

 

53,259

 

53.69

 

Vested

 

(69,464

)

60.45

 

(120,096

)

57.32

 

(9,194

)

56.59

 

Forfeited

 

 

 

(500

)

60.65

 

(16,679

)

57.64

 

Unvested restricted stock and units outstanding, end of year

 

32,882

 

$

65.03

 

97,240

 

$

60.78

 

137,687

 

$

56.74

 

 

7. BUSINESS SEGMENT INFORMATION

 

In accordance with the provisions of FASB ASC 280-10, Segment Reporting, the Company has determined that it has only one operating segment, the X-ray product segment. This includes X-ray detection and imaging products used primarily for the detection of illegal drugs, weapons and explosives, and smuggled goods. The equipment is purchased by sophisticated government and commercial clients focused on the detection of organic material in complex backgrounds and the ability to see the contents of containers with precision.

 

Geographical Data

 

All of the Company’s export sales originate from the United States.  At March 31, 2011, approximately 1.6% of the Company’s assets were in foreign countries.  The foreign assets were comprised of cash in foreign banks, and inventory in international depots for field replacements or systems shipped internationally but not accepted by fiscal year end.

 

The following table shows the breakdown of net sales and contract revenues to international and domestic customers based upon customer’s country of domicile and the major regions of international activity:

 

Net Sales and Contract Revenues

 

 

 

Fiscal Year

 

(Dollars in thousands)

 

2011

 

2010

 

2009

 

Domestic

 

$

190,769

 

68

%

$

163,873

 

68

%

$

138,240

 

63

%

International

 

87,807

 

32

%

78,220

 

32

%

80,127

 

37

%

Net Sales and Contract Revenues

 

$

278,576

 

100

%

$

242,093

 

100

%

$

218,367

 

100

%

Percent of International Revenue by Major Region:

 

 

 

 

 

 

 

 

 

 

 

 

 

Middle East & Africa

 

 

 

84

%

 

 

81

%

 

 

85

%

Pacific Rim

 

 

 

7

%

 

 

8

%

 

 

7

%

Europe

 

 

 

7

%

 

 

9

%

 

 

8

%

All Other

 

 

 

2

%

 

 

2

%

 

 

%

 

43



Table of Contents

 

Major Customers:  Sales to major customers (representing in excess of 10% of consolidated revenues) consisted of the following:

 

Fiscal 2011:   $82,634,000, $32,316,000 and $31,072,000, respectively, to three customers.

 

Fiscal 2010:   $59,204,000 and $28,591,000, respectively, to two customers.

 

Fiscal 2009:   $39,187,000 and $34,635,000, respectively, to two customers.

 

Domestically, the Company’s primary client base is comprised of agencies of the U.S. government. Approximately 65%, 63% and 56% of the Company’s sales in fiscal 2011, 2010, and 2009 respectively, were derived from either (i) contracting directly with the U.S. government, or (ii) contracting with contractors working directly with the U.S. government. Certain of the Company’s contracts with the U.S. government provide the U.S. government with the standard unilateral right to terminate these contracts for convenience. During fiscal 2011, one of the Company’s contracts with the U.S. government was terminated for convenience by the U.S. government.  During fiscal 2010, one of the Company’s contracts with the U.S. government was terminated for convenience by the U.S. government.  During fiscal 2009, two of the Company’s contracts with the U.S. government were partially terminated for convenience by the U.S. government.  These terminations of these contracts did not result in material losses to the Company.

 

8. FAIR VALUE MEASUREMENTS

 

FASB ASC 820, Fair Value Measurements and Disclosures, defines and establishes a framework for measuring fair value and expands disclosures about fair value measurements. In accordance with ASC 820, we have categorized our financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument.

 

Financial assets recorded on the Consolidated Balance Sheets are categorized based on the inputs to the valuation techniques as follows:

 

Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include active exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities).

 

Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.  Level 2 inputs include the following:

 

·             Quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal bonds which trade infrequently);

 

·             Inputs other than quoted prices that are observable for substantially the full term of the asset or liability (examples include interest rate and currency swaps); and

 

·             Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability (examples include certain securities and derivatives).

 

Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities.

 

The following table presents the financial assets and liabilities we measure at fair value on a recurring basis, based on the fair value hierarchy as of March 31, 2011 and March 31, 2010:

 

(In thousands)

 

March 31,
2011

 

March 31,
2010

 

Level 1 — Financial Assets

 

 

 

 

 

U.S. Treasury bills

 

$

20,120

 

$

35,005

 

Level 2 — Financial Assets

 

 

 

 

 

Corporate debentures/bonds

 

44,586

 

42,588

 

Government agency bonds

 

13,099

 

28,589

 

Commercial paper

 

57,512

 

25,983

 

Money market funds

 

10,249

 

19,705

 

Certificates of deposit

 

4,000

 

12,001

 

Total Level 2 Financial Assets

 

129,446

 

128,866

 

Total cash equivalents and short-term investments

 

$

149,566

 

$

163,871

 

 

44



Table of Contents

 

These investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. The unrealized holding gains or losses on these securities are included as a component of comprehensive income in the Consolidated Statements of Stockholders’ Equity and Comprehensive Income.

 

 

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Fair Value

 

2011:

 

 

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

Corporate debentures/bonds

 

$

44,585

 

$

13

 

$

(12

)

$

44,586

 

Treasury bills

 

20,095

 

25

 

 

20,120

 

Government agency bonds

 

6,593

 

7

 

 

6,600

 

Commercial paper

 

34,834

 

1

 

 

34,835

 

Certificates of deposit

 

4,000

 

 

 

4,000

 

Total short-term investments

 

$

110,107

 

$

46

 

$

(12

)

$

110,141

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

Money market funds

 

10,249

 

 

 

10,249

 

Government agency bonds

 

6,500

 

 

(1

)

6,499

 

Commercial paper

 

22,677

 

 

 

22,677

 

Total cash equivalents

 

$

39,426

 

$

 

$

(1

)

$

39,425

 

 

 

 

 

 

 

 

 

 

 

2010:

 

 

 

 

 

 

 

 

 

Short-term investments:

 

 

 

 

 

 

 

 

 

Corporate debentures/bonds

 

$

42,585

 

$

26

 

$

(23

)

$

42,588

 

Treasury bills

 

34,982

 

28

 

(5

)

35,005

 

Government agency bonds

 

28,600

 

2

 

(13

)

28,589

 

Commercial paper

 

25,982

 

1

 

 

25,983

 

Certificates of deposit

 

12,001

 

 

 

12,001

 

Total short-term investments

 

$

144,150

 

$

57

 

$

(41

)

$

144,166

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

Money market funds

 

$

19,705

 

$

 

$

 

$

19,705

 

 

9.  DERIVATIVE FINANCIAL INSTRUMENTS

 

The Company purchased in the fourth quarter of fiscal year 2010, a foreign currency put option contract to manage the risk associated with foreign currency exchange rate fluctuations on an anticipated obligation and transaction.  The foreign currency put option contract was paid in full at execution and was related to our activities in Europe. The put option contract provided us with the option to exchange Euros for U.S. dollars at a fixed exchange rate such that, if the Euro were to depreciate against the U.S. dollar to predetermined levels as set by the contract, we could exercise our option and mitigate our foreign currency exchange losses. This contract did not qualify for hedge accounting treatment and was marked-to-market through the results of operations until it was settled.   This contract was sold during the second quarter ending September 30, 2010.  The Company recorded net mark-to-market income for this contract of $122,000, which is included in other income and expense in the consolidated statements of operations.  The Company had no option contracts outstanding at March 31, 2011.

 

10. COMMITMENTS AND CONTINGENCIES

 

Purchase Commitments

 

In the normal course of business, the Company enters into purchase orders with its vendors for the purchase of materials or services to meet its production needs. At March 31, 2011, the Company had $16,589,000 of open purchase orders which are expected to be substantially fulfilled within the next two years. Certain single source vendors or vendors producing custom material require significant lead times from order to delivery of their material. Should the demand for the Company’s products decline significantly, or should there be a significant shift in the mix of products being demanded, the Company may incur cancellation charges related to these commitments, that could be material to the Company’s results of operations. To date, the Company has not experienced any material losses related to cancellation penalties.

 

45



Table of Contents

 

Employment Agreements

 

The Compensation Committee of the Board of Directors of the Company approved revisions to the Company’s employment agreement with its Chief Executive Officer, Anthony Fabiano and such revisions became effective on June 1, 2011.  Under revisions to the agreement, Mr. Fabiano, in the event of a termination pursuant to a change of control (as defined in the agreement), is eligible to receive a payment equal to 2.9 times his base salary in effect on the date of termination plus a pro rata portion of his bonus for the fiscal year in which the termination occurred, his annual target bonus, the continuation of health benefits for a period of three years, the vesting of awards under the Company’s 2005 Equity and Incentive Plan and the continuation of certain life insurance benefits.  In addition, in the event that any of Mr. Fabiano’s awards under the Company’s 2005 Equity and Incentive Plan are not assumed or replaced upon a change of control of the Company, his options, restricted stock and cash-based long-term incentive awards will fully vest upon the change of control, regardless of termination of employment.  In the event of a qualifying termination not pursuant to a change of control, Mr. Fabiano is eligible for a payment equal to two times his base salary in effect at the date of termination, plus a pro rata portion of his bonus for the fiscal year in which the termination occurred, his annual target bonus, the continuation of health benefits for a period of eighteen months and the continuation of certain life insurance benefits.

 

The Compensation Committee of the Board of Directors of the Company approved revisions to the Company’s Change in Control and Severance Benefit Agreements covering members of its executive staff including its Chief Financial Officer and such revisions became effective on June 1, 2011. Under the revisions to these agreements, these executives, in the event of termination within two years following a change of control (as defined in the revised agreements), are eligible to receive a payment equal to two times the highest annual rate of base salary payable to the executive during the one-year period ending on the change of control date (or date of shareholder approval, if the executive’s employment is terminated without cause prior to the change in control date) or the termination date (whichever results in a higher amount) plus his or her annual target bonus, the continuation of health benefits for a period of three years and the vesting of all awards under the Company’s 2005 Equity and Incentive Plan.  In addition, in the event that an executive’s awards under the Company’s 2005 Equity and Incentive Plan are not assumed or replaced upon a change of control of the Company, his or her options, restricted stock and cash-based long-term incentive awards will fully vest upon the change of control, regardless of termination of employment.  In the event of qualifying termination not pursuant to a change of control, the members of the executive staff are eligible to receive a payment equal to one times his or her highest annual rate of base salary payable to the executive during the one-year period ending on the termination date and the continuation of health benefits for one year.

 

Retirement Savings Plan

 

The Company maintains a 401(k) Retirement Savings Plan (the “Plan”) for all employees.   Employees are eligible to participate on the first of the month following date of employment.  The Plan is funded by elective employee contributions of up to 100% of their compensation up to IRS limits. Under the Plan the Company at its discretion matches 50% of the first 6% of employee contributions for each participant in the form of Company common stock or cash. In fiscal 2011, the Company began matching employee’s contributions in cash instead of Company common stock as it had in prior years.  Expenses under the Plan, consisting of Company contributions which were made in Company stock or cash and Plan administrative expenses paid by the Company, totaled $1,139,000, $993,000 and $789,000, in 2011, 2010, and 2009 respectively.

 

46



Table of Contents

 

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

UNAUDITED QUARTERLY CONSOLIDATED FINANCIAL DATA

FOR THE YEARS ENDED MARCH 31, 2011 AND MARCH 31, 2010

(In thousands, except per shares amounts)

 

 

 

2011 by quarter

 

2010 by quarter

 

 

 

1st

 

2nd

 

3rd

 

4th

 

1st

 

2nd

 

3rd

 

4th

 

Net sales and contract revenues

 

$

53,643

 

$

80,637

 

$

76,588

 

$

67,708

 

$

54,692

 

$

61,248

 

$

54,889

 

$

71,264

 

Gross profit

 

$

23,812

 

$

39,844

 

$

34,704

 

$

30,842

 

$

25,620

 

$

29,454

 

$

22,627

 

$

33,369

 

Operating income

 

$

8,989

 

$

23,622

 

$

17,362

 

$

14,471

 

$

11,112

 

$

16,494

 

$

8,851

 

$

17,867

 

Net income

 

$

6,801

 

$

14,669

 

$

11,782

 

$

9,565

 

$

7,336

 

$

10,695

 

$

5,819

 

$

12,326

 

Net income per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

— Basic

 

$

0.75

 

$

1.63

 

$

1.31

 

$

1.05

 

$

0.83

 

$

1.21

 

$

0.65

 

$

1.37

 

— Diluted

 

$

0.74

 

$

1.59

 

$

1.28

 

$

1.03

 

$

0.81

 

$

1.18

 

$

0.64

 

$

1.34

 

 

47



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

AMERICAN SCIENCE AND ENGINEERING, INC.

 

 

DATED: June 9, 2011

By:

/s/ ANTHONY R. FABIANO

 

 

 

 

 

Anthony R. Fabiano

 

 

President and Chief Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the dates indicated:

 

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ ANTHONY R. FABIANO

 

Director and President and Chief Executive Officer

 

June 9, 2011

Anthony R. Fabiano

 

(Principal Executive Officer)

 

 

 

 

 

 

 

/s/ KENNETH J. GALAZNIK

 

Senior Vice President, Chief Financial Officer and

 

June 9, 2011

Kenneth J. Galaznik

 

Treasurer (Principal Financial and Accounting

 

 

 

 

Officer)

 

 

 

 

 

 

 

/s/ DENIS R. BROWN

 

Chairman of the Board, Director

 

June 9, 2011

Denis R. Brown

 

 

 

 

 

 

 

 

 

/s/ JOHN A. GORDON

 

Director

 

June 9 2011

John A. Gordon

 

 

 

 

 

 

 

 

 

/s/ HAMILTON W. HELMER

 

Director

 

June 9, 2011

Hamilton W. Helmer

 

 

 

 

 

 

 

 

 

/s/ DON R. KANIA

 

Director

 

June 9, 2011

Don R. Kania

 

 

 

 

 

 

 

 

 

/s/ ERNEST J. MONIZ

 

Director

 

June 9, 2011

Ernest J. Moniz

 

 

 

 

 

 

 

 

 

/s/ MARK S. THOMPSON

 

Director

 

June 9, 2011

Mark S. Thompson

 

 

 

 

 

 

 

 

 

/s/ CARL W. VOGT

 

Director

 

June 9, 2011

Carl W. Vogt

 

 

 

 

 

48



Table of Contents

 

EXHIBIT INDEX

 

Exhibit
Number

 

Description of Exhibit
(and Statement of Incorporation by Reference, If Applicable)

 

 

 

3.1

 

Restated Articles of Organization of the Company, as amended, including Certificate of Designation, Preferences, and Rights of Preferred Stock of the Company, dated April 16, 2008 (filed as Exhibit 3.1 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)

3.5

 

Amended and Restated By-laws of the Company (filed as Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2003, and incorporated herein by reference)

4.2

 

Rights Agreement, dated April 17, 2008, between the Company and American Stock Transfer & Trust Company (filed as Exhibit 4.1 to the Company’s filing on Form 8-A12B filed on April 18, 2008 and incorporated herein by reference)

10.1

*

1997 Non-Qualified Stock Option Plan (filed as Exhibit 99 to the Company’s Registration Statement on Form S-8, File No. 333-27927, filed on May 28, 1997 and incorporated herein by reference)

10.2

*

1998 Non-Qualified Stock Option Plan (filed as Exhibit (10)(b)(xiii) to the Company’s Annual Report on Form 10-K for the year ended March 31, 1998 and incorporated herein by reference)

10.3

 

Lease of Billerica property (filed as Exhibit 10(c) to the Company’s Annual Report on Form 10-K for the year ended March 31, 1995 and incorporated herein by reference)

10.4

 

Amendment to Lease of Billerica property (filed as Exhibit 10(c)(ii) to the Company’s Annual Report on Form 10-K for the year ended March 28, 1997 and incorporated herein by reference)

10.5

*

1999 Combination Stock Option Plan (filed as Exhibit 99 to the Company’s Registration Statement on Form S-8, File No. 333-91801, filed on November 30, 1999 and incorporated herein by reference)

10.6

*

2000 Combination Stock Option Plan (filed as Exhibit A to the Definitive Proxy Statement on Schedule 14A filed on August 18, 2000 and incorporated herein by reference)

10.7

*

2002 Combination Stock Option Plan (filed as Exhibit 99.1 to the Company’s Registration Statement on Form S-8, No. 333-102338, filed on January 3, 2003 and incorporated herein by reference)

10.10

 

Second Amendment of Lease of 829 Middlesex Turnpike, Billerica, Massachusetts (filed as Exhibit 10(c)(vii) to the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2004 and incorporated herein by reference)

10.11

*

Amendment of 2002 Combination Stock Option Plan (filed as Exhibit 99.1 to the Company’s Registration Statement on Form S-8, No. 333-102338, filed on January 3, 2003 and incorporated herein by reference)

10.12

*

2003 Stock Plan for Non-Employee Directors (filed as Exhibit 4.1 to the Company’s Registration Statement on Form S-8, File No. 333-117843, filed on July 30, 2004 and incorporated herein by reference)

10.13

*

Amendment to 2003 Stock Plan for Non-Employee Directors (filed as Exhibit 10(c)(xx) to the Company’s Annual Report on Form 10-K for the year ended March 31, 2005 and incorporated herein by reference)

10.14

*

2005 Equity and Incentive Plan (filed as Exhibit 99.1 to the Company’s Registration Statement on Form S-8, No. 333-162291, filed on October 2, 2009 and incorporated herein by reference)

10.17

*

Form of Restricted Stock Agreement (Performance) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10(c)(xxiv) to the Company’s Annual Report on Form 10-K for the year ended March 31, 2006 and incorporated herein by reference)

10.18

*

Form of Stock Option Agreement (Performance) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10(c)(xxv) to the Company’s Annual Report on Form 10-K for the year ended March 31, 2006 and incorporated herein by reference)

10.19

*

Form of Stock Option Agreement (ISO) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10(c)(xxvi) to the Company’s Annual Report on Form 10-K for the year ended March 31, 2006 and incorporated herein by reference)

10.20

 

Form of Stock Option Agreement (NQ) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10(c)(xxvi) to the Company’s Annual Report on Form 10-K for the year ended March 31, 2006 and incorporated herein by reference)

10.21

 

Third Amendment of Lease of 829 Middlesex Turnpike, Billerica, Massachusetts (filed as Exhibit 10(c)(xxviii) to the Company’s Annual Report on Form 10-K for the year ended March 31, 2007 and incorporated herein by reference)

10.22

*†

Revised Agreement between the Company and Anthony Fabiano dated June 1, 2011 and filed herewith

10.24

*

Form of Restricted Stock Agreement (Performance) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008 and incorporated herein by reference)

10.25

*

Form of Incentive Stock Agreement (Performance) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10.3 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008 and incorporated herein by reference)

10.26

*

Form of Long-Term Incentive Plan Agreement — Cash Component (filed as Exhibit 10.4 to the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2008 and incorporated herein by reference)

10.27

*

Revised Form of Change in Control & Severance Benefit Agreement between the Company and each of its executive officers other than its President and Chief Executive Officer (filed as Exhibit 10.2 to the Company’s Report on Form 8-K dated April 28, 2011 and incorporated herein by reference)

10.28

 

American Science and Engineering, Inc. 401(k) and Profit Sharing Plan (filed as Exhibit 4.1 to the Company’s Registration Statement on Form S-8 dated July 25, 2008 and incorporated herein by reference)

 

49



Table of Contents

 

10.39

 

Form of Short Term Incentive Bonus Plan Document (filed as Exhibit 10.1 to the Company’s filing on Form 10-Q dated November 5, 2009 and incorporated herein by reference)

10.41

*

Form of Restricted Stock Agreement (Performance) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10.41 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)

10.42

*

Form of Nonstatutory Stock Option Agreement (Performance) under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10.42 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)

10.43

*

Form of Long-Term Incentive Plan Agreement — Cash Component (filed as Exhibit 10.43 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)

10.44

 

Form of Non-Employee Director Restricted Stock Award Agreement under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10.44 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)

10.45

 

Form of Non-Statutory Stock Option Agreement For Directors under the Company’s 2005 Equity and Incentive Plan (filed as Exhibit 10.45 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)

10.46

*

Form of Indemnification Agreement between the Company and each of its directors and executive officers (filed as Exhibit 10.1 to the Company’s Report on Form 8-K dated September 8, 2010 and incorporated herein by reference)

10.47

*†

Form of Restricted Stock Agreement (Time Vesting) under the Company’s 2005 Equity and Incentive Plan (filed herewith)

10.48

Fourth Amendment of Lease of 829 Middlesex Turnpike, Billerica, Massachusetts dated January 18, 2011 (filed herewith)

21.1

Subsidiaries of Registrant

23.1

Consent of Independent Registered Public Accounting Firm

23.2

Consent of Independent Registered Public Accounting Firm

31.1

Certification of Chief Executive Officer pursuant to Rule 13a-14(a)

31.2

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 


†   Filed herewith

*   Management contract or compensatory plan

 

50


EX-10.22 2 a11-14447_1ex10d22.htm EX-10.22

Exhibit 10.22

 

AGREEMENT

 

AGREEMENT made and entered into in Billerica, Massachusetts, by and between American Science and Engineering, Inc. (the “Company”), a Massachusetts corporation with its principal place of business at Billerica, Massachusetts, and Anthony Fabiano (the “Executive”), effective as of the 1st day of June, 2011 (the “Effective Date”).

 

WHEREAS, the Executive has been employed by the Company since 2002, most recently as its Chief Executive Officer;

 

WHEREAS, the Company wishes to continue to retain the services of the Executive, and the Executive wishes to continue in the employ of the Company, from and after the Effective Date, under the terms and subject to the conditions set forth in this Agreement, in extension and modification of the terms in effect under the prior version of this Agreement dated February 7, 2008;

 

NOW, THEREFORE, in consideration of the foregoing premises and the mutual promises, terms, provisions and conditions set forth in this Agreement, the parties hereby agree:

 

1.                                  Employment. Subject to the terms and conditions set forth in this Agreement, the Company hereby offers, and the Executive hereby accepts, continued employment.

 

2.                                  Term. Subject to earlier termination as hereinafter provided, the Executive’s employment hereunder shall be for a term commencing on the Effective Date hereof and continuing through April 28, 2014, and shall renew automatically thereafter for successive terms of one (1) year each, unless either party provides written notice to the other at least three (3) months prior to the expiration of the original or any extension of any such term that the Agreement is not to be extended. The term of the Executive’s employment under this Agreement, as from time to time extended or renewed, is hereafter referred to as “the term of this Agreement” or “the term hereof”.

 

3.                                  Capacity and Performance.

 

(a)                             During the term hereof, the Executive shall serve the Company as its President and Chief Executive Officer. The Executive shall report directly and solely to the Board of Directors of the Company (the “Board”). The Company agrees to propose to the shareholders of the Company at each appropriate annual meeting during the term hereof the election of the Executive as a member of the Board, provided that the failure of the shareholders to so elect the Executive shall not constitute Good Reason for termination by the Executive hereunder, and provided further that the Executive shall resign from the Board effective immediately upon termination of his employment for any reason. In addition, and without further compensation, the Executive shall serve as a director and/or officer of one or more of the Company’s Affiliates if so elected or appointed from time to time.

 

(b)                            During the term hereof, the Executive shall be employed by the Company on a full-time basis and shall, subject to the control of the Board, have general charge and supervision of the business of the Company and such other duties and responsibilities on behalf of the Company and its Affiliates as are consistent with the foregoing and as may be reasonably designated from time to time by the Board or by its Chair or other designee (which designee shall be a member of the Board). The principal place of performance of the Executive’s duties and responsibilities hereunder shall be Billerica,

 



 

Massachusetts, provided, however, that the Executive shall be required to engage in business travel to the extent reasonably required by the Company.

 

(c)                             During the term hereof, the Executive shall devote all of his business time and his best efforts, business judgment, skill and knowledge exclusively to the advancement of the business and interests of the Company and its Affiliates and to the discharge of his duties and responsibilities hereunder. The Executive agrees that, during his employment with the Company, he will not undertake any outside activity, whether or not violative of the provisions of Section 7, 8 or 9 hereof, that could reasonably give rise to a conflict of interest or otherwise interfere with his duties and obligations to the Company or any of its Affiliates. The Executive shall devote all of his working time and attention to the performance of his duties and responsibilities hereunder; provided, the Executive may make passive personal investments and otherwise manage his personal affairs, serve as a member of the board of directors of one company that is not competitive with the business of the Company or any of its Affiliates, and serve on the board of directors for one civic, educational or charitable organization, provided that such activities do not violate the provisions of Sections 7, 8 or 9 hereof, or otherwise interfere, individually or in the aggregate, with the performance of the Executive’s duties and responsibilities.

 

4.                                  Compensation and Benefits. As compensation for all services performed by the Executive under and during the term hereof:

 

(a)                             Base Salary. During the term hereof, the Company shall pay the Executive a base salary at the rate of Six Hundred Three Thousand Five Hundred Twelve Dollars ($603,512) per annum, payable in accordance with the regular payroll practices of the Company for its executives and subject to increase (but not decrease) from time to time by the Board, in its sole discretion. Such base salary, as from time to time increased, is hereafter referred to as the “Base Salary.”

 

(b)                            Incentive and Bonus Compensation. Each fiscal year during the term hereof, the Executive shall be considered by the Board (or the Compensation Committee thereof) for a cash bonus with a target of 100% of Base Salary (the “Target Bonus Amount”), and a maximum of 200% of the Base Salary (the “Bonus”). The Bonus shall be determined by performance criteria meeting the requirements for performance-based compensation within the meaning of Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), preestablished by the Board (or the Compensation Committee thereof), in writing, in consultation with the Executive, no later than ninety (90) days after the period of service to which the performance relates (or at such earlier time as is required to qualify the Bonus as performance-based under Section 162(m) of the Code). A performance criterion must be an objectively determinable measure of performance relating to any or any combination of the following (measured either absolutely or by reference to an index or indices and determined either on a consolidated basis or, as the context permits, on a divisional, subsidiary, line of business, project or geographical basis or in combinations thereof): sales; revenues; assets; expenses; earnings before or after deduction for all or any portion of interest, taxes, depreciation, or amortization, whether or not on a continuing operations or an aggregate or per share basis; return on equity, investment, capital or assets; one or more operating ratios; borrowing levels, leverage ratios or credit rating; market share; capital expenditures; cash flow; stock price; stockholder return; sales of particular products or services; customer acquisition or retention; acquisitions and divestitures (in whole or in part); joint ventures and strategic alliances; spin-offs, split-ups and the like; reorganizations; or recapitalizations, restructurings, financings (issuance of debt or equity) or refinancings. Except as otherwise expressly provided under the terms of this Agreement, the Executive shall not be entitled to earn any Bonus or other incentive compensation pro-rata for any period of service less than a full year. Any Bonus due to the Executive hereunder will be payable on or before

 

2



 

the 75th calendar day following the close of the fiscal year for which the Bonus was earned (and in any event no later than March 15 of the calendar year following the calendar year in which the Bonus was earned).

 

(c)                             Long-Term Incentive Plans. Each fiscal year during the term hereof, the Executive will be eligible to participate in the Company’s long-term incentive programs (including but not limited to equity-based programs) (“LTIPs”). The Executive will be eligible to participate in such LTIPs in accordance with the terms thereof, as in effect from time to time, and on a basis at least as favorable as awards to other senior-level executives of the Company, provided, however, that nothing contained herein shall obligate the Company to adopt or continue any particular LTIP.

 

(d)                            Vacations. During the term hereof, the Executive shall be entitled to earn vacation at the rate of five (5) weeks per year, to be taken at such times and intervals as shall be determined by the Executive, subject to the reasonable business needs of the Company. Vacation shall otherwise be governed by the policies of the Company, as in effect from time to time.

 

(e)                             Other Benefits. During the term hereof, the Executive shall be entitled to participate in any and all Employee Benefit Plans from time to time in effect for employees of the Company generally, including but not limited to medical, dental, long-term disability and life insurance plans and a 401(k) plan, and on a basis at least as favorable as benefits to other senior- level executives of the Company, except to the extent any such Employee Benefit Plan is a type of benefit otherwise provided herein to the Executive (e.g., a severance pay plan). Such participation shall be subject to the terms of the applicable plan documents and generally applicable Company policies. In addition, during the term hereof, the Company (1) shall (i) pay for and maintain a $765,000 term life insurance policy on the Executive’s life (under which the Executive shall have the right to designate the beneficiary(s) thereunder) and (ii) promptly (and in any event within thirty (30) days of the submission by the Executive of documentation as may be reasonably specified by the Company from time to time which substantiates the Executive expenditures) reimburse the Executive for the premium cost of obtaining supplemental term life insurance coverage, which premium cost shall not exceed Five Thousand Dollars ($5,000) annually, and (2) shall (i) maintain the Executive’s current coverage under the Company’s long-term disability insurance plan or, in its discretion, reimburse the Executive for the premium cost of obtaining long-term disability coverage which provides at least $6,000 of monthly benefits, and (ii) shall promptly (and in any event within thirty (30) days of the submission by the Executive of documentation as may be reasonably specified by the Company from time to time which substantiates the Executive’s expenditures) reimburse the Executive for the premium cost of obtaining supplemental long-term disability insurance coverage, which premium cost shall not exceed Six Thousand Dollars ($6,000) annually. The Company may alter, modify, add to or delete its Employee Benefit Plans at any time as it, in its sole judgment, determines to be appropriate, without recourse by the Executive. For purposes of this Agreement, “Employee Benefit Plan” shall have the meaning ascribed to such term in Section 3(3) of ERISA, as amended from time to time.

 

(f)                               Business Expenses. The Company shall pay or reimburse the Executive for all reasonable and necessary business expenses incurred or paid by the Executive in the performance of his duties and responsibilities hereunder, subject to any maximum annual limit and other restrictions on such expenses set by the Board and communicated in writing to the Executive and to such reasonable substantiation and documentation as may be specified by the Company from time to time. All expenses eligible for reimbursement hereunder shall be paid to the Executive promptly in accordance with the Company’s customary business expense reimbursement practices but in no event later than sixty (60)

 

3



 

days following the close of the calendar year in which such expenses were incurred. The expenses incurred by the Executive in any calendar year that are eligible for reimbursement hereunder shall not affect the expenses incurred by the Executive in any other calendar year that are eligible for reimbursement hereunder. The Executive’s right to reimbursement hereunder shall not be subject to liquidation or exchange for any other benefit.

 

(g)                            Legal Fees.  Within thirty (30) days after the submission by the Executive of reasonable substantiation and documentation as may be specified by the Company, the Company shall cause to be paid the reasonable legal fees and expenses the Executive incurs with respect to the negotiation and preparation of this revised Agreement.

 

(h)                            Perquisites. During the term hereof, the Executive shall be provided perquisites on a basis no less favorable than provided to other similarly situated senior-level executives of the Company. In addition, the Executive shall be provided the following perquisites:

 

(i)                                The Executive shall promptly (and in any event within thirty (30) days of the submission of the documentation referred to in this Section 4(h) below) be reimbursed the cost to him of an annual physical examination, which currently costs approximately Three Thousand Dollars ($3,000), but which shall be subject to reasonable increase;

 

(ii)                             The Executive shall promptly (and in any event within thirty (30) days of the submission of the documentation referred to in this Section 4(h) below) be reimbursed the cost to him of annual financial planning and tax preparation services, in an amount not to exceed Seven Thousand Five Hundred Dollars ($7,500) per year; and

 

(iii)                               The Executive shall be promptly (and in any event within thirty (30) days of the submission of the documentation referred to in this Section 4(h) below) reimbursed the cost to him of the annual membership dues for the Young Presidents’ Organization and the CEO Network;

 

all subject to such reasonable substantiation and documentation as may be specified by the Company from time to time.

 

(i)                                Timing of Reimbursements. Any reimbursements made pursuant to this Section 4 shall be paid no later than sixty (60) days following the close of the calendar year in which the expense was incurred.

 

5.                                  Termination of Employment and Severance Benefits. Notwithstanding the provisions of Section 2 hereof, the Executive’s employment hereunder shall terminate prior to the expiration of the term hereof under the following circumstances:

 

(a)                             Death. In the event of the Executive’s death during the term hereof, the Executive’s employment hereunder shall immediately and automatically terminate.

 

(i)                                     In such event, the Company shall, as applicable, pay or provide to the Executive’s designated beneficiary or, if no beneficiary has been designated by the Executive in writing, to his estate (A) (i) any Base Salary earned but not paid during the final payroll period of the Executive’s employment through the date of termination in accordance with normal

 

4



 

payroll procedures, (ii) pay for any vacation time earned but not used through the date of termination, (iii) any bonus and other incentive compensation awarded for the fiscal year preceding that in which termination occurs, but unpaid on the date of termination payable in accordance with the applicable bonus or other incentive compensation award, (iv) any business expenses incurred by the Executive but unreimbursed on the date of termination, provided that such expenses and required substantiation and documentation are submitted within sixty (60) days after termination and that such expenses are reimbursable under Company policy; and (v) other vested benefits, if any, that Executive has accrued under and in accordance with the terms and conditions of the Company’s Employee Benefit Plans as of the date of termination of his employment (all of the foregoing, “Final Compensation”) and (B) a lump sum amount, payable within thirty (30) days after death, equal to two (2) times the average of each of the last three (3) years of Base Salary.

 

(ii)                                  In addition, the Company shall provide the Executive’s designated beneficiary or, if no beneficiary has been designated by the Executive in writing, his estate, with a pro-rata Bonus award for the fiscal year in which termination occurs, calculated based on the Target Bonus Amount for the fiscal year in which termination occurs and the number of days in such year that the Executive was employed, to be paid in a single lump sum payment within ninety (90) days following the date of termination of employment but in no event later than March 15 of the calendar year following the year in which termination occurs (the “Pro Rata Bonus”).

 

(iii)                          Any outstanding option, stock appreciation right, restricted stock, restricted stock unit or other equity-based award granted by the Company to the Executive pursuant to the Company’s 2005 Equity and Incentive Plan, any successor plan or agreement or any other equity compensation plan or agreement previously adopted by the Board in which Executive participated (the “Stock-Based Awards”) and any cash-based awards granted under the Company’s 2005 Equity and Incentive Plan as such (“Cash-Based Awards” and, collectively with the Stock-Based Awards, “Plan Awards”) shall be governed by the terms of the applicable plans and agreements.

 

(iv)                         If the Executive is enrolled in the Company’s medical and dental plans on the date of termination of his employment, and if his estate elects to continue participation of his eligible dependents in those plans, then for eighteen (18) months following the date of termination of the Executive’s employment, the Company will contribute 100% of the premium cost of the Executive’s eligible dependents under those plans.

 

(v)                            The Company shall have no further obligation to Executive hereunder for (A) compensation or (B) benefits pursuant to Employee Benefit Plans or otherwise described in Section 4 hereof.

 

(b)                            Disability.

 

(i)                                The Company may terminate the Executive’s employment hereunder, upon written notice to the Executive, in the event that the Executive becomes unable, during his employment hereunder through any medically determinable illness, injury, accident or condition of either a physical or psychological nature that constitutes a “disability” within the meaning of the long-term disability policy then in effect at the Company, to perform substantially all of his

 

5



 

duties and responsibilities hereunder, notwithstanding the provision of any reasonable accommodation, for a period of 180 consecutive days (a “Disability”). In the event of such termination:

 

(A)                         the Company shall, as applicable, pay or provide the Executive with the Final Compensation and the Pro Rata Bonus;

 

(B)                           if the Executive is enrolled in the Company’s medical and dental plans on the date of termination of his employment, and if he elects to continue his participation and that of his eligible dependents in those plans under the federal law known as “COBRA,” then for eighteen (18) months following the date of termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) coverage through a new employer, the Company will contribute 100% of the premium cost of the Executive’s coverage and that of his eligible dependents under those plans, provided the Executive and his dependents remain eligible for such coverage under applicable law and plan terms;

 

(C)                           the Company will continue to maintain the life insurance coverage that was in effect for the Executive on the date of termination of his employment, and will continue to reimburse the Executive for the premium cost of obtaining supplemental term life insurance coverage, which premium cost shall not exceed Five Thousand Dollars ($5,000) annually in accordance with Section 4(e) hereof, for the period of eighteen (18) months following the termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) life insurance coverage through a new employer, provided such continued coverage is permitted by applicable law and plan terms. In the event such continued coverage is not permitted by applicable law or plan terms, the Company shall, on the first business day of each month, in addition to the premium cost for supplemental term life insurance provided for above, pay the Executive monthly payments in an amount equal to the premium payments that the Company would have made had the Executive remained eligible for such continued coverage, for the period of eighteen (18) months following the termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) life insurance coverage through a new employer;

 

(D)                          any outstanding Plan Awards shall be governed by the terms of the applicable plans and agreements, except that for purposes of Plan Awards, termination by reason of Disability pursuant to this Section 5(b) shall be treated in the same manner as termination by reason of the Executive’s death pursuant to Section 5(a) hereof; and

 

(E)                            The Company shall have no further obligation to Executive hereunder for (A) compensation or (B) benefits pursuant to Employee Benefit Plans or otherwise described in Section 4 hereof.

 

6



 

(F)                            Any obligation of the Company to provide the compensation and benefits described in this Section 5(b)(i) is conditioned on (y) the Executive’s signing and return of a timely and effective release of claims in the form attached to this Agreement as Exhibit A (the “Employee Release”) and delivering it to the Company and having it become irrevocable within sixty (60) calendar days of the date his employment terminates (or such shorter period as the Company specifies but not below thirty (30) days), and (z) the Executive refraining from making any oral or written statement to any person or entity which has the effect of damaging the reputation of, or otherwise working in any way to the detriment of the Company, any of its Affiliates, or any of their respective officers, directors, or management (the “Non-Disparagement Obligation”). Notwithstanding anything to the contrary contained herein, the Non-Disparagement Obligation shall not prevent the Executive from making any truthful statement to the extent (i) necessary with respect to any litigation, arbitration or mediation involving this Agreement, including, but not limited to, the enforcement of this Agreement or (ii) required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with jurisdiction over the Executive.

 

(ii)                             The Board may designate another employee to act in the Executive’s place during any period of the Executive’s Disability. Notwithstanding any such designation, the Executive shall continue to receive the Base Salary in accordance with Section 4(a) and benefits in accordance with Section 4(e), to the extent permitted by the then-current terms of the applicable Employee Benefit Plans, until the Executive becomes eligible for disability income benefits under the Company’s disability income plan or until the termination of his employment, whichever shall first occur.

 

(iii)                          While receiving disability income payments under the Company’s disability income plan, the Executive shall not be entitled to receive any Base Salary under Section 4(a) hereof, but shall continue to participate in Company Employee Benefit Plans in accordance with Section 4(e) and the terms of such plans, until the termination of his employment.

 

(iv)                         If any question shall arise as to whether during any period the Executive is unable, through any illness, injury, accident or condition of either a physical or psychological nature, to perform substantially all of his duties and responsibilities hereunder, notwithstanding the provision of any reasonable accommodation, the Executive may, and at the request of the Company shall, submit to a medical examination by a physician selected by the Company to whom the Executive or his duly appointed guardian, if any, has no reasonable objection to determine whether the Executive is so disabled (within the meaning of subsection (b)(i)) and such determination shall for the purposes of this Agreement be conclusive of the issue. If such question shall arise and the Executive shall fail to submit to such medical examination, the Company’s determination of the issue shall be binding on the Executive.

 

(c)                                  By the Company for Cause. The Company may terminate the Executive’s employment hereunder for Cause at any time upon written notice to the Executive setting forth in reasonable detail the nature of such Cause. The following, as determined by the Board in its reasonable judgment, shall constitute Cause for termination:

 

(i)                                     The Executive’s breach of fiduciary duty;

 

7



 

(ii)                                  The Executive’s failure to perform (other than by reason of Disability), or gross neglect in the performance of, his duties and responsibilities to the Company or any of its Affiliates, which failure or neglect, if susceptible of cure, remains uncured or continues or recurs after fifteen (15) business days’ written notice from the Company specifying in reasonable detail the nature of such failure or neglect;

 

(iii)                               material breach by the Executive of any provision of this Agreement or any other agreement with the Company or any of its Affiliates, which breach, if susceptible to cure, remains uncured or continues or recurs after fifteen (15) business days’ written notice from the Company specifying in reasonable detail the nature of the breach (for the avoidance of doubt, any breach of Section 7, 8 and 9 hereof is not susceptible to cure);

 

(iv)                              fraud or embezzlement or other dishonesty with respect to the Company or any of its Affiliates; or

 

(v)                                 conviction of a felony or any crime involving moral turpitude under any applicable law.

 

Upon the giving of written notice of termination of the Executive’s employment hereunder for Cause setting forth in reasonable detail the nature of such Cause and following any applicable cure period, the Company shall have no further obligation to the Executive for (A) compensation or (B) benefits pursuant to Employee Benefit Plans or otherwise described in Section 4 hereof, other than for Final Compensation. Any outstanding Plan Awards shall be governed by the terms of the applicable plans and agreements.

 

(d)                                 By the Company Other than for Cause. The Company may terminate the Executive’s employment hereunder other than for Cause at any time upon written notice to the Executive. In the event of such termination, in addition to the Final Compensation, and provided that no benefits are payable to the Executive under a separate severance agreement as a result of such termination, the Company shall pay or provide, as applicable, the Executive with the following (together, the “Severance Payments and Benefits”):

 

(i)                                     the Pro Rata Bonus;

 

(ii)                                  an amount equal to two (2) times the sum of (A) Base Salary, at the rate in effect on the date of termination of the Executive’s employment (prior to any reduction constituting Good Reason), plus (B) the Target Bonus Amount for the year in which termination occurs (the “Lump Sum Payment”);

 

(iii)                               if the Executive is enrolled in the Company’s medical and dental plans on the date of termination of his employment, and if he elects to continue his participation and that of his eligible dependents in those plans under the federal law known as “COBRA,” then for eighteen (18) months following the date of termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) coverage through a new employer, the Company will contribute 100% of the premium cost of his coverage and that of his eligible dependents under those plans, provided the Executive and his dependents remain eligible for such coverage under applicable law and plan terms; and

 

8



 

(iv)                              the Company will continue to maintain the life insurance coverage that was in effect for the Executive on the date of termination of his employment, and will continue to reimburse the Executive for the premium cost of obtaining supplemental term life insurance coverage which premium cost shall not exceed Five Thousand Dollars ($5,000) annually, all in accordance with Section 4(e) hereof, for the period of eighteen (18) months following the termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) life insurance coverage through a new employer, provided such continued coverage is permitted by applicable law and plan terms. In the event any such continued coverage is not permitted by applicable law or plan terms, the Company shall, on or prior to the first business day of each month, pay the Executive monthly payments in an amount equal to the premium payments that the Company would have made in respect of the Executive’s current term life insurance coverage and the premium cost for supplemental term life insurance coverage, had the Executive remained eligible for such coverage, for the period of eighteen (18) months following the termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent life insurance coverage through a new employer.

 

Any outstanding Plan Awards shall be governed by the terms of the applicable plans and agreements. Any obligation of the Company to provide the Severance Payments and Benefits is conditioned on (y) the Executive’s signing and return of a timely and effective Employee Release and delivering it to the Company and having it become irrevocable within sixty (60) calendar days of the date his employment terminates (or such shorter period as the Company specifies but not below thirty (30) days), and (z) complying with the Non-Disparagement Obligation. The Pro Rata Bonus and the Lump Sum Payment to which the Executive is entitled hereunder shall be payable in a single lump sum within (60) days after the date the Executive’s employment terminates, except as required by Section 5(i) below. The Employee Release required for separation benefits in accordance with Sections 5(b), 5(d), 5(e) or 5(g) creates legally binding obligations on the part of the Executive and the Company and its Affiliates therefore advise the Executive to seek the advice of an attorney before signing it.

 

(e)                             By the Executive for Good Reason. The Executive may terminate his employment hereunder for Good Reason, but must first provide written notice to the Company of the condition giving rise to the Good Reason no later than sixty (60) days following the date on which the Executive obtains knowledge of the occurrence of the condition and give the Company thirty (30) days to remedy the condition. The following conditions arising without the Executive’s prior written consent shall constitute Good Reason for termination by the Executive:

 

(i)                                any action by the Company (including, for this purpose, the Board or any committee thereof) which results in a diminution in Executive’s position, titles, reporting relationship, authority, duties or responsibilities (other than pursuant to Section 4(b)(ii) in connection with Disability); provided, however, that a sale or transfer of less than all or substantially all of the business of the Company or any of its subsidiaries or other reduction of less than all of its business or that of its subsidiaries, or the fact that the Company has become a subsidiary of another company or that the securities of the Company are no longer publicly traded, shall not be taken into account when determining whether a material diminution in Executive’s authority, duties or responsibilities has occurred;

 

9



 

(ii)                             a diminution in Executive’s rate of annual Base Salary or bonus opportunity pursuant to Section 4(b) hereof;

 

(iii)                          the Company’s requiring the Executive to be based at any office or location that is more than twenty-five (25) miles distant from Executive’s then-current base office or work location, unless the new location is closer to the Executive’s residence at the time the requirement is imposed; or

 

(iv)                         any other action or inaction that constitutes a material breach by the Company of this Agreement.

 

In the event of termination in accordance with this Section 5(e), and provided that no benefits are payable to the Executive under a separate severance agreement as a result of such termination, then the Executive will be entitled to the same payments and benefits, and at the same time(s), he would have been entitled to receive had the Executive been terminated by the Company other than for Cause in accordance with Section 5(d) above; provided that the Executive signs and delivers to the Company a timely and effective Employee Release under the same rules as apply under Section 5(d) and complies with the Non-Disparagement Obligation.

 

(f)                               By the Executive Other than for Good Reason. The Executive may terminate his employment hereunder at any time for other than Good Reason upon sixty (60) days’ written notice to the Company. In the event of termination of the Executive pursuant to this Section 5(f), the Board may elect to waive the period of notice, or any portion thereof, without additional compensation to the Executive. In such circumstances, the Company shall have no further obligation to the Executive for (A) compensation or (B) benefits pursuant to Employee Benefit Plans or otherwise described in Section 4 hereof, other than for any Final Compensation due to him. Any outstanding Plan Awards shall be governed by the terms of the applicable plans and agreements.

 

(g)                            Upon a Change of Control.

 

(i)                                     If a Change of Control occurs and, within two years following such Change of Control, the Company terminates the Executive’s employment other than for Cause, or the Executive terminates his employment for Good Reason, then, in lieu of any payments to or on behalf of the Executive under Section 5(d) or 5(e) hereof, and provided that the Executive signs and delivers to the Company a timely and effective Employee Release under the same rules as apply under Section 5(d), and complies with the Non-Disparagement Obligation, then in addition to the Final Compensation, the Company shall provide the Executive with the following:

 

(A)                         the Pro Rata Bonus;

 

(B)                           an amount equal to 2.9 times the sum of (A) Base Salary at the rate in effect on the date of termination of the Executive’s employment (prior to any reduction constituting Good Reason), plus (B) the Target Bonus Amount for the year in which termination occurs (the “Change of Control Severance Payment”);

 

(C)                           if the Executive is enrolled in the Company’s medical and dental plans on the date of termination of his employment, and if he elects to continue his participation and that of his eligible dependents in those plans under the federal law

 

10



 

known as “COBRA,” then for thirty six (36) months following the date of termination of the Executive’s employment or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) coverage through a new employer (the “Continuation Period”), the Company will contribute 100% of the premium cost of his coverage and that of his eligible dependents under those plans, provided the Executive and his dependents remain eligible under applicable law and plan terms. In the event that such continued coverage is not permitted under applicable law or plan terms, the Company shall, on or prior to the first business day of each month, pay the Executive monthly payments in an amount equal to the premium payments that the Company would have made had the Executive remained eligible for such coverage, for the remainder of the Continuation Period;

 

(D)                          the Company will continue to maintain the life insurance coverage that was in effect for the Executive on the date of termination of his employment, and will continue to reimburse the Executive for the premium cost of obtaining supplemental term life insurance coverage which premium cost shall not exceed Five Thousand Dollars ($5,000) annually, all in accordance with Section 4(e) hereof, for the Continuation Period or, if earlier, until the Executive becomes eligible for substantially equivalent (as to the extent of coverage and the cost to the Executive) life insurance coverage through a new employer, provided such continued coverage is permitted by applicable law and plan terms. In the event any such continued coverage is not permitted by applicable law or plan terms, the Company shall, on or prior to the first business day of each month, pay the Executive monthly payments in an amount equal to the premium payments that the Company would have made in respect of the Executive’s current term life insurance coverage, the premium cost for supplemental term life insurance coverage, had the Executive remained eligible for such coverage, for the remainder of the Continuation Period;

 

(E)                            notwithstanding anything to the contrary in the applicable plans and agreements, any and all outstanding and unvested Stock-Based Awards shall immediately become vested and fully exercisable on the date of termination of the Executive’s employment hereunder, and any Cash-Based Awards that are not being used to provide the Bonus under Section 4(b) shall immediately become vested and payable, subject to any requirements under Section 409A. Except as otherwise expressly provided herein, all Plan Awards shall be governed by the terms of the applicable plans and agreements.

 

The Pro Rata Bonus and the Change of Control Severance Payment shall be payable in one lump sum on the date which is sixty (60) calendar days from the date the Executive’s employment terminates.

 

(ii)                             Notwithstanding anything to the contrary contained herein or in any plan or agreement, if a Stock-Based Award held by Executive is not assumed or replaced, or to be assumed or replaced, upon a Change of Control, each unvested Stock-Based Award held by the Executive, whether or not his employment has been terminated hereunder, shall become fully vested and exercisable effective immediately prior to the Change of Control, and in the event the Executive holds a Stock-Based Award requiring exercise, the Company shall give the Executive adequate notice and opportunity to exercise the Stock-Based Award.

 

11



 

(iii)                          “Change of Control” or “Change in Control of the Company” shall mean the occurrence hereafter of any of the following:

 

(A)                         any Person, other than the Company or an Affiliate, becomes a beneficial owner (within the meaning of Rule 13d-3, as amended, as promulgated under the Securities Exchange Act of 1934, as amended), directly or indirectly, in one or a series of transactions, of securities representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities;

 

(B)                           the consummation of a merger or consolidation of the Company with any other Person, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation;

 

(C)                           the closing of a sale or other disposition by the Company of all or substantially all of the assets of the Company;

 

(D)                          individuals who constitute the Board of Directors on the date hereof (“Incumbent Directors”) cease for any reason to constitute at least a majority of the Board; provided, that any individual who becomes a member of the Board subsequent to the date hereof, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors shall be treated as an Incumbent Director unless he or she assumed office as a result of an actual or threatened election contest with respect to the election or removal of directors; or

 

(E)                            a complete liquidation or dissolution of the Company;

 

provided, in each case, that such event also constitutes a “change in control event” within the meaning of Treasury Regulation Section 1.409A-3(i)(5).

 

(iv)                              Potential Change of Control.  If the Company’s stockholders approve a transaction described in Section 5(g)(iii)(B) and thereafter the Company terminates Executive’s employment without Cause before the consummation of the transaction described in such section, Executive shall receive the severance and benefits specified in Section 5(d) (applicable without a Change of Control), subject to the terms and conditions of that subsection.  If the approved transaction or another acquisition by the same entity closes by the first anniversary of the stockholder approval, any incremental benefits under Section 5(g)(i) with respect to a termination after a Change of Control will be provided as though the date of termination had corresponded with the date of closing and will be subject to an additional release of claims.  To effectuate this treatment for equity compensation, the Company will, with respect to the incremental equity treatment in Section 5(g)(ii), vest but freeze the incremental options and restricted stock units such that Executive cannot exercise or dispose of the equity unless and until the transaction is consummated by the first anniversary following approval and providing further that any such incremental equity compensation will, if no closing occurs by the first anniversary, expire and be

 

12



 

forfeited on the earliest of that first anniversary, its original term (for options and stock appreciation rights), or 90 days following the closing of the change of control.

 

(h)                                 Limitation on Payments. If any payments pursuant to the Agreement would be subject to tax under Section 4999 of the Internal Revenue Code (the “Payments”), then Executive shall receive either (i) the full Payments or (ii) such lesser amount of the Payments as would yield the greatest net amount to Executive on an after-tax basis (applying the then highest aggregate marginal tax rates and Section 4999).  If a reduction of the Payments is required pursuant to subpart (ii), then the Payments will be reduced in the following order: (i) any cash payments, (ii) any taxable benefits, (iii) any nontaxable benefits, and (iv) any vesting of equity awards in each case in reverse order beginning with payments or benefits that are to be paid the farthest in time from the date that triggers the applicability of the excise tax, to the extent necessary to maximize the reduced Payment.  The Company may elect to contest at its expense any initial IRS determination with respect to the Executive.  The Executive shall cooperate reasonably with the Company in any effort by the Company to contest an IRS determination under this paragraph, including by the making of such filings and appeals as the Company may reasonably require, but nothing herein shall be construed as requiring the Executive to bear any cost or expense of such a contest or in connection therewith to compromise any tax item (including without limitation any deduction or credit) other than the Section 4999 tax and related interest and penalties, if any, that are the subject of the contested IRS determination.  In the event of any underpayment or overpayment under this Agreement, as determined by the nationally recognized accounting firm, the amount of such underpayment or overpayment shall be promptly paid to the Executive or refunded to the Company, as the case may be, with interest at 120% of the applicable Federal rate provided for in Section 7872(f)(2) of the Internal Revenue Code.  All tax determinations under this Section 5(h) shall be made at the Company’s expense by a nationally recognized accounting firm selected by the Company in its reasonable discretion.  Any good faith determinations of this accounting firm made hereunder shall be final, binding and conclusive upon the Company and the Executive.

 

(i)                                     Timing of Payments and other 409A Issues. All payments by the Company to the Executive under this Section 5 shall, except as otherwise expressly provided in this Section 5, be made on or before the sixtieth (60th) day after the date on which the Executive’s employment terminates hereunder. Notwithstanding the foregoing or anything to the contrary contained in any other provision of this Agreement, if the Executive is a “specified employee” within the meaning of the Section 409A Rules (as defined below) at the time of the Executive’s “separation from service” within the meaning of the Section 409A Rules, then any payment otherwise required to be made to the Executive under this Agreement on account of the Executive’s separation from service, to the extent such payment (after taking in to account all exclusions applicable to such payment under the Section 409A Rules) is properly treated as deferred compensation subject to the Section 409A Rules, shall not be made until the first business day after (i) the expiration of six (6) months from the date of the Executive’s separation from service or (ii) if earlier, the date of the Executive’s death (the “Delayed Payment Date”). On the Delayed Payment Date, there shall be paid to the Executive or, if the Executive has died, to the Executive’s estate, in a single cash lump sum, an amount equal to the aggregate amount of the payments delayed pursuant to the preceding sentence. For purposes of the foregoing, the “Section 409A Rules” shall mean Section 409A of the Code, the regulations issued thereunder, and all notices, rulings and other guidance issued by the Internal Revenue Service interpreting the same. For the avoidance of doubt, the compensation, benefits and other payments described in this Agreement (collectively, the “Payments”) are intended either to comply with the Section 409A Rules (to the extent they are subject to such Section) or to be exempt from the requirements of the Section 409A Rules (where an exemption is available), and shall be construed accordingly. The Executive acknowledges, however, that any payment pursuant to this

 

13



 

Agreement could be treated as deferred compensation under the Section 409A Rules, and accordingly could be subject to excise tax, interest and other payments pursuant to the Section 409A Rules (the “409A Tax Payments”). The Executive acknowledges and agrees that the Executive shall be solely responsible for all 409A Tax Payments. The Company shall have no obligation to indemnify or reimburse the Executive for any 409A Tax Payments or otherwise be liable for any 409A Tax Payments that may be due.

 

(j)                                Mitigation, Etc. The Executive shall not be obligated to seek other employment or take other action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement and, except as otherwise expressly provided herein, in no event shall the amount of any payment hereunder be reduced by any compensation earned by, or any benefit provided to, the Executive as a result of employment by another employer.

 

(k)                             Post-Agreement Employment. In the event the Executive remains in the employ of the Company or any of its Affiliates following termination of the term of this Agreement, by the expiration of the term or otherwise, then such employment shall be at will.

 

6.                                  Effect of Termination. The provisions of this Section 6 shall apply to any termination, whether due to the expiration of the term hereof, pursuant to Section 5 or otherwise.

 

(a)                             Payment by the Company of any severance pay and benefits that may be due the Executive in each case under the applicable termination provision of Section 5 shall constitute the entire obligation of the Company to the Executive for (A) compensation or (B) benefits pursuant to Employee Benefit Plans or otherwise described in Section 4 hereof. The Executive shall promptly give the Company notice of all facts necessary for the Company to determine the amount and duration of its obligations in connection with any termination pursuant to Section 5(b), 5(d), 5(e) or 5(g) hereof.

 

(b)                            Except for any right of the Executive to continue medical and dental plan participation and life insurance participation in accordance with the applicable termination provision of Section 5 and applicable law, benefits shall terminate pursuant to the terms of the applicable benefit plans based on the date of termination of the Executive’s employment without regard to any continuation of Base Salary or other payment to the Executive following such date of termination.

 

(c)                                  Provisions of this Agreement shall survive any termination if so provided herein or if necessary or desirable to accomplish the purposes of other surviving provisions, including without limitation Sections 5(h), 5(i), 5(j) and 5(k), the obligations of the Executive under Sections 7, 8 and 9 hereof and the obligations of both parties under Sections 13 and 14. The obligation of the Company to make payments to or on behalf of the Executive under Section 5 hereof is expressly conditioned upon the Executive’s continued full performance of obligations under Sections 7, 8 and 9 hereof. The Executive recognizes that, except as expressly provided in Section 5(a), 5(b), 5(d) or 5(e) or 5(g), no compensation is earned after termination of employment.

 

7.                                       Confidential Information.

 

(a)                                  The Executive acknowledges that the Company and its Affiliates continually develop Confidential Information, that the Executive may develop Confidential Information for the Company or its Affiliates and that the Executive may learn of Confidential Information during the course of employment. The Executive will comply with the policies and procedures of the Company and its

 

14



 

Affiliates disclosed to him for protecting Confidential Information and shall not disclose to any Person or use, other than for the proper performance of his duties and responsibilities to the Company and its Affiliates, any Confidential Information obtained by the Executive incident to his employment or other association with the Company or any of its Affiliates. The Executive understands that this restriction shall continue to apply after his employment terminates, regardless of the reason for such termination. The confidentiality obligation under this Section 7 shall not apply to information (i) which is generally known or readily available to the public or in the relevant trade or industry at the time of disclosure or becomes so generally known through no wrongful act on the part of the Executive, (ii) when disclosure is required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with jurisdiction to order the Executive to disclose or make accessible any information, or (iii) with respect to any litigation, arbitration or mediation involving enforcement of this Agreement.

 

(b)                                 All documents, records, tapes and other media of every kind and description relating to the business, present or otherwise, of the Company or its Affiliates and any copies, in whole or in part, thereof (the “Documents”), whether or not prepared by the Executive, shall be the sole and exclusive property of the Company and its Affiliates. The Executive shall safeguard all Documents in his possession or control and shall surrender to the Company at the time his employment terminates, or at such earlier time or times as the Board or its designee may specify, all Documents then in the Executive’s possession or control. Anything to the contrary notwithstanding, the Executive shall be entitled to retain (i) papers and other materials of a personal nature, including, but not limited to, photographs and personal correspondence, (ii) information showing his compensation or relating to reimbursement of expenses, (iii) information that he reasonably believes may be needed for tax purposes, and (iv) copies of plans, programs and agreements relating to his employment, or termination thereof, with the Company; provided, however, that the Executive may not retain any of the items specified in (i) through (iv) hereof if the item contains Confidential Information.

 

8.                                  Assignment of Rights to Intellectual Property. The Executive shall promptly and fully disclose all Intellectual Property to the Company. The Executive hereby assigns and agrees to assign to the Company (or as otherwise directed by the Company) the Executive’s full right, title and interest in and to all Intellectual Property. The Executive agrees to execute any and all applications for domestic and foreign patents, copyrights or other proprietary rights and to do such other acts (including without limitation the execution and delivery of instruments of further assurance or confirmation) reasonably requested by the Company to assign the Intellectual Property to the Company and to permit the Company to enforce any patents, copyrights or other proprietary rights to the Intellectual Property. The Executive will not charge the Company for time reasonably requested to be spent in complying with these obligations. All copyrightable works that the Executive creates shall be considered “work made for hire” and shall, upon creation, be owned exclusively by the Company. The Company will promptly reimburse the Executive’s out-of-pocket expenses incurred in complying with Company requests hereunder. Prior to commencing any project on behalf of the Company, the Executive shall disclose any information or Intellectual Property that may be relevant to such project to which he may claim a right or interest by reason of having invented, discovered, or originated the same prior to the commencement of employment for the Company; the burden of proving such prior right or interest shall be on the Executive, and the Executive’s failure to notify the Company of such rights or interests will be deemed a waiver of such rights and interests.

 

15



 

9.                                  Restricted Activities. The Executive agrees that some restrictions on his activities during and after his employment are necessary to protect the goodwill, Confidential Information and other legitimate interests of the Company and its Affiliates:

 

(a)                                  While the Executive is employed by the Company and for a period of one (1) year after his employment terminates (unless the Executive’s employment is terminated by the Company without Cause or by the Executive for Good Reason within two (2) years following a Change of Control pursuant to Section 5(g) hereof) (together, the “Non-Competition Period”), the Executive shall not, directly or indirectly, whether as owner, partner, investor, consultant, agent, employee, co-venturer or otherwise, compete with the Company or any of its Affiliates within the United States or in any other geographic area in which the Company or any of its Affiliates is then doing business. Specifically, but without limiting the foregoing, the Executive agrees not to engage in any manner in any activity that is directly or indirectly competitive with the business of the Company or any of its Affiliates as conducted or under active consideration by the Company at the time the Executive’s employment is terminated hereunder or at any time during the two year period prior to the termination of the Executive’s employment, and further agrees not to work or provide services, in any capacity, whether as an employee, independent contractor or otherwise, whether with or without compensation, to any Person who is engaged in any business that is competitive with the business as conducted or under active consideration by the Company or any of its Affiliates for which the Executive has provided services at the time of termination of the Executive’s employment hereunder or at any time during the two year period prior to the termination of the Executive’s employment. For the purposes of this Section 9, the business of the Company and its Affiliates shall include all Products and the Executive’s undertaking shall encompass all items, products and services that may be used in substitution for Products. The foregoing, however, shall not prevent the Executive’s passive ownership of two percent (2%) or less of the equity or other securities of any publicly traded company.

 

(b)                                 The Executive agrees that, during the Non-Competition Period, the Executive will not directly or indirectly (a) solicit or encourage any customer or vendor of the Company or any of its Affiliates to terminate or diminish its relationship with them; or (b) seek to persuade any such customer, vendor or prospective customer or vendor of the Company or any of its Affiliates to conduct with anyone else any business or activity which such customer, vendor or prospective customer or vendor conducts or could reasonably conduct with the Company or any of its Affiliates.

 

(c)                                  The Executive agrees that during the Non-Competition Period, the Executive will not, and will not assist any other Person to, (a) hire or solicit for hiring any employee of the Company or any of its Affiliates or seek to persuade any employee of the Company or any of its Affiliates to discontinue employment or (b) solicit or encourage any independent contractor providing services to the Company or any of its Affiliates to terminate or diminish its relationship with them. For the purposes of this Agreement, an “employee” of the Company or any of its Affiliates is any person who was such at any time within the preceding two years.

 

10.                            Reserved.

 

11.                            Enforcement of Covenants. The Executive acknowledges that he has carefully read and considered all the terms and conditions of this Agreement, including the restraints imposed upon him pursuant to Sections 7, 8 and 9 hereof. The Executive agrees without reservation that each of the restraints contained herein is necessary for the reasonable and proper protection of the goodwill, Confidential Information and other legitimate interests of the Company and its Affiliates; that each and every one of

 

16



 

those restraints is reasonable in respect to subject matter, length of time and geographic area; and that these restraints, individually or in the aggregate, will not prevent him from obtaining other suitable employment during the period in which the Executive is bound by these restraints. The Executive further agrees that he will never assert, or permit to be asserted on his behalf, in any forum, any position contrary to the foregoing. The Executive further acknowledges that, were he to breach any of the covenants contained in Sections 7, 8 or 9 hereof, the damage to the Company would be irreparable. The Executive therefore agrees that the Company, in addition to any other remedies available to it, shall be entitled to preliminary and permanent injunctive relief against any breach or threatened breach by the Executive of any of said covenants, without having to post bond. The parties further agree that, in the event that any provision of Section 7, 8 or 9 hereof shall be determined by any court of competent jurisdiction to be unenforceable by reason of its being extended over too great a time, too large a geographic area or too great a range of activities, such provision shall be deemed to be modified to permit its enforcement to the maximum extent permitted by law. The Executive agrees that the Non-Competition Period shall be tolled, and shall not run, during any period of time in which he is in violation of the terms of Sections 7, 8 or 9 hereof, in order that the Company shall have the agreed upon temporal protection set forth in this Agreement. No breach of any provision of this Agreement or any other purported violation of law by the Company shall operate to excuse the Executive’s obligation to fulfill the requirements of Sections 7, 8 and 9 hereof.

 

12.                            Reserved.

 

13.                            Insurance and Indemnification. During the term hereof, the Company will maintain directors’ and officers’ (D&O) liability insurance coverage and will provide such coverage to the Executive on the same basis as other senior executives of the Company, in accordance with the terms of the applicable insurance policy. The Company shall indemnify the Executive to the extent provided in its then-current Articles and By-Laws (provided, however, that if the Company amends the indemnification provisions in its Articles or By-Laws following the Effective Date, any such amendment shall be applicable to directors and officers of the Company generally and shall not apply exclusively to the Executive). The Executive agrees to promptly notify the Company of any actual or threatened claim arising out of or as a result of his employment with the Company.

 

14.                            Dispute Resolution. Except for disputes arising under Sections 7, 8 or 9 of this Agreement, if any dispute arises between the parties with respect to this Agreement, such dispute shall be submitted to binding arbitration for resolution in Boston, Massachusetts in accordance with the rules and procedures of the Employment Dispute Resolution Rules of the American Arbitration Association then in effect. The decision of the appointed arbitrator shall be final and binding on both parties, and any court of competent jurisdiction may enter judgment upon the award. In the event that an action is brought to enforce a provision of this Agreement (pursuant to this Section 14 or otherwise), the Company shall reimburse the Executive for the legal fees he incurs in connection with such action to the extent that the Executive prevails on any material issue raised in such action, otherwise, each party shall bear its own costs and expenses, including legal fees, in connection with any such action.

 

15.                            Definitions. Words or phrases which are initially capitalized or are within quotation marks shall have the meanings provided in this Section and as provided elsewhere herein. For purposes of this Agreement, the following definitions apply:

 

(a)                                  “Affiliates” means any business entity in which the Company holds, directly or indirectly, an equity, profits or voting interest of 30% or more, and includes any subsidiary.

 

17



 

(b)                                 “Confidential Information” means any and all information of the Company and its Affiliates that is not generally known by those with whom the Company or any of its Affiliates competes or does business, or with whom the Company or any of its Affiliates actively plans to compete or do business and any and all information, publicly known in whole or in part or not, which, if disclosed by the Company or any of its Affiliates would assist in competition against them. Confidential Information includes without limitation such information relating to (i) the development, research, testing, manufacturing, marketing and financial activities of the Company and its Affiliates, (ii) the Products, (iii) the costs, sources of supply, financial performance and strategic plans of the Company and its Affiliates, (iv) the identity and special needs of the customers of the Company and its Affiliates and (v) the people and organizations with whom the Company and its Affiliates have business relationships and the nature and substance of those relationships. Confidential Information also includes any information that the Executive knows or should know that the Company or any of its Affiliates has received, or may receive hereafter, belonging to customers or others with respect to which there is any understanding, express or implied, that the information would not be disclosed.

 

(c)                                  “Employee Benefit Plan” shall have the meaning ascribed to such term in Section 3(3) of ERISA, as amended from time to time.

 

(d)                                 Reserved.

 

(e)                                  “Intellectual Property” means inventions, discoveries, developments, methods, processes, compositions, works, concepts and ideas (whether or not patentable or copyrightable or constituting trade secrets) conceived, made, created, developed or reduced to practice by the Executive (whether alone or with others, whether or not during normal business hours or on or off Company premises) in the course of the Executive’s employment and during the period of twelve (12) months immediately following termination of his employment that, in any case, relate to either the Products or any prospective activity of the Company or any of its Affiliates or that make use of Confidential Information or any of the equipment or facilities of the Company or any of its Affiliates.

 

(e)                                  “Person” means an individual, a corporation, a limited liability company, an association, a partnership, an estate, a trust and any other entity or organization (including a group within the meaning of Sections 13(d) or 14(d)(2) of the Securities Exchange Act of 1934, as amended), other than the Company or any of its Affiliates.

 

(f)                                    “Products” mean all products actively planned, researched, developed, tested, manufactured, sold, licensed, leased or otherwise distributed or put into use by the Company or any of its Affiliates, together with all services provided or actively planned by the Company or any of its Affiliates, during the Executive’s employment.

 

16.                       Withholding. All payments made by the Company under this Agreement shall be reduced by any tax or other amounts required to be withheld by the Company under applicable law.

 

17.                      Assignment. Neither the Company nor the Executive may make any assignment of this Agreement or any interest herein, by operation of law or otherwise, without the prior written consent of the other; provided, however, that the Company may assign its rights and obligations under this Agreement without the consent of the Executive in the event that the Company shall hereafter effect a reorganization, consolidate with, or merge into, any Person or transfer all or substantially all of its

 

18



 

properties or assets to any Person. This Agreement shall inure to the benefit of and be binding upon the Company and the Executive, their respective successors, executors, administrators, heirs and permitted assigns.

 

18.                            Severability. If any portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

 

19.                            Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of either party to require the performance of any term or obligation of this Agreement, or the waiver by either party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

 

20.                            Notices. Any and all notices, requests, demands and other communications provided for by this Agreement shall be in writing and shall be effective when delivered in person, two (2) business days after being consigned to a reputable national courier service or three (3) business days after being deposited in the United States mail, postage prepaid, registered or certified, and addressed to the Executive at his last known address on the books of the Company or, in the case of the Company, at its principal place of business, attention of the Chair of the Board, or to such other address as either party may specify by notice to the other actually received.

 

21.                            Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior communications, agreements and understandings, written or oral, with respect to the subject matter hereof, including without limitation the Severance Benefit and Change of Control Agreement dated November 3, 2005 and the AS&E Employee Representation, Rights in Data, and Non-Compete Agreement dated September 12, 2003, but excluding the Executive’s obligations with respect to the securities of the Company and any outstanding loans to the Executive from, or any other outstanding obligations of the Executive to, the Company or any of its Affiliates or any of their Employee Benefit Plans, all of which shall remain in full force and effect in accordance with their terms; provided, however, that this Agreement shall not supersede any effective assignment of any invention or other intellectual property to the Company or any of its Affiliates in effect on the Effective Date and shall not constitute a waiver by the Company or any of its Affiliates of any existing right any of them now has or might now have, directly, by assignment or otherwise, under any agreement imposing obligations on the Executive with respect to confidentiality, non- competition, non-solicitation of employees, customers or suppliers or like obligations.

 

22.                            Amendment. This Agreement may be amended or modified only by a written instrument signed by the Executive and by an expressly authorized representative of the Company.  Absent the Executive’s written consent to the contrary, the provisions of Section 5(d), (e), and (g) will survive any termination or nonextension of this Agreement, and the Company may not terminate this Agreement within two years following a Change in Control or provide a notice of nonrenewal effective within such two years, other than a termination or notice of nonrenewal following a cessation of employment that does not qualify under the terms of Section 5(g) for the compensation that subsection specifies (i.e., after a termination for Cause or a resignation without Good Reason).

 

19



 

23.                            Headings. The headings and captions in this Agreement are for convenience only and in no way define or describe the scope or content of any provision of this Agreement.

 

24.                            Counterparts. This Agreement may be executed in two or more counterparts, including by fax or pdf, each of which shall be an original and all of which together shall constitute one and the same instrument.

 

25.                            Governing Law. This is a Massachusetts contract and shall be construed and enforced under and be governed in all respects by the laws of the Commonwealth of Massachusetts, without regard to the conflict of laws principles thereof.

 

26.                            Company’s Successors. The Company will require any successor to the business of the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.

 

[Signature page follows immediately.]

 

20



 

IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument by the Company, by its duly authorized representative, and by the Executive, as of the date first above written.

 

 

THE EXECUTIVE:

AMERICAN SCIENCE AND ENGINEERING, INC.

 

 

 

 

By:

 

 

 

 

Anthony R. Fabiano

 

Kenneth J. Galaznik

 

 

 

 

Title:

Senior Vice President and Chief Financial Officer

 

21



 

EXHIBIT A
RELEASE OF CLAIMS

 

FOR AND IN CONSIDERATION OF the benefits to be provided me in connection with the termination of my employment, as set forth in the agreement between me and American Science and Engineering, Inc. (the “Company”) dated as of June 1, 2011 (the “Agreement”), which are conditioned on my signing this Release of Claims and to which I am not otherwise entitled, I, Anthony Fabiano, on my own behalf and on behalf of my heirs, executors, administrators, beneficiaries, representatives and assigns, and all others connected with or claiming through me, hereby release and forever discharge the Company, its subsidiaries and other affiliates and all of their respective past, present and future officers, directors, trustees, shareholders, employees, agents, general and limited partners, members, managers, joint venturers, representatives, successors and assigns, and all others connected with any of them, both individually and in their official capacities, from any and all causes of action, rights or claims of any type or description, known or unknown, which I have had in the past, now have, or might now have, through the date of my signing of this Release of Claims, in any way resulting from, arising out of or connected with my employment by the Company or any of its subsidiaries or other affiliates or the termination of that employment or pursuant to any federal, state or local law, regulation or other requirement (including without limitation, pursuant to Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Americans with Disabilities Act, and the fair employment practices laws of the state or states in which I have been employed by the Company or any of its subsidiaries or other affiliates, each as amended from time to time).

 

Excluded from the scope of this Release of Claims is (i) any claim arising after the effective date of this Release of Claims, including without limitation under the terms of the Agreement, and (ii) any right of indemnification or contribution that I have pursuant to the Articles of Incorporation or By-Laws of the Company or any of its subsidiaries or other affiliates, or under applicable law, and any right under an applicable Directors’ and Officers’ Insurance policy.

 

In signing this Release of Claims, I acknowledge my understanding that I may not sign it prior to the termination of my employment, but that I may consider the terms of this Release of Claims for up to twenty-one (21) days (or such longer period as the Company may specify) from the later of the date my employment with the Company terminates or the date I receive this Release of Claims. I also acknowledge that I am advised by the Company and its subsidiaries and other affiliates to seek the advice of an attorney prior to signing this Release of Claims; that I have had sufficient time to consider this Release of Claims and to consult with an attorney, if I wished to do so, or to consult with any other person of my choosing before signing; and that I am signing this Release of Claims voluntarily and with a full understanding of its terms.

 

I further acknowledge that, in signing this Release of Claims, I have not relied on any promises or representations, express or implied, that are not set forth expressly in the Agreement. I understand that I may revoke this Release of Claims at any time within seven (7) days of the date of my signing by written notice to the Vice President of Human Resources of the Company and that this Release of Claims will take effect only upon the expiration of such seven-day revocation period and only if I have not timely revoked it.

 

Intending to be legally bound, I have signed this Release of Claims under seal as of the Date written below.

 

22



 

Signature:

 

 

 

 

 

Name (please print):

 

 

 

 

 

Date Signed:

 

 

 

23


EX-10.47 3 a11-14447_1ex10d47.htm EX-10.47

Exhibit 10.47

 

[Participant’s Name]

 

American Science & Engineering, Inc.

2005 Equity and Incentive Plan

 

Restricted Stock Award Agreement

 

American Science & Engineering, Inc.

829 Middlesex Turnpike

Billerica, Massachusetts 01821

 

Ladies and Gentlemen:

 

The undersigned (i) acknowledges that he has received an award (the “Award”) of restricted stock from American Science & Engineering, Inc. (the “Company”) under the 2005 Equity & Incentive Plan (the “Plan”), subject to the terms set forth below and in the Plan; (ii) further acknowledges receipt of a copy of each of the Plan as in effect on the date hereof and the most recently issued prospectus with respect to the shares issued under the Plan; and (iii) agrees with the Company as follows:

 

1.               Effective Date.  This Agreement shall take effect as of [Effective Date], which is the date of grant of the Award.

 

2.               Shares Subject to Award.  The Award consists of [# of shares] shares (the “Shares”) of common stock of the Company (“Stock”).  The undersigned’s rights to the Shares are subject to the restrictions described in this Agreement and the Plan (which is incorporated herein by reference with the same effect as if set forth herein in full) in addition to such other restrictions, if any, as may be imposed by law.

 

3.               Meaning of Certain Terms.  Except as otherwise expressly provided, all terms used herein shall have the same meaning as in the Plan.  The term “vest” as used herein with respect to any Share means the lapsing of the restrictions described herein with respect to such Share.

 

4.               Nontransferability of Shares.  The Shares acquired by the undersigned pursuant to this Agreement shall not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of except as provided below and in the Plan.

 

5.               Forfeiture Risk.  If the undersigned ceases to be employed by the Company and its subsidiaries for any reason, including death (except as to the proration provided for in Paragraph 11 below), any then outstanding and unvested Shares acquired by the undersigned hereunder shall be automatically and immediately forfeited.  The undersigned hereby (i) appoints the Company as the attorney-in-fact of the undersigned to take such actions as may be necessary or appropriate to effectuate a transfer of the record ownership of any such shares that are unvested and forfeited hereunder, (ii) agrees to deliver to the Company, as a precondition to the issuance of any certificate or certificates with respect to unvested Shares hereunder, one or more stock powers, endorsed in blank, with respect to such Shares, and (iii) agrees to sign such other powers and take such other actions as the Company may reasonably request to accomplish the transfer or forfeiture of any unvested Shares that are forfeited hereunder.

 

6.               Retention of Certificates.  Any certificates representing unvested Shares shall be held by the Company.  If unvested Shares are held in book entry form, the undersigned agrees that the Company may give stop transfer instructions to the depository to ensure compliance with the provisions hereof.

 

7.               Vesting of Shares; Change of Control.  The Shares acquired hereunder shall vest in [#] equal increments on each anniversary of the grant date.  Notwithstanding the foregoing, no shares shall vest on any vesting date specified above unless the undersigned is then, and since the date of grant has continuously been, employed by the Company or its subsidiaries.  In the event of a Change in Control, the Administrator may require that any amounts delivered, exchanged or otherwise paid in respect of outstanding and then unvested Shares be placed in escrow or otherwise made subject to such restrictions as the Administrator deems appropriate to carry out the intent of the Plan.  References in this

 



 

Agreement to the Shares shall refer, mutatis mutandis, to any such restricted amounts. The term ‘Change in Control’ or ‘Change in Control of the Company’ shall mean the occurrence hereafter of any of the following:

 

(a)          Any Person, other than the Company or an Affiliate, becomes a beneficial owner (within the meaning of Rule 13d-3, as amended, as promulgated under the Securities Exchange Act of 1934, as amended), directly or indirectly, in one or a series of transactions, of securities representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities;

 

(b)         The consummation of a merger or consolidation of the Company with any other Person, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation;

 

(c)          The closing of a sale or other disposition by the Company of all or substantially all of the assets of the Company;

 

(d)         Individuals who constitute the Board of Directors on the date hereof (“Incumbent Directors”) cease for any reason to constitute at least a majority of the board; provided, that any individual who becomes a member of the Board subsequent to the date hereof, whose election or nomination for election was approved by a vote of at least two-thirds of the Incumbent Directors shall be treated as an Incumbent Director unless he or she assumed office as a result of an actual or threatened election contest with respect to the election or removal of directors; or

 

(e)          A complete liquidation or dissolution of the Company;

 

provided, in each case, that such event also constitutes a “change in control event” within the meaning of Treasury Regulation Section 1.409A-3(i)(5).

 

8.               Vesting Upon Death.  If the Participant’s employment is terminated by reason of his or her death, the Shares shall become vested, and the restrictions lifted, on a prorated basis reflecting the percentage of such Shares that was accrued by the Company on its books at the time of the Participant’s death.  In such event, the restrictions will be lifted from such prorated portion of the Shares, and such prorated Shares shall be freely transferable to the person(s) to whom the Participant’s share rights pass by will or by the applicable laws of descent and distribution.

 

9.               Legend.  Any certificates representing unvested Shares shall be held by the Company, and any such certificate shall contain a legend substantially in the following form:

 

THE TRANSFERABILITY OF THIS CERTIFICATE AND THE SHARES OF STOCK REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS (INCLUDING FORFEITURE) OF AMERICAN SCIENCE & ENGINEERING, INC, 2005 EQUITY AND INCENTIVE PLAN AND A RESTRICTED STOCK AWARD AGREEMENT ENTERED INTO BETWEEN THE REGISTERED OWNER AND AMERICAN SCIENCE & ENGINEERING, INC.  COPIES OF SUCH PLAN AND AGREEMENT ARE ON FILE IN THE OFFICES OF AMERICAN SCIENCE & ENGINEERING, INC.

 

As soon as practicable following the vesting of any such Shares the Company shall cause a certificate or certificates covering such Shares, without the aforesaid legend, to be issued and delivered to the undersigned.  If any Shares are held in book-entry form, the Company may take such steps as it deems necessary or appropriate to record and manifest the restrictions applicable to such Shares.

 

10.         Dividends, etc.  The undersigned shall be entitled to (i) receive any and all dividends or other distributions paid with respect to those Shares of which he is the record owner on the record date for such dividend or other distribution, and (ii) vote any Shares of which he is the record owner on the record date for such vote; provided, however, that any property (other than cash) distributed with respect to a share of Stock (the “associated share”) acquired hereunder, including without limitation a distribution of Stock by reason of a stock dividend, stock split or otherwise, or a distribution of other securities with respect to an associated share, shall be subject to the restrictions of this Agreement in the same manner and for so long as the associated share remains subject to such restrictions, and shall be promptly forfeited if and

 

2



 

when the associated share is so forfeited;  and further provided, that the Administrator may require that any cash distribution with respect to the Shares other than a normal cash dividend be placed in escrow or otherwise made subject to such restrictions as the Administrator deems appropriate to carry out the intent of the Plan.  References in this Agreement to the Shares shall refer, mutatis mutandis, to any such restricted amounts.

 

11.         Sale of Vested SharesThe undersigned understands that he will be free to sell any Share once it has vested, subject to (i) satisfaction of any applicable tax withholding requirements with respect to the vesting or transfer of such Share; (ii) the completion of any administrative steps (for example, but without limitation, the transfer of certificates) that the Company may reasonably impose; and (iii) applicable requirements of federal and state securities laws.

 

12.         Certain Tax Matters.  The undersigned expressly acknowledges the following:

 

(a)          The undersigned has been advised to confer promptly with a professional tax advisor to consider whether the undersigned should make a so-called “83(b) election” with respect to the Shares.  Any such election, to be effective, must be made in accordance with applicable regulations and within thirty (30) days following the date of this Award.  The Company has made no recommendation to the undersigned with respect to the advisability of making such an election.

 

(b)         The award or vesting of the Shares acquired hereunder, and the payment of dividends with respect to such Shares, may give rise to “wages” subject to withholding.  The undersigned expressly acknowledges and agrees that his rights hereunder are subject to his promptly paying to the Company in cash (or by such other means as may be acceptable to the Company in its discretion, including, if the Administrator so determines, by the delivery of previously acquired Stock or shares of Stock acquired hereunder or by the withholding of amounts from any payment hereunder) all taxes required to be withheld in connection with such award, vesting or payment.

 

 

 

Very truly yours,

 

 

 

 

 

 

 

 

(Signature of Employee)

 

 

 

Dated:

 

 

 

 

 

 

The foregoing Restricted Stock

 

 

Award Agreement is hereby accepted:

 

 

 

 

 

AMERICAN SCIENCE & ENGINEERING, INC.

 

 

 

 

 

 

 

 

By

 

 

 

 

3


EX-10.48 4 a11-14447_1ex10d48.htm EX-10.48

Exhibit 10.48

 

FOURTH AMENDMENT TO LEASE

 

This FOURTH AMENDMENT TO LEASE (this “Amendment”) is made as of the 18th day of January, 2011 (the “Effective Date”) by and between DIRECT INVEST — 829 MIDDLESEX, LLC; DIRECT INVEST — 829 MIDDLESEX 1, LLC; DIRECT INVEST — 829 MIDDLESEX 2, LLC; DIRECT INVEST — 829 MIDDLESEX 3, LLC; DIRECT INVEST — 829 MIDDLESEX 4, LLC; DIRECT INVEST — 829 MIDDLESEX 5, LLC; DIRECT INVEST — 829 MIDDLESEX 6, LLC; DIRECT INVEST — 829 MIDDLESEX 7, LLC; DIRECT INVEST — 829 MIDDLESEX 8, LLC; DIRECT INVEST — 829 MIDDLESEX 9, LLC; DIRECT INVEST — 829 MIDDLESEX 10, LLC; DIRECT INVEST — 829 MIDDLESEX 11, LLC; DIRECT INVEST — 829 MIDDLESEX 12, LLC; DIRECT INVEST — 829 MIDDLESEX 13, LLC; DIRECT INVEST — 829 MIDDLESEX 14, LLC; DIRECT INVEST — 829 MIDDLESEX 15, LLC; DIRECT INVEST — 829 MIDDLESEX 16, LLC; DIRECT INVEST — 829 MIDDLESEX 17, LLC; and DIRECT INVEST — 829 MIDDLESEX 18, LLC (“Landlord”), and AMERICAN SCIENCE AND ENGINEERING, INC., (“Tenant”).

 

R E C I T A L S

 

A.            The Landlord and Tenant entered into that certain Lease dated January 12, 1995, as amended by that certain First Amendment dated June 11, 1997, that certain Second Amendment to Lease dated December 3, 2004 and that certain Third Amendment to Lease, dated January 1, 2007 (the “Original Lease”), of certain premises consisting of approximately 186,200 rentable square feet of space (the “Premises”) within the building located at 829 Middlesex Turnpike, Billerica, Massachusetts (the “Building”), for a Term that is scheduled to expire on February 29, 2016, as more particularly described in the Original Lease.

 

B.            Landlord and Tenant wish to amend the Original Lease to permit the use by Tenant of certain radioactive materials in connection with Tenant’s operations in the Premises. The Original Lease, as amended by this Amendment, is hereinafter referred to as the “Lease”.

 

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, Landlord and Tenant agree as follows:

 

1      Permitted Use.  Notwithstanding anything to the contrary contained in the Original Lease, Landlord hereby agrees that Tenant may bring onto the Premises certain radioactive materials  (“RAM”) for use in connection with Tenant’s operations at the Premises, subject to all of the terms and conditions of the Original Lease and this Amendment and in compliance with all applicable laws, codes, ordinances and regulations, including without limitation, the Radiation Control Program of the Massachusetts Department of Public Health.  All RAM in the Premises that is not exempt in accordance with applicable laws shall be encapsulated (sealed) and no individual source shall exceed 50 millicurie in strength.

 

2      Surrender of Premises.

 

2.1   Tenant shall cause the Premises to be vacated and surrendered to Landlord on or before the expiration or earlier termination of the Lease in the condition required by Section 6.1.9 of the Lease.  Without limiting the generality of the foregoing description of Tenant’s surrender obligations, Tenant shall complete all RAM Decontamination in accordance with this Section 2 below.  Tenant shall perform the foregoing obligations at Tenant’s sole cost and expense, and in compliance with all federal state and local laws, rules, regulations and ordinances, any decommissioning or decontamination requirements imposed by any licenses or permits maintained by Tenant in connection with the conduct of its business in the Premises, and the terms and conditions of the Original Lease as affected by this Amendment.  Prior to the expiration or earlier termination of this Lease, Tenant shall deliver to Landlord copies of all applicable closure certifications from governmental authorities with jurisdiction over such decommissioning, including, without limitation, Agency Form 120.100-3 from the Radiation Control Program of the Massachusetts Department of Public Health (or equivalent information satisfactory to the Massachusetts Department of Public Health) with respect to any portions of the Premises that have been contaminated with RAM by Tenant or anyone claiming by, through or under Tenant.  If Tenant shall fail to deliver the Premises to Landlord in the condition

 



 

required by this Section 2 as of the last day of the Term, such failure shall constitute a holding over subject to Section 6.1.9 of the Lease until Tenant has surrendered the Premises in accordance with this Section 2.

 

2.2   In connection with Tenant’s surrender of the Premises, Tenant shall perform the following actions prior to the expiration or earlier termination of the Lease (the “RAM Decontamination”).  Tenant will submit the required application for removal of the Premises from Tenant’s license from the Radiation Control Program, undertake the necessary decommissioning activities to be entitled to obtain such removal, report on the activities of Tenant in removing all RAM from the Premises, and obtain and furnish notice of such removal to Landlord.  Tenant shall also confirm that the closeout of the Premises complies with Tenant’s license and all other applicable regulations of the Commonwealth of Massachusetts.

 

3      Ratification.  Except as expressly modified by this Amendment, the Lease shall remain in full force and effect, and as further modified by this Amendment, is expressly ratified and confirmed by the parties hereto.  This Amendment shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns, subject to the provisions of the Lease regarding assignment and subletting.

 

4      Governing Law; Interpretation and Partial Invalidity.  This Amendment shall be governed and construed in accordance with the laws of the Commonwealth of Massachusetts.  If any term of this Amendment, or the application thereof to any person or circumstances, shall to any extent be invalid or unenforceable, the remainder of this Amendment, or the application of such term to persons or circumstances other than those as to which it is invalid or unenforceable, shall not be affected thereby, and each term of this Amendment shall be valid and enforceable to the fullest extent permitted by law.  This Amendment contains all of the agreements of the parties with respect to the subject matter hereof, and supersedes all prior dealings between them with respect to such subject matter.

 

5      Counterparts and Authority. This Amendment may be executed in multiple counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same document.  Landlord and Tenant each warrant to the other that the person or persons executing this Amendment on its behalf has or have authority to do so and that such execution has fully obligated and bound such party to all terms and provisions of this Amendment.

 

IN WITNESS WHEREOF, the undersigned executed this Amendment as of the date and year first written above.

 

 

LANDLORD:

 

DIRECT INVEST PROPERTY MANAGEMENT, L.L.C.,

a Delaware limited liability company, as authorized agent of Landlord

 

 

By:

Direct Invest, L.L.C., a Delaware limited liability company, its Sole Member

 

 

 

 

 

 

 

 

 

By:

NPV DI, L.L.C., a Delaware limited liability company, its Managing Member

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BY:

/s/ William F. Rand III

 

 

 

 

 

Name:

William F. Rand III

 

 

 

 

 

Title:

Manager

 

 

 

 

 

 

 

 

TENANT:

 

 

 

 

 

 

 

AMERICAN SCIENCE AND ENGINEERING, INC.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BY:

/s/ Robert B. Cline

 

 

 

 

Name:

Robert B. Cline

 

 

 

Title:

Sr. Vice President of Operations

 

 

2


EX-21.1 5 a11-14447_1ex21d1.htm EX-21.1

Exhibit 21.1

 

SUBSIDIARIES OF THE REGISTRANT

 

The following are the subsidiaries of American Science and Engineering, Inc. as of March 31, 2011 and the states or jurisdictions in which they are organized.

 

 

 

State or Jurisdiction

Name

 

of Entity

AS&E Global, Inc.

 

Massachusetts

AS&E Mexico Detection Systems S de RL de CV

 

Mexico

AS&E Brasil Sistemas de Deteccao e Segurancca LTDA

 

Brazil

AS&E Europe, B.V.

 

Netherlands

Global International Holding, Inc.

 

Delaware

AS & E (Hong Kong) Limited

 

Hong Kong

AS & E Detection Systems Pte. Ltd.

 

Singapore

 


EX-23.1 6 a11-14447_1ex23d1.htm EX-23.1

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in Registration Statements (Nos. 333-05797,  333-13259, 333-27927, 333-69717, 333-91801, 333-53842, 333-102338, 333-117843, 333-117844, 333-129851, 333-152541, 333-155215 and 333-162291 ) on Form S-8 and (Nos. 033-61903, 333-09151 and 333-89836) on Form S-3 of American Science and Engineering, Inc. and subsidiaries of our report dated June 9, 2011, relating to our audit of the consolidated financial statements and internal control over financial reporting, which appear in this Annual Report on Form 10-K of American Science and Engineering, Inc. and subsidiaries for the year ended March 31, 2011.

 

/s/ McGladrey & Pullen, LLP

 

Boston, Massachusetts

June 9, 2011

 


EX-23.2 7 a11-14447_1ex23d2.htm EX-23.2

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-05797,  333-13259, 333-27927, 333-69717, 333-91801, 333-53842, 333-102338, 333-117843, 333-117844, 333-129851, 333-152541, 333-155215 and 333-162291 ) and Form S-3 (Nos. 033-61903, 333-09151 and 333-89836) of the report of Caturano and Company, P.C. (whose name has since been changed to Caturano and Company, Inc.) dated June 7, 2010 relating to the consolidated financial statements as of and for the two years ended March 31, 2010 of American Science and Engineering, Inc. and subsidiary, which appear in this Annual Report on Form 10-K.

 

/s/ Caturano and Company, Inc.

 

Boston, Massachusetts

June 9, 2011

 


EX-31.1 8 a11-14447_1ex31d1.htm EX-31.1

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Section 302 Certification

 

I, Anthony R. Fabiano, certify that:

 

1.         I have reviewed this annual report on Form 10-K of American Science and Engineering, Inc.;

 

2.                           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)                    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

b)                   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)                    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)                   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)                    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)                   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: June 9, 2011

 

 

/s/ ANTHONY R. FABIANO

 

Anthony R. Fabiano

 

President and Chief Executive Officer

 


EX-31.2 9 a11-14447_1ex31d2.htm EX-31.2

Exhibit 31.2

 

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Section 302 Certification

 

I, Kenneth J. Galaznik, certify that:

 

1.         I have reviewed this annual report on Form 10-K of American Science and Engineering, Inc.;

 

2.                           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.                           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.                           The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)                    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

b)                   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)                    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)                   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.                           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)                    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)                   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: June 9, 2011

 

 

/s/ KENNETH J. GALAZNIK

 

Kenneth J. Galaznik

 

Senior Vice President. Chief Financial Officer and
Treasurer

 


EX-32.1 10 a11-14447_1ex32d1.htm EX-32.1

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, the President and Chief Executive Officer of American Science and Engineering, Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:

 

1.                         the Company’s Annual Report on Form 10-K for the year ended March 31, 2011 (“10-K”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                         the information contained in the Company’s 10-K being filed fairly presents, in all material respects, the financial condition and results of operation of the Company

 

Date: June 9, 2011

 

 

/s/ ANTHONY R. FABIANO

 

Anthony R. Fabiano

 

President and Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to American Science and Engineering, Inc. and will be retained by American Science and Engineering, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 


EX-32.2 11 a11-14447_1ex32d2.htm EX-32.2

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, the Senior Vice President, Chief Financial Officer and Treasurer of American Science and Engineering, Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:

 

1.                    the Company’s Annual Report on Form 10-K for the year ended March 31, 2011(“10-K”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.                    the information contained in the Company’s 10-K being filed fairly presents, in all material respects, the financial condition and results of operation of the Company

 

Date: June 9, 2011

 

 

/s/ KENNETH J. GALAZNIK

 

Kenneth J. Galaznik

 

Senior Vice President, Chief Financial Officer and
Treasurer

 

A signed original of this written statement required by Section 906 has been provided to American Science and Engineering, Inc. and will be retained by American Science and Engineering, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 


GRAPHIC 12 g144471ba05i001.gif GRAPHIC begin 644 g144471ba05i001.gif M1TE&.#EA<`)'`7<`,2'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E`"'Y M!`$`````+"\`"0`>`C`!AP``````````,P``9@``F0``S```_P`S```S,P`S M9@`SF0`SS``S_P!F``!F,P!F9@!FF0!FS`!F_P"9``"9,P"99@"9F0"9S`"9 M_P#,``#,,P#,9@#,F0#,S`#,_P#_``#_,P#_9@#_F0#_S`#__S,``#,`,S,` M9C,`F3,`S#,`_S,S`#,S,S,S9C,SF3,SS#,S_S-F`#-F,S-F9C-FF3-FS#-F M_S.9`#.9,S.99C.9F3.9S#.9_S/,`#/,,S/,9C/,F3/,S#/,_S/_`#/_,S/_ M9C/_F3/_S#/__V8``&8`,V8`9F8`F68`S&8`_V8S`&8S,V8S9F8SF68SS&8S M_V9F`&9F,V9F9F9FF69FS&9F_V:9`&:9,V:99F:9F6:9S&:9_V;,`&;,,V;, M9F;,F6;,S&;,_V;_`&;_,V;_9F;_F6;_S&;__YD``)D`,YD`9ID`F9D`S)D` M_YDS`)DS,YDS9IDSF9DSS)DS_YEF`)EF,YEF9IEFF9EFS)EF_YF9`)F9,YF9 M9IF9F9F9S)F9_YG,`)G,,YG,9IG,F9G,S)G,_YG_`)G_,YG_9IG_F9G_S)G_ M_\P``,P`,\P`9LP`F,&S-^U.A1),-6K4A*#,FR9,M6@E*.G&FR)39!`0+0M-EQ M9=3N7!=DK@>R\+NW ME>`KD!4S=@M3Z$!!5Q+?=-.% M<,6W(87[$<@<4$)Y=Z)REQ4H(4HT7A:`9J8=5!N)``+7X4/6R2>7?]P!!Y]^ M+&H($VD5+G>=>ZNI1^656!)6))%]#=GE7.-UZ)Q<BTFGZ!SSH523MMAHRA\ MB;()V&*`*H13CI,"6N2E6QY$J:*2-IJHJ6O65A%\T'7IEW:+I?_4J)A#*E3D MH#IBBB:DAY+J'9S'S?ECEK-92>RQR"+FZ$-+&KEC<`["^:A0@]9%W4T'";I= M2C@M6B>,LG:X9YN_.2>KVA+,'ZG^G;GFP7ZQ"..:SZ:HE[QM"M6LB=J&5VBDN+8IGV_N,B9: MJM4Y*&.R5:*L\LJZE]B^([(F3:*D>II!2W*Z2U(JNX\+I#:^JR MG8!F_">#>7K:<'STT:HU=J9C73M+)F36++?_96S?@+>WK$(YZ27:P_0&VJ]>FY:* MY^(PZS4>WH`^3)ZYMJH-^4.#B\HFP#+"]W/BL0;*'YY%GDSJJ+WFM#6[CB8!JYFW_\!VPJ^9+5"="5>V"@><$=H(9GS*8:"8>$//M$QFBZ$/Y>@" M(?<9[52"69:>,K-"M]5JB>[J88@P@YF]U6=)<8.>LXCFP;18KXYXI(R>S.,L MNRD&.H>25+]8R#@P128X+CS4>#+4IYX5")&ZJ4T@XY*:$)6.-%EL8W`D5Q]( MDDR3?(03&R]3.ALE)S$@#.0.?V/*)":L+Z/YT"L'-SDFJ?(AE!35L-Y3.N=8 MT9-VFHPL+5FKX3!H2?W)Y7LL$YSIY1$ASXPF;"H9&O\I9$H1TLV5L+D6;DH3 M-MJ3>N6\IS[WR?_/?OK3 M/?G\IT`'2M""&C2@!DVH0A?*4&DBM*$0C:A$)TJEAU+THAC-J$;MN-&.>O2C M('UG2$=*TI(RU*(F3:E*5UI'E++TI3"-*;%<*M.:VO2FK*$I3G?*TYZ61:<^ M#:I0;0K4H1KUJ"8M*E*7RE2-*K6I4(WJ2:5*U:J2]*E6S:I6XSD1<6[UJV!U MYT2D$]:RFE6L2HK899@3'0.U]:QPC2LYSQ43%P+F(0#[8W_DRM>^5O1$>,41 M*J/SQOQXU:^(32Q'@9DP35GK/2/BFV(G2]FU&`2'ZG*,X:A5GT".3#>[(6ME M1]O7KO+12***R2;QT\2TE(BTL/7K1=JH),;_=69KK#W1=5X;V]["52#1@
=KG8%2I#JCO-['HWJUA%"V^_ M2UZFAE>\Y4VO>;$T7O6ZMZ?G3>Y[YPM?]EZ7OOCU:'S!F=_^QG2_9&FO?P=\ MU2S=E\`(GNHV#YS@!A<4P`%VL(0["N'`3OC"&*TP7C',88EJV#\,[K"(V_GA M;([XQ`0ML810S&*!JEAV+8[Q/E4L8!G;F)TO#O&-=PRXL7Y0QSP.,LH,TB>V MG4:+9>.NB87,Y&@*9).J_5AT+R/<8\8$N8@!5;#!*D:\ZS_XFR,MPM-UQC--M9-951%UN([-SBKLHR%_HL:(-[YT+# MAHUOMJR;G_MFQ_AHL[O5LJ'13%A$KYE9SZT3;9=)2NQ,^M.AH<]CD.PWW487 M1ZX$3W3X(YC5BE?2H+XQCA!-ZU:7^FS+.?6J&3EEU\;ZU]8EK&DJ/6HLHX7( ML,XRL&.-$F*_-3O%3I*BV;ML0S=;U(1&TJJWK>=CV]>@#))=N)-=;85>VS/! M'4UHUZWDAAC8H,%=-4S>6NZ5SAO=449,O/?M31J3&X]U9?>_Z]U/;M6ZSD@2 M>+NA2>V"*OQ)!!\I=(>-S68_O-_?+FC`-SZAB&]TUJ/F384X3G*(3WN;`_^E M4+PO3J$F>=S<;0LY:E3.[6N3O-MG\;<^1_[PDOM\W0X3-XQ?SDZ0LY$_=+XX MC'M^:Y3#LT(VW[;*6=[RC7.[YJIM.<*)?KUS4QRT4<^ZR(7N59VKD^1=>ZC#QWM0!\Z>G+\S:I??3=RATM=][UP<%:=YE>7M]A; M?IZI:[W>]_XZB&T.>+T#-.,;Q'O:+8\8V47YWW%W^\_7WG%4LL7GY7;VY^'. M^;\V''!H_[O+]X+S<&K=XHF7>L`?CQNE@SKR@EF\[`=N%[.C[/";AW5VB$^8 MT./^[6EG^J>=G9FUMYXUFBW^NXF%?'[/'IV][KO_N&\_;ZRO?/#,'W#Y\4UX MQG_P,Y=>\'K&#?V.OR;NH46T_8L>(6Y-G>1V9G2/(7#IAU=S$WX<]'JQX7=8 MYWYX=B/EQVVE@6[1EG7[Y'M,!GS!MW+?YQXQ5QKBU%4_MAKA-GK[YVN:5VNU M9AK1UH*(QH+*&Q,"(27A2[[H2Z8 M)6=@IBD/EUS/QW'.QVZ[IH(4J()N2'9H07V;%GLN&'Q>"'MVZ'\RV&%7=G!5 M&$[+<5N`01^W4W:Z97)S_Y,PLV8D..),^;=Q@85[N4=X<*KB5LM_-L\.<6P)4CQ\1)K74AFX9+4+A[E2B' MP#B'+KA[=M@>SL<6/%=L,%A])]A!S^>*0R5]`4:*A,@RUX:(P:<;B:9H;0,: MP?%HN8@OZA9&Z=8W M$X=N_T9DIV0@DH,O4`)G>`&%>RB*>==V$C5RFWAPGT<]E@A;<*=PU;@RU^A< MV3AP%^%'J/5'X=A:`8:'BU>(*N5WZ#B!Z\B/14A:;5B)$:B2[9AEHA:+6CA; MC/]&()U6(+OH6!4HCS&%B2FI?Q')?7E'6?5'DM:H@QI9>WNW'(3%.,AD)-$1 M2'2A9H)'A_2&5`PH:NS7C,9XA4C9?O(FDTN)0_`XDQ!!2H>Q?H;3D[96%@EI M15*EA\`8B,A(&:%U?68EE`^YD2HSB=@(E+FQ7>>1B6"HEAU%BNFXCE/BE-]! MCWQUA7C(AQBIB&G),L8G(7,#F74I(8,XE`-8E$KBFM('_?U?&65BA]3:5*7@YAI&JSI>E128VCI9;T)FG\I MBHUQE%;UC)RI@FH)BXE(1A[$=_JVB)6%DL[9?/(6G<'_F6MR"(VNZ8^PV70> M6!S_D8CI:5/0IG\'AGNVN9#QN8?N89U769Q#)INH`8^P17W#!I[[R)57^):? ML7YQ2'S6:9GFM)EGD9RC59GZ!XJHZ5/2N5;9"!Q_F!L-FFWJI)W8@6V4A6WP MB&WS67Y!%8$(2ISL]:&FZ628AQTZ&*-A=8R_N:%!")TRE:'DB9W&>(A-69MY M)*+(B)9$*E<3QY_,R:0817.:`5U;.7\U*7GV!*&GIY'9%9]):A]U]5(^FF=` MBAY>%XM=ZE#^J4?HEEV)N1DM:5*IR%O"9J/@Z1DV.5!82AF=^9X\970'1HPA M%:9<2J9,N8AG&J)I>A<`BEV1_T>GNE&@B^F;TC6+LS&)!QB7"96G=I&KN`1FJ'JG M'C:CV+>GWD5L_$F?$#6J/\I@7LF9/'@@G8I/Z+6`E8JDWM5L+CJ$;YI04/JH MU4I[G.A<>$E15F)R2\:7H'68R;&-OB6LUP6H*<>C4K8@JE$:.[B(S9J=R.&> M-6)*=.EKC8>BT^JO0SBK_%2KVKJMC=&M]8I'KI$DD74N,:)(2J:JV-&9ARI7 MP'E8Q'J![NJG>%:H=HJK#;6PZ\,8^O%(/3BNA[FFWW6K&!N>]I2M@F>P`7N` MM`FP(__E&MV8&/XH*7(6:512E0BH7'67I.S:3L9*5SHZL\OZ>1^2L,]D);K9 M1`42:-8T>>+Z03;[J@FJEZMFM)*)5UE[I)>*J6J84G^C'[351GR4?4>X8NQU M@!4;5T97FT>;1W4+G$&(F;0IL1F%LZ(B%&O[*C*CG"B;G]Z:7A?[%E^+BBR* M&#L;:E/(MQOE&A381,+FL,KT'8HI7,Q*7AP;&GO)N$5;A@/H3>>YGTY[3^HA M2]JF&2#ZK,@2MHPZIUYUK5VWN).:M.(UG*V6NC,6H;(ANFUI%XUNACI MKO:QM:[EL=^J7:Q*+%[INS@5KT>0K/@^U7RVS=(6KXWQ;+HZ[*-A[\CZ;^YNX/P:U7B&YCD*\$W M58YYB<`=^Z7<*Y]@2[,"&U8/'#CTJ[4R&YG9VWP8G,&Z>Y[$*<+@"L#7(\#J M-;<5_"0A5H?Z5KH@QL`=;%8O?#W3^UY2:KKZ2Z-3K&T]LL!+*[Q-]<&!P[ES MYKF#NA83Z6GT*7+QR2!ZV\*)U<0;I(@@.Z$:K+DNZS!-0GG70<"\^\9,[,-U M!,3N):8V^I(FV,$VJ,1:K%5L[$&<_SI?C5K!YY>$6W>KDYQNA"G>'M+:WE'Q3 MHOQ,3YS)I.Q86%A[_;C#_67)S^3%>CRA=O<[LSRI"GG+/F4LR>;,$^MP%>HAH9B2,"C.0T6YS.0CN5HC/GM/QLS/'W1:=61Z^->&HJBWRZK.%X:S MM[0@`RF2L$O0!VC0C:>R\S=^AQ=V$GB.3(B(V-BM^MS+ZXP:M,F6/>)950N: MN^%/Y+Q0S?\$K&\X>LV)CB2]K#O=TSS]TSL]ER:JR1UF+++D*WX1:&4&=?_T M@:;G3O1W>_GHE2;-B22]/$!MIUK=K4.=>(['CM)8@O+:JRV/68=B?RZUIR8 MHDC8E4K(@E5=USY=TEQ]TJT(>&"MT!FTI#-T[=3UY.]@35GV72\'I2* MV/E1\ST7=_1>]]S9]_Z76_SW=_5 MQM\`OFS_/>"_)N`&'FL%GN"?AN`,/FD+_N"%YN`2?F<17N%H%J[*!]\8KECJ M465@BR37K4T='G'L_!C%=2@P],7E6N($)[)_D;9DYFDN[M^_@V7D&&<&J;DU M;N,WOK9R`EE"TGMBV>,!+E[FH4F=U;,1%B5&3N!IT4:E<1PF2^-/?N#*_!^& M(XDWT2L1R^%7WMX!1LVK0B#Q+,]A#FK=O-QIKN#YW>9<1N%P'F,7/N=D[=YV M'F1UGN"SF%[7N@1_XWGB*[=@;[HC"Y_CLYDAQ[I"4;H ME%[IC7[IFZWHFF[HF=[I&&;IH#[,=QB\HVYCW7Q:A,4L"FQAIT[GCAN>Y3<9 M5WGF9O;J=_X77F8>/$FX;HOK@(T8+,ZS:'VR'`KLP>ZX8!9=C/32O(GL)P;- MJIXA2JT6<0OMZ576:Z6S^=&\V`[H>%%7MA2JF[17%_WMB3Z2#F*Y5PQ#H8WN MGHX`5_PL>7O"`];![_P MHZ7P#E]9#1_QDP7Q%._A^W[Q`$_P&C_P"MCQ[F7Q(,]7$S_RL$].HD].=$]./$I.74 MD[3UC8>-K0V%[WG)4%#_[O&''6U&[%S.XZU'321^Z]>$YE_?]6'O]2;6EF!? MN%Q/]L>N]EM_]FMO]F*/]F[?]G&_]F-_]V4O]W5/]VR?]GAO]WJ/+8`_^'S_ M]X4?^(;/]4@?&G1)M;CAA@08^9`_^4`G^95/^;Z(^=)=JY:?^9?_^9X?^ILO M^EFG^:7/^:;_?Z._^J=/^JK?^JS_^O^7FZ`?^R]Y^YUO^[D/^ZU/^ZZ/^ZD/ M_+7/^[(O_'J,4&TC*9$U=GOO]XC__(3O_-$_]])_^-/?_-2?_=B__7W_K_W= MS_V)[_WA#_[0;_WF7_WH+_[EOV>;&B,S?O,(EO35QR2M-NSPW^]'NNY*,N+W M_U[Y!/,`@4W@0((%#1Y$F%#A0H8-'3Z$&%'B1(H5+5[$F%'C1HX=/7($\%'D M2)(E39Y$F5+E2I8M74(,^5+F3)HU;=[$F5/GRY@[??X$&E3H4*)%$?8TFE3I M4J9-G39%^E3J5*I5K5Z=&!7K5JY=O7[-J17L6+)ES9Z%B5;M6K9MNXIU&U?N M7+HUX=;%FU?OWHMW&[9J91!PQ%:"!!4T?-@GX,`$!T5P;V%K3Z M9JL`OCFS8!&1A2#>APU?$<3"N.7BCI$K9PX=6ZOFRW\2G[[].L3ES;=W%SZ\ M^O'DN]N?A\XB?"/2M/@+?TPE#$*Q/NR$('2E*A)2>\-#PR^1/PM^2D MB_',)>6,K,(X_91S._]^\_//40,KM:!3#4J5N`AM$U)4(AOE3M;#6!13,O^8 MY*Y5FQ0E-3A3?S663#X5L]6GY+3K-540Q9N/4S=AJS0A^8BL5K'@%,7F/4C- M]0U!8VFJULC`VBN,20M9`W7,``3$DEW?EMP5WAMA!;->:._M[%#+]G67S'AQ M=%'@T.Y=L]@Y^4S87WD;EO2]0^5%E-]I`Z/6R^0FW`\V2=/\KZ(XR55043*M MO7719]U<=R8%$PTQ9R-_A7:P(Z/+L.8L<[Y9YT1G[A!D<:>%ULR;BB[ZO)W_ MD;[LYQU?+)'HG*4^>LS,>MUV3\O:^Q)DI2UT=L75).T6H4.+._O#Z-X]"#K` M&";:IZ(A%G%"[[#>4V*4@]I[3[^=\U-$B7D#.-^7"A=OWK\3AS/$#IU^.F>^ M1S9N\H/N'HSM^_5)Y6Y'YFWJ?> M#Y6S/B>CKUXZ,*_X'DF;TG,\J/A#VVK^UAV;RO[5[`>*?\SRUPCL^#)``A:0 M+@(T8`(5N$"O()"!#X1@!)/B0`E6T((7I`D%,;A!_PYV\",:]&`(13A"AX"0 MA"=$(0E-F$(6MM""*W1A#&5H0!C.T(8W/"`.=;A#"-:0AS\$(E=\&$0B%M$I M0S1B$I4H%"0NT8E/M$D3H3A%*JI$BE7$8A8]!-) M#6'`%3O_>01FDP$20Q(YD4,^I)*D:UV$[J([!Q& MLCDB#'53EP'<):0LZ2AV'D9-AE1.,AB?-"7-1G$5:M;4Z3G M(.]+`:MJD;[%*@U%R7/A1-!SK/0<"CE4K%6EJK8<@[RV4O6=(Q$.24>*I?K< M4ZO_0:,9J^3**H!&MB3YS*0GIYE9BHI'2.O4D^N.%QXM.8E%7GW4X+0$J[7V M=6Y5TB>Z*BM6D0"`-]+!+?MT>UO=YC:WJ7H2F8!&VYFEZEOD.PQ_+.H;T6D* MK52;&:;2Y=*?`NQ:F)$3?^`4(9B!"JE(I5N+LFJXKQYMG)-BD7;:8\HT<95K MF$.L8N4[4OJ2M#*@\M1Z00;6P:+56>R+I>E(@C,M%9A[!S9PT#9F.J32K%BI M5%>:I+3>C=/!1AB6^R-^G;K5!*+6,1(!2MKPT:QQJ+RO^\Z MZ(V8NS[!'%5,R;5;G+@[+^GQ-:&O397'?B-7#S5):8U%_UOO]G6IR%A542^2 M4X:?=;3/9;=./$[),[4<&2T[D\NM02OC=$RO6AKDN)25+6++^58$`\?-\LP0 MCNSVK2B'SSJ(6W'Y"@NV+NUH,G)NVD!6-679IGF+4`WJ-8$3U`C%UJYX1EIV M!THAF845;_-BY7'*Y2&>;5)C6"XS9/M%W5W%\J?'>Y39M#G>R)T66_?K)Z`Q MS%.W59?5*\$LK.;+V9!&EEKL^RXG9YOCQK!W([FN9X&OQ.M('>;#^$6:29FV M8EG?;+O.JO#*KAOI=,$6N+<$XT*RH[NZ06A:A!WZKP"W:#_H;I"6LIS[G&[F M%N:XO[IYT$!'VUV-G)D+21*C&A+)B8I+7$/%;T&#:TV`G8]ZK+SM-+LY)!`M M!V2_&2VT>M1CL[F)KD3OK:X%2C&^4B^EHTTI[OH))J.3W=IKBUC<;5X@^)JD MON/:970DM>A>61P^,^HXJTC>S#9G',XVUW:F:397;1K9LV:7.]/_^J2W?M9Y MB+\I@$][OWO>U![[N@]_[X?]^]0%(/6^$OWSB,[]E7O_G7 @-S[VJ:]]ZV??^]O_?O?!/W[QES\DT>=^^L-/_(```#L_ ` end